rank | gene | description | n | cos | n_cos | N_cos | cos_ev | p | q |
---|---|---|---|---|---|---|---|---|---|
1 | A2M | alpha-2-macroglobulin | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2 | A4GALT | alpha 1,4-galactosyltransferase (globotriaosylceramide synthase) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3 | A4GNT | alpha-1,4-N-acetylglucosaminyltransferase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4 | AACS | acetoacetyl-CoA synthetase | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
5 | AATK | apoptosis-associated tyrosine kinase | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
6 | ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
7 | ABCA10 | ATP-binding cassette, sub-family A (ABC1), member 10 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
8 | ABCA12 | ATP-binding cassette, sub-family A (ABC1), member 12 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
9 | ABCA13 | ATP-binding cassette, sub-family A (ABC1), member 13 | 16 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
10 | ABCA3 | ATP-binding cassette, sub-family A (ABC1), member 3 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
11 | ABCA4 | ATP-binding cassette, sub-family A (ABC1), member 4 | 8 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
12 | ABCA5 | ATP-binding cassette, sub-family A (ABC1), member 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
13 | ABCA6 | ATP-binding cassette, sub-family A (ABC1), member 6 | 5 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
14 | ABCA7 | ATP-binding cassette, sub-family A (ABC1), member 7 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
15 | ABCA9 | ATP-binding cassette, sub-family A (ABC1), member 9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
16 | ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | 9 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
17 | ABCB10 | ATP-binding cassette, sub-family B (MDR/TAP), member 10 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
18 | ABCB5 | ATP-binding cassette, sub-family B (MDR/TAP), member 5 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
19 | ABCB6 | ATP-binding cassette, sub-family B (MDR/TAP), member 6 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
20 | ABCB8 | ATP-binding cassette, sub-family B (MDR/TAP), member 8 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
21 | ABCC10 | ATP-binding cassette, sub-family C (CFTR/MRP), member 10 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
22 | ABCC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 11 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
23 | ABCC3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
24 | ABCC4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
25 | ABCC5 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
26 | ABCD2 | ATP-binding cassette, sub-family D (ALD), member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
27 | ABCD4 | ATP-binding cassette, sub-family D (ALD), member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
28 | ABCF2 | ATP-binding cassette, sub-family F (GCN20), member 2 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
29 | ABCF3 | ATP-binding cassette, sub-family F (GCN20), member 3 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
30 | ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
31 | ABHD12B | abhydrolase domain containing 12B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
32 | ABHD2 | abhydrolase domain containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
33 | ABHD3 | abhydrolase domain containing 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
34 | ABHD4 | abhydrolase domain containing 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
35 | ABI1 | abl-interactor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
36 | ABL1 | c-abl oncogene 1, receptor tyrosine kinase | 0 | 25 | 0 | 3,375 | 0 | 1.00 | 1.00 |
37 | ABL2 | v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene) | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
38 | ABLIM1 | actin binding LIM protein 1 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
39 | ABTB2 | ankyrin repeat and BTB (POZ) domain containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
40 | ACACA | acetyl-Coenzyme A carboxylase alpha | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
41 | ACAD9 | acyl-Coenzyme A dehydrogenase family, member 9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
42 | ACADM | acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
43 | ACADS | acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
44 | ACADSB | acyl-Coenzyme A dehydrogenase, short/branched chain | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
45 | ACAP1 | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 | |
46 | ACAT2 | acetyl-Coenzyme A acetyltransferase 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
47 | ACCN1 | amiloride-sensitive cation channel 1, neuronal (degenerin) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
48 | ACCN3 | amiloride-sensitive cation channel 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
49 | ACCS | 1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
50 | ACHE | acetylcholinesterase (Yt blood group) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
51 | ACIN1 | apoptotic chromatin condensation inducer 1 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
52 | ACLY | ATP citrate lyase | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
53 | ACO2 | aconitase 2, mitochondrial | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
54 | ACOT11 | acyl-CoA thioesterase 11 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
55 | ACOX3 | acyl-Coenzyme A oxidase 3, pristanoyl | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
56 | ACP5 | acid phosphatase 5, tartrate resistant | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
57 | ACRBP | acrosin binding protein | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
58 | ACSL4 | acyl-CoA synthetase long-chain family member 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
59 | ACSL5 | acyl-CoA synthetase long-chain family member 5 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
60 | ACSM1 | acyl-CoA synthetase medium-chain family member 1 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
61 | ACSM2B | acyl-CoA synthetase medium-chain family member 2B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
62 | ACSS3 | acyl-CoA synthetase short-chain family member 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
63 | ACTG1 | actin, gamma 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
64 | ACTL9 | 6 | 2 | 0 | 270 | 0 | 1.00 | 1.00 | |
65 | ACTN1 | actinin, alpha 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
66 | ACTR10 | actin-related protein 10 homolog (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
67 | ACTR1A | ARP1 actin-related protein 1 homolog A, centractin alpha (yeast) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
68 | ACTR8 | ARP8 actin-related protein 8 homolog (yeast) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
69 | ACTRT1 | actin-related protein T1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
70 | ACVR1 | activin A receptor, type I | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
71 | ACVR1B | activin A receptor, type IB | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
72 | ACVR1C | activin A receptor, type IC | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
73 | ACVR2A | activin A receptor, type IIA | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
74 | ACVR2B | activin A receptor, type IIB | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
75 | ACVRL1 | activin A receptor type II-like 1 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
76 | ACY1 | aminoacylase 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
77 | ADA | adenosine deaminase | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
78 | ADAM10 | ADAM metallopeptidase domain 10 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
79 | ADAM12 | ADAM metallopeptidase domain 12 (meltrin alpha) | 2 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
80 | ADAM15 | ADAM metallopeptidase domain 15 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
81 | ADAM18 | ADAM metallopeptidase domain 18 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
82 | ADAM19 | ADAM metallopeptidase domain 19 (meltrin beta) | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
83 | ADAM2 | ADAM metallopeptidase domain 2 (fertilin beta) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
84 | ADAM20 | ADAM metallopeptidase domain 20 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
85 | ADAM22 | ADAM metallopeptidase domain 22 | 8 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
86 | ADAM23 | ADAM metallopeptidase domain 23 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
87 | ADAM28 | ADAM metallopeptidase domain 28 | 2 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
88 | ADAM29 | ADAM metallopeptidase domain 29 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
89 | ADAM30 | ADAM metallopeptidase domain 30 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
90 | ADAM32 | ADAM metallopeptidase domain 32 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
91 | ADAM33 | ADAM metallopeptidase domain 33 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
92 | ADAM7 | ADAM metallopeptidase domain 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
93 | ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
94 | ADAMTS10 | ADAM metallopeptidase with thrombospondin type 1 motif, 10 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
95 | ADAMTS12 | ADAM metallopeptidase with thrombospondin type 1 motif, 12 | 20 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
96 | ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
97 | ADAMTS15 | ADAM metallopeptidase with thrombospondin type 1 motif, 15 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
98 | ADAMTS16 | ADAM metallopeptidase with thrombospondin type 1 motif, 16 | 6 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
99 | ADAMTS17 | ADAM metallopeptidase with thrombospondin type 1 motif, 17 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
100 | ADAMTS18 | ADAM metallopeptidase with thrombospondin type 1 motif, 18 | 0 | 11 | 0 | 1,485 | 0 | 1.00 | 1.00 |
101 | ADAMTS19 | ADAM metallopeptidase with thrombospondin type 1 motif, 19 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
102 | ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
103 | ADAMTS20 | ADAM metallopeptidase with thrombospondin type 1 motif, 20 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
104 | ADAMTS3 | ADAM metallopeptidase with thrombospondin type 1 motif, 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
105 | ADAMTS4 | ADAM metallopeptidase with thrombospondin type 1 motif, 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
106 | ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 (aggrecanase-2) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
107 | ADAMTS8 | ADAM metallopeptidase with thrombospondin type 1 motif, 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
108 | ADAMTS9 | ADAM metallopeptidase with thrombospondin type 1 motif, 9 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
109 | ADAMTSL1 | ADAMTS-like 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
110 | ADAMTSL3 | ADAMTS-like 3 | 0 | 12 | 0 | 1,620 | 0 | 1.00 | 1.00 |
111 | ADAR | adenosine deaminase, RNA-specific | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
112 | ADARB2 | adenosine deaminase, RNA-specific, B2 (RED2 homolog rat) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
113 | ADAT3 | adenosine deaminase, tRNA-specific 3, TAD3 homolog (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
114 | ADCY1 | adenylate cyclase 1 (brain) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
115 | ADCY4 | adenylate cyclase 4 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
116 | ADCY8 | adenylate cyclase 8 (brain) | 8 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
117 | ADD3 | adducin 3 (gamma) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
118 | ADH1A | alcohol dehydrogenase 1A (class I), alpha polypeptide | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
119 | ADH6 | alcohol dehydrogenase 6 (class V) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
120 | ADH7 | alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
121 | ADHFE1 | alcohol dehydrogenase, iron containing, 1 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
122 | ADK | adenosine kinase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
123 | ADM | adrenomedullin | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
124 | ADNP2 | ADNP homeobox 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
125 | ADORA1 | adenosine A1 receptor | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
126 | ADORA3 | adenosine A3 receptor | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
127 | ADRA1A | adrenergic, alpha-1A-, receptor | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
128 | ADRBK1 | adrenergic, beta, receptor kinase 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
129 | ADRBK2 | adrenergic, beta, receptor kinase 2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
130 | ADSS | adenylosuccinate synthase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
131 | ADSSL1 | adenylosuccinate synthase like 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
132 | AFF1 | AF4/FMR2 family, member 1 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
133 | AFF3 | AF4/FMR2 family, member 3 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
134 | AFF4 | AF4/FMR2 family, member 4 | 3 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
135 | AGAP2 | 4 | 4 | 0 | 540 | 0 | 1.00 | 1.00 | |
136 | AGAP3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 | |
137 | AGBL5 | ATP/GTP binding protein-like 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
138 | AGER | advanced glycosylation end product-specific receptor | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
139 | AGFG1 | 1 | 5 | 0 | 675 | 0 | 1.00 | 1.00 | |
140 | AGFG2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
141 | AGL | amylo-1, 6-glucosidase, 4-alpha-glucanotransferase (glycogen debranching enzyme, glycogen storage disease type III) | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
142 | AGPAT1 | 1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
143 | AGPS | alkylglycerone phosphate synthase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
144 | AGRN | agrin | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
145 | AGTPBP1 | ATP/GTP binding protein 1 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
146 | AGTR2 | angiotensin II receptor, type 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
147 | AHDC1 | AT hook, DNA binding motif, containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
148 | AHI1 | Abelson helper integration site 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
149 | AHR | aryl hydrocarbon receptor | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
150 | AHRR | aryl-hydrocarbon receptor repressor | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
151 | AHSA2 | AHA1, activator of heat shock 90kDa protein ATPase homolog 2 (yeast) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
152 | AIFM1 | apoptosis-inducing factor, mitochondrion-associated, 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
153 | AIFM2 | apoptosis-inducing factor, mitochondrion-associated, 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
154 | AIFM3 | apoptosis-inducing factor, mitochondrion-associated, 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
155 | AJAP1 | adherens junctions associated protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
156 | AK3L1 | adenylate kinase 3-like 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
157 | AK5 | adenylate kinase 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
158 | AKAP10 | A kinase (PRKA) anchor protein 10 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
159 | AKAP11 | A kinase (PRKA) anchor protein 11 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
160 | AKAP12 | A kinase (PRKA) anchor protein (gravin) 12 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
161 | AKAP13 | A kinase (PRKA) anchor protein 13 | 4 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
162 | AKAP3 | A kinase (PRKA) anchor protein 3 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
163 | AKAP4 | A kinase (PRKA) anchor protein 4 | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
164 | AKAP6 | A kinase (PRKA) anchor protein 6 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
165 | AKAP8 | A kinase (PRKA) anchor protein 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
166 | AKAP9 | A kinase (PRKA) anchor protein (yotiao) 9 | 5 | 10 | 0 | 1,350 | 0 | 1.00 | 1.00 |
167 | AKNA | AT-hook transcription factor | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
168 | AKR7A2 | aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
169 | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
170 | AKT3 | v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
171 | ALDH18A1 | aldehyde dehydrogenase 18 family, member A1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
172 | ALDH1A1 | aldehyde dehydrogenase 1 family, member A1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
173 | ALDH1A2 | aldehyde dehydrogenase 1 family, member A2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
174 | ALDH1A3 | aldehyde dehydrogenase 1 family, member A3 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
175 | ALDH1L1 | aldehyde dehydrogenase 1 family, member L1 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
176 | ALDH2 | aldehyde dehydrogenase 2 family (mitochondrial) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
177 | ALDH3B2 | aldehyde dehydrogenase 3 family, member B2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
178 | ALDH7A1 | aldehyde dehydrogenase 7 family, member A1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
179 | ALDOA | aldolase A, fructose-bisphosphate | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
180 | ALDOB | aldolase B, fructose-bisphosphate | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
181 | ALG13 | asparagine-linked glycosylation 13 homolog (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
182 | ALK | anaplastic lymphoma receptor tyrosine kinase | 6 | 25 | 0 | 3,375 | 0 | 1.00 | 1.00 |
183 | ALKBH1 | alkB, alkylation repair homolog 1 (E. coli) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
184 | ALMS1 | Alstrom syndrome 1 | 10 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
185 | ALOX12 | arachidonate 12-lipoxygenase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
186 | ALOX15 | arachidonate 15-lipoxygenase | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
187 | ALOXE3 | arachidonate lipoxygenase 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
188 | ALPI | alkaline phosphatase, intestinal | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
189 | ALPK1 | alpha-kinase 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
190 | ALPK2 | alpha-kinase 2 | 10 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
191 | ALPK3 | alpha-kinase 3 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
192 | ALPL | alkaline phosphatase, liver/bone/kidney | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
193 | ALS2 | amyotrophic lateral sclerosis 2 (juvenile) | 1 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
194 | ALS2CL | ALS2 C-terminal like | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
195 | ALS2CR11 | amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 11 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
196 | ALS2CR12 | amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
197 | AMDHD1 | amidohydrolase domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
198 | AMDHD2 | amidohydrolase domain containing 2 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
199 | AMFR | autocrine motility factor receptor | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
200 | AMMECR1L | AMME chromosomal region gene 1-like | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
201 | AMPD1 | adenosine monophosphate deaminase 1 (isoform M) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
202 | AMPD2 | adenosine monophosphate deaminase 2 (isoform L) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
203 | AMPD3 | adenosine monophosphate deaminase (isoform E) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
204 | AMTN | amelotin | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
205 | ANAPC13 | anaphase promoting complex subunit 13 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
206 | ANAPC4 | anaphase promoting complex subunit 4 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
207 | ANAPC5 | anaphase promoting complex subunit 5 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
208 | ANGEL1 | angel homolog 1 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
209 | ANK1 | ankyrin 1, erythrocytic | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
210 | ANK2 | ankyrin 2, neuronal | 0 | 10 | 0 | 1,350 | 0 | 1.00 | 1.00 |
211 | ANK3 | ankyrin 3, node of Ranvier (ankyrin G) | 6 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
212 | ANKHD1 | ankyrin repeat and KH domain containing 1 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
213 | ANKK1 | ankyrin repeat and kinase domain containing 1 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
214 | ANKMY1 | ankyrin repeat and MYND domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
215 | ANKMY2 | ankyrin repeat and MYND domain containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
216 | ANKRD10 | ankyrin repeat domain 10 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
217 | ANKRD11 | ankyrin repeat domain 11 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
218 | ANKRD12 | ankyrin repeat domain 12 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
219 | ANKRD17 | ankyrin repeat domain 17 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
220 | ANKRD18A | ankyrin repeat domain 18A | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
221 | ANKRD26 | ankyrin repeat domain 26 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
222 | ANKRD29 | ankyrin repeat domain 29 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
223 | ANKRD30A | ankyrin repeat domain 30A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
224 | ANKRD44 | ankyrin repeat domain 44 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
225 | ANKRD49 | ankyrin repeat domain 49 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
226 | ANKRD5 | ankyrin repeat domain 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
227 | ANKRD50 | ankyrin repeat domain 50 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
228 | ANLN | anillin, actin binding protein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
229 | ANO2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
230 | ANO3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
231 | ANO5 | 10 | 3 | 0 | 405 | 0 | 1.00 | 1.00 | |
232 | ANO7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
233 | ANO9 | 3 | 3 | 0 | 405 | 0 | 1.00 | 1.00 | |
234 | ANP32D | acidic (leucine-rich) nuclear phosphoprotein 32 family, member D | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
235 | ANXA1 | annexin A1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
236 | ANXA7 | annexin A7 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
237 | ANXA8 | annexin A8 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
238 | AOC3 | amine oxidase, copper containing 3 (vascular adhesion protein 1) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
239 | AP1M1 | adaptor-related protein complex 1, mu 1 subunit | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
240 | AP3B1 | adaptor-related protein complex 3, beta 1 subunit | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
241 | APAF1 | apoptotic peptidase activating factor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
242 | APBA1 | amyloid beta (A4) precursor protein-binding, family A, member 1 (X11) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
243 | APBB1IP | amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
244 | APC | adenomatous polyposis coli | 7 | 842 | 0 | 113,670 | 0 | 1.00 | 1.00 |
245 | APC2 | adenomatosis polyposis coli 2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
246 | APCS | amyloid P component, serum | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
247 | API5 | apoptosis inhibitor 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
248 | APOB | apolipoprotein B (including Ag(x) antigen) | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
249 | APOBEC3G | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
250 | APOBEC3H | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
251 | APOC4 | apolipoprotein C-IV | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
252 | APOL1 | apolipoprotein L, 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
253 | APPL1 | adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
254 | AQP10 | aquaporin 10 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
255 | AQP8 | aquaporin 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
256 | AR | androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
257 | ARAF | v-raf murine sarcoma 3611 viral oncogene homolog | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
258 | ARAP3 | 2 | 4 | 0 | 540 | 0 | 1.00 | 1.00 | |
259 | ARFGAP3 | ADP-ribosylation factor GTPase activating protein 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
260 | ARFGEF1 | ADP-ribosylation factor guanine nucleotide-exchange factor 1(brefeldin A-inhibited) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
261 | ARFGEF2 | ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
262 | ARFRP1 | ADP-ribosylation factor related protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
263 | ARGFX | arginine-fifty homeobox | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
264 | ARHGAP1 | Rho GTPase activating protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
265 | ARHGAP10 | Rho GTPase activating protein 10 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
266 | ARHGAP11A | Rho GTPase activating protein 11A | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
267 | ARHGAP20 | Rho GTPase activating protein 20 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
268 | ARHGAP23 | Rho GTPase activating protein 23 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
269 | ARHGAP29 | Rho GTPase activating protein 29 | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
270 | ARHGAP32 | 3 | 3 | 0 | 405 | 0 | 1.00 | 1.00 | |
271 | ARHGAP33 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
272 | ARHGAP4 | Rho GTPase activating protein 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
273 | ARHGAP5 | Rho GTPase activating protein 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
274 | ARHGAP6 | Rho GTPase activating protein 6 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
275 | ARHGAP9 | Rho GTPase activating protein 9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
276 | ARHGDIG | Rho GDP dissociation inhibitor (GDI) gamma | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
277 | ARHGEF1 | Rho guanine nucleotide exchange factor (GEF) 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
278 | ARHGEF10L | Rho guanine nucleotide exchange factor (GEF) 10-like | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
279 | ARHGEF11 | Rho guanine nucleotide exchange factor (GEF) 11 | 7 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
280 | ARHGEF19 | Rho guanine nucleotide exchange factor (GEF) 19 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
281 | ARHGEF4 | Rho guanine nucleotide exchange factor (GEF) 4 | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
282 | ARHGEF7 | Rho guanine nucleotide exchange factor (GEF) 7 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
283 | ARHGEF9 | Cdc42 guanine nucleotide exchange factor (GEF) 9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
284 | ARID1A | AT rich interactive domain 1A (SWI-like) | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
285 | ARID1B | AT rich interactive domain 1B (SWI1-like) | 5 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
286 | ARID2 | AT rich interactive domain 2 (ARID, RFX-like) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
287 | ARID4A | AT rich interactive domain 4A (RBP1-like) | 5 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
288 | ARID4B | AT rich interactive domain 4B (RBP1-like) | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
289 | ARL1 | ADP-ribosylation factor-like 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
290 | ARL4C | ADP-ribosylation factor-like 4C | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
291 | ARMCX3 | armadillo repeat containing, X-linked 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
292 | ARNT | aryl hydrocarbon receptor nuclear translocator | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
293 | ARNT2 | aryl-hydrocarbon receptor nuclear translocator 2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
294 | ARR3 | arrestin 3, retinal (X-arrestin) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
295 | ARSA | arylsulfatase A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
296 | ARSE | arylsulfatase E (chondrodysplasia punctata 1) | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
297 | ARSH | arylsulfatase family, member H | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
298 | ARV1 | ARV1 homolog (S. cerevisiae) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
299 | ASAP3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
300 | ASB11 | ankyrin repeat and SOCS box-containing 11 | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
301 | ASB15 | ankyrin repeat and SOCS box-containing 15 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
302 | ASB16 | ankyrin repeat and SOCS box-containing 16 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
303 | ASB4 | ankyrin repeat and SOCS box-containing 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
304 | ASB8 | ankyrin repeat and SOCS box-containing 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
305 | ASCL4 | achaete-scute complex homolog 4 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
306 | ASGR1 | asialoglycoprotein receptor 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
307 | ASH1L | ash1 (absent, small, or homeotic)-like (Drosophila) | 5 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
308 | ASH2L | ash2 (absent, small, or homeotic)-like (Drosophila) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
309 | ASIP | agouti signaling protein, nonagouti homolog (mouse) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
310 | ASL | argininosuccinate lyase | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
311 | ASMT | acetylserotonin O-methyltransferase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
312 | ASPM | asp (abnormal spindle) homolog, microcephaly associated (Drosophila) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
313 | ASTN1 | astrotactin 1 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
314 | ASTN2 | astrotactin 2 | 10 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
315 | ASXL1 | additional sex combs like 1 (Drosophila) | 6 | 27 | 0 | 3,645 | 0 | 1.00 | 1.00 |
316 | ASZ1 | ankyrin repeat, SAM and basic leucine zipper domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
317 | ATAD1 | ATPase family, AAA domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
318 | ATAD2B | ATPase family, AAA domain containing 2B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
319 | ATF2 | activating transcription factor 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
320 | ATF7IP | activating transcription factor 7 interacting protein | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
321 | ATG5 | ATG5 autophagy related 5 homolog (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
322 | ATG7 | ATG7 autophagy related 7 homolog (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
323 | ATG9A | ATG9 autophagy related 9 homolog A (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
324 | ATHL1 | ATH1, acid trehalase-like 1 (yeast) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
325 | ATL1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
326 | ATL2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
327 | ATM | ataxia telangiectasia mutated | 4 | 247 | 0 | 33,345 | 0 | 1.00 | 1.00 |
328 | ATP10B | ATPase, class V, type 10B | 10 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
329 | ATP11C | ATPase, class VI, type 11C | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
330 | ATP12A | ATPase, H+/K+ transporting, nongastric, alpha polypeptide | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
331 | ATP13A1 | ATPase type 13A1 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
332 | ATP13A2 | ATPase type 13A2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
333 | ATP1A2 | ATPase, Na+/K+ transporting, alpha 2 (+) polypeptide | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
334 | ATP1B4 | ATPase, (Na+)/K+ transporting, beta 4 polypeptide | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
335 | ATP2A1 | ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
336 | ATP2A3 | ATPase, Ca++ transporting, ubiquitous | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
337 | ATP2B1 | ATPase, Ca++ transporting, plasma membrane 1 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
338 | ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
339 | ATP2C1 | ATPase, Ca++ transporting, type 2C, member 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
340 | ATP2C2 | ATPase, Ca++ transporting, type 2C, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
341 | ATP6V0B | ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
342 | ATP6V1E1 | ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
343 | ATP6V1G3 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
344 | ATP7B | ATPase, Cu++ transporting, beta polypeptide | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
345 | ATP8A1 | ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 | 5 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
346 | ATP8B1 | ATPase, class I, type 8B, member 1 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
347 | ATR | ataxia telangiectasia and Rad3 related | 0 | 17 | 0 | 2,295 | 0 | 1.00 | 1.00 |
348 | ATRN | attractin | 3 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
349 | ATRNL1 | attractin-like 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
350 | ATRX | alpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
351 | ATXN1 | ataxin 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
352 | ATXN3L | ataxin 3-like | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
353 | AURKA | aurora kinase A | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
354 | AURKB | aurora kinase B | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
355 | AURKC | aurora kinase C | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
356 | AUTS2 | autism susceptibility candidate 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
357 | AVEN | apoptosis, caspase activation inhibitor | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
358 | AVIL | advillin | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
359 | AVPI1 | arginine vasopressin-induced 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
360 | AVPR2 | arginine vasopressin receptor 2 (nephrogenic diabetes insipidus) | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
361 | AXIN2 | axin 2 (conductin, axil) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
362 | AXL | AXL receptor tyrosine kinase | 0 | 8 | 0 | 1,080 | 0 | 1.00 | 1.00 |
363 | AZGP1 | alpha-2-glycoprotein 1, zinc-binding | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
364 | AZI1 | 5-azacytidine induced 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
365 | B3GALNT2 | beta-1,3-N-acetylgalactosaminyltransferase 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
366 | B4GALNT2 | beta-1,4-N-acetyl-galactosaminyl transferase 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
367 | BAAT | bile acid Coenzyme A: amino acid N-acyltransferase (glycine N-choloyltransferase) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
368 | BACH2 | BTB and CNC homology 1, basic leucine zipper transcription factor 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
369 | BAD | BCL2-antagonist of cell death | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
370 | BAI1 | brain-specific angiogenesis inhibitor 1 | 5 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
371 | BAI2 | brain-specific angiogenesis inhibitor 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
372 | BAI3 | brain-specific angiogenesis inhibitor 3 | 0 | 11 | 0 | 1,485 | 0 | 1.00 | 1.00 |
373 | BAMBI | BMP and activin membrane-bound inhibitor homolog (Xenopus laevis) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
374 | BAP1 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
375 | BARD1 | BRCA1 associated RING domain 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
376 | BAT2 | HLA-B associated transcript 2 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
377 | BAT3 | HLA-B associated transcript 3 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
378 | BAX | BCL2-associated X protein | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
379 | BAZ1A | bromodomain adjacent to zinc finger domain, 1A | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
380 | BAZ1B | bromodomain adjacent to zinc finger domain, 1B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
381 | BBS9 | Bardet-Biedl syndrome 9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
382 | BCAR1 | breast cancer anti-estrogen resistance 1 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
383 | BCAR3 | breast cancer anti-estrogen resistance 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
384 | BCAS1 | breast carcinoma amplified sequence 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
385 | BCAS2 | breast carcinoma amplified sequence 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
386 | BCAS3 | breast carcinoma amplified sequence 3 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
387 | BCCIP | BRCA2 and CDKN1A interacting protein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
388 | BCL11A | B-cell CLL/lymphoma 11A (zinc finger protein) | 0 | 8 | 0 | 1,080 | 0 | 1.00 | 1.00 |
389 | BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | 0 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 |
390 | BCL2 | B-cell CLL/lymphoma 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
391 | BCL2L12 | BCL2-like 12 (proline rich) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
392 | BCL2L13 | BCL2-like 13 (apoptosis facilitator) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
393 | BCL2L14 | BCL2-like 14 (apoptosis facilitator) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
394 | BCL2L2 | BCL2-like 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
395 | BCL3 | B-cell CLL/lymphoma 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
396 | BCL6 | B-cell CLL/lymphoma 6 (zinc finger protein 51) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
397 | BCL6B | B-cell CLL/lymphoma 6, member B (zinc finger protein) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
398 | BCOR | BCL6 co-repressor | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
399 | BCORL1 | BCL6 co-repressor-like 1 | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
400 | BCR | breakpoint cluster region | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
401 | BDKRB2 | bradykinin receptor B2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
402 | BEND2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
403 | BEND7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
404 | BEST1 | bestrophin 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
405 | BEX4 | BEX family member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
406 | BEX5 | BEX family member 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
407 | BFSP1 | beaded filament structural protein 1, filensin | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
408 | BGN | biglycan | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
409 | BICC1 | bicaudal C homolog 1 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
410 | BICD1 | bicaudal D homolog 1 (Drosophila) | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
411 | BICD2 | bicaudal D homolog 2 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
412 | BIN1 | bridging integrator 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
413 | BIRC3 | baculoviral IAP repeat-containing 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
414 | BIRC5 | baculoviral IAP repeat-containing 5 (survivin) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
415 | BIRC6 | baculoviral IAP repeat-containing 6 (apollon) | 10 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
416 | BIRC7 | baculoviral IAP repeat-containing 7 (livin) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
417 | BIRC8 | baculoviral IAP repeat-containing 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
418 | BLK | B lymphoid tyrosine kinase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
419 | BMP1 | bone morphogenetic protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
420 | BMP2K | BMP2 inducible kinase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
421 | BMP3 | bone morphogenetic protein 3 (osteogenic) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
422 | BMP6 | bone morphogenetic protein 6 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
423 | BMPER | BMP binding endothelial regulator | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
424 | BMPR1A | bone morphogenetic protein receptor, type IA | 2 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
425 | BMPR1B | bone morphogenetic protein receptor, type IB | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
426 | BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
427 | BMX | BMX non-receptor tyrosine kinase | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
428 | BNC2 | basonuclin 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
429 | BNIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
430 | BOC | Boc homolog (mouse) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
431 | BPIL1 | bactericidal/permeability-increasing protein-like 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
432 | BRAF | v-raf murine sarcoma viral oncogene homolog B1 | 4 | 102 | 0 | 13,770 | 0 | 1.00 | 1.00 |
433 | BRCA1 | breast cancer 1, early onset | 5 | 39 | 0 | 5,265 | 0 | 1.00 | 1.00 |
434 | BRCA2 | breast cancer 2, early onset | 0 | 61 | 0 | 8,235 | 0 | 1.00 | 1.00 |
435 | BRCC3 | BRCA1/BRCA2-containing complex, subunit 3 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
436 | BRD3 | bromodomain containing 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
437 | BRDT | bromodomain, testis-specific | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
438 | BRE | brain and reproductive organ-expressed (TNFRSF1A modulator) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
439 | BRF1 | BRF1 homolog, subunit of RNA polymerase III transcription initiation factor IIIB (S. cerevisiae) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
440 | BRMS1L | breast cancer metastasis-suppressor 1-like | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
441 | BRP44L | brain protein 44-like | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
442 | BRPF1 | bromodomain and PHD finger containing, 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
443 | BRSK1 | BR serine/threonine kinase 1 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
444 | BSDC1 | BSD domain containing 1 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
445 | BSN | bassoon (presynaptic cytomatrix protein) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
446 | BST1 | bone marrow stromal cell antigen 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
447 | BTAF1 | BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
448 | BTBD1 | BTB (POZ) domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
449 | BTBD3 | BTB (POZ) domain containing 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
450 | BTC | betacellulin | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
451 | BTG2 | BTG family, member 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
452 | BTK | Bruton agammaglobulinemia tyrosine kinase | 2 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
453 | BTNL2 | butyrophilin-like 2 (MHC class II associated) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
454 | BTNL9 | butyrophilin-like 9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
455 | BUB1 | BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
456 | BUB1B | BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
457 | BUD13 | BUD13 homolog (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
458 | C10orf128 | chromosome 10 open reading frame 128 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
459 | C10orf137 | chromosome 10 open reading frame 137 | 3 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
460 | C10orf18 | chromosome 10 open reading frame 18 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
461 | C10orf26 | chromosome 10 open reading frame 26 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
462 | C10orf47 | chromosome 10 open reading frame 47 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
463 | C10orf54 | chromosome 10 open reading frame 54 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
464 | C10orf72 | chromosome 10 open reading frame 72 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
465 | C10orf81 | chromosome 10 open reading frame 81 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
466 | C11orf30 | chromosome 11 open reading frame 30 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
467 | C11orf57 | chromosome 11 open reading frame 57 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
468 | C11orf92 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 | |
469 | C12orf11 | chromosome 12 open reading frame 11 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
470 | C12orf12 | chromosome 12 open reading frame 12 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
471 | C12orf42 | chromosome 12 open reading frame 42 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
472 | C12orf5 | chromosome 12 open reading frame 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
473 | C12orf60 | chromosome 12 open reading frame 60 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
474 | C12orf68 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
475 | C12orf76 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
476 | C13orf28 | chromosome 13 open reading frame 28 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
477 | C14orf101 | chromosome 14 open reading frame 101 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
478 | C14orf102 | chromosome 14 open reading frame 102 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
479 | C14orf115 | chromosome 14 open reading frame 115 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
480 | C14orf145 | chromosome 14 open reading frame 145 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
481 | C14orf159 | chromosome 14 open reading frame 159 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
482 | C14orf21 | chromosome 14 open reading frame 21 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
483 | C14orf38 | chromosome 14 open reading frame 38 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
484 | C14orf43 | chromosome 14 open reading frame 43 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
485 | C14orf49 | chromosome 14 open reading frame 49 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
486 | C15orf2 | chromosome 15 open reading frame 2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
487 | C15orf52 | chromosome 15 open reading frame 52 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
488 | C15orf55 | chromosome 15 open reading frame 55 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
489 | C16orf58 | chromosome 16 open reading frame 58 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
490 | C16orf72 | chromosome 16 open reading frame 72 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
491 | C16orf78 | chromosome 16 open reading frame 78 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
492 | C16orf79 | chromosome 16 open reading frame 79 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
493 | C17orf57 | chromosome 17 open reading frame 57 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
494 | C17orf66 | chromosome 17 open reading frame 66 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
495 | C17orf68 | chromosome 17 open reading frame 68 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
496 | C18orf1 | chromosome 18 open reading frame 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
497 | C18orf19 | chromosome 18 open reading frame 19 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
498 | C18orf25 | chromosome 18 open reading frame 25 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
499 | C19orf2 | chromosome 19 open reading frame 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
500 | C19orf6 | chromosome 19 open reading frame 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
501 | C1QB | complement component 1, q subcomponent, B chain | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
502 | C1orf101 | chromosome 1 open reading frame 101 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
503 | C1orf107 | chromosome 1 open reading frame 107 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
504 | C1orf116 | chromosome 1 open reading frame 116 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
505 | C1orf131 | chromosome 1 open reading frame 131 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
506 | C1orf151 | chromosome 1 open reading frame 151 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
507 | C1orf158 | chromosome 1 open reading frame 158 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
508 | C1orf172 | chromosome 1 open reading frame 172 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
509 | C1orf173 | chromosome 1 open reading frame 173 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
510 | C1orf175 | chromosome 1 open reading frame 175 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
511 | C1orf201 | chromosome 1 open reading frame 201 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
512 | C1orf55 | chromosome 1 open reading frame 55 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
513 | C1orf59 | chromosome 1 open reading frame 59 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
514 | C1orf64 | chromosome 1 open reading frame 64 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
515 | C1orf65 | chromosome 1 open reading frame 65 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
516 | C1orf68 | chromosome 1 open reading frame 68 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
517 | C1orf87 | chromosome 1 open reading frame 87 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
518 | C1orf93 | chromosome 1 open reading frame 93 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
519 | C20orf103 | chromosome 20 open reading frame 103 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
520 | C20orf114 | chromosome 20 open reading frame 114 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
521 | C20orf160 | chromosome 20 open reading frame 160 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
522 | C20orf177 | chromosome 20 open reading frame 177 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
523 | C21orf29 | chromosome 21 open reading frame 29 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
524 | C22orf24 | chromosome 22 open reading frame 24 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
525 | C2orf29 | chromosome 2 open reading frame 29 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
526 | C2orf3 | chromosome 2 open reading frame 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
527 | C2orf44 | chromosome 2 open reading frame 44 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
528 | C2orf56 | chromosome 2 open reading frame 56 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
529 | C2orf68 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
530 | C3orf14 | chromosome 3 open reading frame 14 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
531 | C3orf26 | chromosome 3 open reading frame 26 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
532 | C3orf35 | chromosome 3 open reading frame 35 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
533 | C3orf63 | chromosome 3 open reading frame 63 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
534 | C4BPA | complement component 4 binding protein, alpha | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
535 | C4orf14 | chromosome 4 open reading frame 14 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
536 | C4orf49 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
537 | C4orf50 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
538 | C4orf7 | chromosome 4 open reading frame 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
539 | C5AR1 | complement component 5a receptor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
540 | C5orf34 | chromosome 5 open reading frame 34 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
541 | C6 | complement component 6 | 11 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
542 | C6orf103 | chromosome 6 open reading frame 103 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
543 | C6orf145 | chromosome 6 open reading frame 145 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
544 | C6orf150 | chromosome 6 open reading frame 150 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
545 | C6orf165 | chromosome 6 open reading frame 165 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
546 | C6orf168 | chromosome 6 open reading frame 168 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
547 | C6orf170 | chromosome 6 open reading frame 170 | 3 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
548 | C6orf204 | chromosome 6 open reading frame 204 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
549 | C7orf11 | chromosome 7 open reading frame 11 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
550 | C7orf16 | chromosome 7 open reading frame 16 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
551 | C7orf49 | chromosome 7 open reading frame 49 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
552 | C8A | complement component 8, alpha polypeptide | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
553 | C8B | complement component 8, beta polypeptide | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
554 | C8orf34 | chromosome 8 open reading frame 34 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
555 | C8orf80 | chromosome 8 open reading frame 80 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
556 | C9orf11 | chromosome 9 open reading frame 11 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
557 | C9orf171 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
558 | C9orf5 | chromosome 9 open reading frame 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
559 | C9orf50 | chromosome 9 open reading frame 50 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
560 | C9orf66 | chromosome 9 open reading frame 66 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
561 | C9orf72 | chromosome 9 open reading frame 72 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
562 | C9orf96 | chromosome 9 open reading frame 96 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
563 | CA2 | carbonic anhydrase II | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
564 | CAB39 | calcium binding protein 39 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
565 | CABIN1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
566 | CABP1 | calcium binding protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
567 | CACNA1E | calcium channel, voltage-dependent, R type, alpha 1E subunit | 14 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
568 | CACNA1F | calcium channel, voltage-dependent, L type, alpha 1F subunit | 3 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
569 | CACNA1I | calcium channel, voltage-dependent, T type, alpha 1I subunit | 7 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
570 | CACNA1S | calcium channel, voltage-dependent, L type, alpha 1S subunit | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
571 | CACNA2D2 | calcium channel, voltage-dependent, alpha 2/delta subunit 2 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
572 | CACNA2D3 | calcium channel, voltage-dependent, alpha 2/delta subunit 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
573 | CACNB1 | calcium channel, voltage-dependent, beta 1 subunit | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
574 | CACNB2 | calcium channel, voltage-dependent, beta 2 subunit | 3 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
575 | CACNG4 | calcium channel, voltage-dependent, gamma subunit 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
576 | CAD | carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | 2 | 8 | 0 | 1,080 | 0 | 1.00 | 1.00 |
577 | CADM2 | cell adhesion molecule 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
578 | CADPS | Ca2+-dependent secretion activator | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
579 | CALCA | calcitonin-related polypeptide alpha | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
580 | CALCR | calcitonin receptor | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
581 | CALM1 | calmodulin 1 (phosphorylase kinase, delta) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
582 | CAMK1 | calcium/calmodulin-dependent protein kinase I | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
583 | CAMK1G | calcium/calmodulin-dependent protein kinase IG | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
584 | CAMK2A | calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
585 | CAMK2B | calcium/calmodulin-dependent protein kinase (CaM kinase) II beta | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
586 | CAMK2G | calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
587 | CAMK4 | calcium/calmodulin-dependent protein kinase IV | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
588 | CAMKK2 | calcium/calmodulin-dependent protein kinase kinase 2, beta | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
589 | CAMKV | CaM kinase-like vesicle-associated | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
590 | CAMSAP1 | calmodulin regulated spectrin-associated protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
591 | CAMSAP1L1 | calmodulin regulated spectrin-associated protein 1-like 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
592 | CAMTA1 | calmodulin binding transcription activator 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
593 | CAPN10 | calpain 10 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
594 | CAPN12 | calpain 12 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
595 | CAPN3 | calpain 3, (p94) | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
596 | CAPN6 | calpain 6 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
597 | CAPZA3 | capping protein (actin filament) muscle Z-line, alpha 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
598 | CARD10 | caspase recruitment domain family, member 10 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
599 | CARD11 | caspase recruitment domain family, member 11 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
600 | CARD14 | caspase recruitment domain family, member 14 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
601 | CARD18 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
602 | CARD6 | caspase recruitment domain family, member 6 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
603 | CARD9 | caspase recruitment domain family, member 9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
604 | CARKD | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
605 | CASC5 | cancer susceptibility candidate 5 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
606 | CASK | calcium/calmodulin-dependent serine protein kinase (MAGUK family) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
607 | CASP10 | caspase 10, apoptosis-related cysteine peptidase | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
608 | CASP14 | caspase 14, apoptosis-related cysteine peptidase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
609 | CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
610 | CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
611 | CASP5 | caspase 5, apoptosis-related cysteine peptidase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
612 | CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
613 | CASQ1 | calsequestrin 1 (fast-twitch, skeletal muscle) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
614 | CAST | calpastatin | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
615 | CBFA2T3 | core-binding factor, runt domain, alpha subunit 2; translocated to, 3 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
616 | CBFB | core-binding factor, beta subunit | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
617 | CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0 | 42 | 0 | 5,670 | 0 | 1.00 | 1.00 |
618 | CBLB | Cas-Br-M (murine) ecotropic retroviral transforming sequence b | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
619 | CBLL1 | Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
620 | CCAR1 | cell division cycle and apoptosis regulator 1 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
621 | CCDC102B | coiled-coil domain containing 102B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
622 | CCDC111 | coiled-coil domain containing 111 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
623 | CCDC135 | coiled-coil domain containing 135 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
624 | CCDC144B | coiled-coil domain containing 144B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
625 | CCDC15 | coiled-coil domain containing 15 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
626 | CCDC157 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
627 | CCDC160 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
628 | CCDC22 | coiled-coil domain containing 22 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
629 | CCDC62 | coiled-coil domain containing 62 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
630 | CCDC91 | coiled-coil domain containing 91 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
631 | CCDC93 | coiled-coil domain containing 93 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
632 | CCK | cholecystokinin | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
633 | CCNA1 | cyclin A1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
634 | CCNB3 | cyclin B3 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
635 | CCND2 | cyclin D2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
636 | CCNE1 | cyclin E1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
637 | CCNF | cyclin F | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
638 | CCNG1 | cyclin G1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
639 | CCNG2 | cyclin G2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
640 | CCNH | cyclin H | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
641 | CCNL1 | cyclin L1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
642 | CCNL2 | cyclin L2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
643 | CCNT1 | cyclin T1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
644 | CCNT2 | cyclin T2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
645 | CCR1 | chemokine (C-C motif) receptor 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
646 | CCR2 | chemokine (C-C motif) receptor 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
647 | CCR3 | chemokine (C-C motif) receptor 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
648 | CCR5 | chemokine (C-C motif) receptor 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
649 | CCT2 | chaperonin containing TCP1, subunit 2 (beta) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
650 | CD109 | CD109 molecule | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
651 | CD163 | CD163 molecule | 5 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
652 | CD163L1 | CD163 molecule-like 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
653 | CD19 | CD19 molecule | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
654 | CD2 | CD2 molecule | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
655 | CD207 | CD207 molecule, langerin | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
656 | CD248 | CD248 molecule, endosialin | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
657 | CD274 | CD274 molecule | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
658 | CD300E | CD300e molecule | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
659 | CD3EAP | CD3e molecule, epsilon associated protein | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
660 | CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
661 | CD40LG | CD40 ligand (TNF superfamily, member 5, hyper-IgM syndrome) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
662 | CD46 | CD46 molecule, complement regulatory protein | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
663 | CD84 | CD84 molecule | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
664 | CD93 | CD93 molecule | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
665 | CD96 | CD96 molecule | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
666 | CD99 | CD99 molecule | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
667 | CD99L2 | CD99 molecule-like 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
668 | CDC123 | cell division cycle 123 homolog (S. cerevisiae) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
669 | CDC14A | CDC14 cell division cycle 14 homolog A (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
670 | CDC25A | cell division cycle 25 homolog A (S. pombe) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
671 | CDC27 | cell division cycle 27 homolog (S. cerevisiae) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
672 | CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
673 | CDC42BPA | CDC42 binding protein kinase alpha (DMPK-like) | 0 | 8 | 0 | 1,080 | 0 | 1.00 | 1.00 |
674 | CDC42BPB | CDC42 binding protein kinase beta (DMPK-like) | 4 | 8 | 0 | 1,080 | 0 | 1.00 | 1.00 |
675 | CDC42BPG | CDC42 binding protein kinase gamma (DMPK-like) | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
676 | CDC5L | CDC5 cell division cycle 5-like (S. pombe) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
677 | CDC7 | cell division cycle 7 homolog (S. cerevisiae) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
678 | CDC73 | cell division cycle 73, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) | 0 | 54 | 0 | 7,290 | 0 | 1.00 | 1.00 |
679 | CDCA8 | cell division cycle associated 8 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
680 | CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 1 | 187 | 0 | 25,245 | 0 | 1.00 | 1.00 |
681 | CDH10 | cadherin 10, type 2 (T2-cadherin) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
682 | CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
683 | CDH18 | cadherin 18, type 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
684 | CDH20 | cadherin 20, type 2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
685 | CDH23 | cadherin-like 23 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
686 | CDH24 | cadherin-like 24 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
687 | CDH26 | cadherin-like 26 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
688 | CDH4 | cadherin 4, type 1, R-cadherin (retinal) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
689 | CDH5 | cadherin 5, type 2, VE-cadherin (vascular epithelium) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
690 | CDH6 | cadherin 6, type 2, K-cadherin (fetal kidney) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
691 | CDH8 | cadherin 8, type 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
692 | CDK12 | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 | |
693 | CDK13 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 | |
694 | CDK14 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 | |
695 | CDK15 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 | |
696 | CDK16 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
697 | CDK17 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 | |
698 | CDK19 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 | |
699 | CDK2 | cyclin-dependent kinase 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
700 | CDK4 | cyclin-dependent kinase 4 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
701 | CDK5 | cyclin-dependent kinase 5 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
702 | CDK5RAP1 | CDK5 regulatory subunit associated protein 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
703 | CDK5RAP2 | CDK5 regulatory subunit associated protein 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
704 | CDK6 | cyclin-dependent kinase 6 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
705 | CDK7 | cyclin-dependent kinase 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
706 | CDK8 | cyclin-dependent kinase 8 | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
707 | CDK9 | cyclin-dependent kinase 9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
708 | CDKL2 | cyclin-dependent kinase-like 2 (CDC2-related kinase) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
709 | CDKL3 | cyclin-dependent kinase-like 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
710 | CDKL5 | cyclin-dependent kinase-like 5 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
711 | CDKN1C | cyclin-dependent kinase inhibitor 1C (p57, Kip2) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
712 | CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0 | 342 | 0 | 46,170 | 0 | 1.00 | 1.00 |
713 | CDKN2B | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
714 | CDKN2C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
715 | CDO1 | cysteine dioxygenase, type I | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
716 | CDON | Cdon homolog (mouse) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
717 | CDS1 | CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
718 | CDT1 | chromatin licensing and DNA replication factor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
719 | CDX1 | caudal type homeobox 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
720 | CDX2 | caudal type homeobox 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
721 | CDYL2 | chromodomain protein, Y-like 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
722 | CEACAM1 | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
723 | CEACAM18 | carcinoembryonic antigen-related cell adhesion molecule 18 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
724 | CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha | 0 | 418 | 0 | 56,430 | 0 | 1.00 | 1.00 |
725 | CECR2 | cat eye syndrome chromosome region, candidate 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
726 | CELA1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
727 | CELF1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 | |
728 | CELF3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
729 | CELF6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
730 | CELSR1 | cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo homolog, Drosophila) | 10 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
731 | CELSR3 | cadherin, EGF LAG seven-pass G-type receptor 3 (flamingo homolog, Drosophila) | 6 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
732 | CENPC1 | centromere protein C 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
733 | CENPE | centromere protein E, 312kDa | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
734 | CENPF | centromere protein F, 350/400ka (mitosin) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
735 | CENPH | centromere protein H | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
736 | CENPI | centromere protein I | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
737 | CEP110 | centrosomal protein 110kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
738 | CEP135 | centrosomal protein 135kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
739 | CEP152 | centrosomal protein 152kDa | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
740 | CEP170 | centrosomal protein 170kDa | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
741 | CERK | ceramide kinase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
742 | CERKL | ceramide kinase-like | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
743 | CES3 | carboxylesterase 3 (brain) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
744 | CETP | cholesteryl ester transfer protein, plasma | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
745 | CFH | complement factor H | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
746 | CFHR5 | complement factor H-related 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
747 | CFL2 | cofilin 2 (muscle) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
748 | CFP | complement factor properdin | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
749 | CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
750 | CGNL1 | cingulin-like 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
751 | CHAD | chondroadherin | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
752 | CHAT | choline acetyltransferase | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
753 | CHD1 | chromodomain helicase DNA binding protein 1 | 3 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
754 | CHD1L | chromodomain helicase DNA binding protein 1-like | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
755 | CHD4 | chromodomain helicase DNA binding protein 4 | 3 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
756 | CHD5 | chromodomain helicase DNA binding protein 5 | 3 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
757 | CHD6 | chromodomain helicase DNA binding protein 6 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
758 | CHD8 | chromodomain helicase DNA binding protein 8 | 6 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
759 | CHD9 | chromodomain helicase DNA binding protein 9 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
760 | CHDH | choline dehydrogenase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
761 | CHEK1 | CHK1 checkpoint homolog (S. pombe) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
762 | CHEK2 | CHK2 checkpoint homolog (S. pombe) | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
763 | CHFR | checkpoint with forkhead and ring finger domains | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
764 | CHI3L2 | chitinase 3-like 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
765 | CHIC2 | cysteine-rich hydrophobic domain 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
766 | CHKA | choline kinase alpha | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
767 | CHL1 | cell adhesion molecule with homology to L1CAM (close homolog of L1) | 3 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
768 | CHN1 | chimerin (chimaerin) 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
769 | CHRM2 | cholinergic receptor, muscarinic 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
770 | CHRM5 | cholinergic receptor, muscarinic 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
771 | CHRNA1 | cholinergic receptor, nicotinic, alpha 1 (muscle) | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
772 | CHRNA3 | cholinergic receptor, nicotinic, alpha 3 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
773 | CHRNA4 | cholinergic receptor, nicotinic, alpha 4 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
774 | CHRNA9 | cholinergic receptor, nicotinic, alpha 9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
775 | CHRND | cholinergic receptor, nicotinic, delta | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
776 | CHST12 | carbohydrate (chondroitin 4) sulfotransferase 12 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
777 | CHST13 | carbohydrate (chondroitin 4) sulfotransferase 13 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
778 | CHST8 | carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
779 | CHTF18 | CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
780 | CHUK | conserved helix-loop-helix ubiquitous kinase | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
781 | CIC | capicua homolog (Drosophila) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
782 | CIDEA | cell death-inducing DFFA-like effector a | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
783 | CIDEC | cell death-inducing DFFA-like effector c | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
784 | CIITA | class II, major histocompatibility complex, transactivator | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
785 | CINP | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
786 | CIR1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
787 | CIT | citron (rho-interacting, serine/threonine kinase 21) | 3 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
788 | CIZ1 | CDKN1A interacting zinc finger protein 1 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
789 | CLASP1 | cytoplasmic linker associated protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
790 | CLASP2 | cytoplasmic linker associated protein 2 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
791 | CLCA2 | chloride channel, calcium activated, family member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
792 | CLCN1 | chloride channel 1, skeletal muscle (Thomsen disease, autosomal dominant) | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
793 | CLCN4 | chloride channel 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
794 | CLCN5 | chloride channel 5 (nephrolithiasis 2, X-linked, Dent disease) | 0 | 8 | 0 | 1,080 | 0 | 1.00 | 1.00 |
795 | CLDN1 | claudin 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
796 | CLDN11 | claudin 11 (oligodendrocyte transmembrane protein) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
797 | CLEC16A | C-type lectin domain family 16, member A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
798 | CLEC1A | C-type lectin domain family 1, member A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
799 | CLEC4E | C-type lectin domain family 4, member E | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
800 | CLEC7A | C-type lectin domain family 7, member A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
801 | CLIC1 | chloride intracellular channel 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
802 | CLIC2 | chloride intracellular channel 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
803 | CLIC6 | chloride intracellular channel 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
804 | CLIP1 | CAP-GLY domain containing linker protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
805 | CLN8 | ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
806 | CLOCK | clock homolog (mouse) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
807 | CLPTM1L | CLPTM1-like | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
808 | CLSPN | claspin homolog (Xenopus laevis) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
809 | CLSTN2 | calsyntenin 2 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
810 | CLSTN3 | calsyntenin 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
811 | CLTA | clathrin, light chain (Lca) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
812 | CLTCL1 | clathrin, heavy chain-like 1 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
813 | CMTM3 | CKLF-like MARVEL transmembrane domain containing 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
814 | CMYA5 | cardiomyopathy associated 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
815 | CNGA2 | cyclic nucleotide gated channel alpha 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
816 | CNKSR1 | connector enhancer of kinase suppressor of Ras 1 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
817 | CNKSR2 | connector enhancer of kinase suppressor of Ras 2 | 7 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
818 | CNNM2 | cyclin M2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
819 | CNNM4 | cyclin M4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
820 | CNOT1 | CCR4-NOT transcription complex, subunit 1 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
821 | CNOT10 | CCR4-NOT transcription complex, subunit 10 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
822 | CNOT7 | CCR4-NOT transcription complex, subunit 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
823 | CNR2 | cannabinoid receptor 2 (macrophage) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
824 | CNTFR | ciliary neurotrophic factor receptor | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
825 | CNTN1 | contactin 1 | 7 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
826 | CNTN4 | contactin 4 | 6 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
827 | CNTN5 | contactin 5 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
828 | CNTN6 | contactin 6 | 4 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
829 | CNTNAP2 | contactin associated protein-like 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
830 | CNTROB | centrobin, centrosomal BRCA2 interacting protein | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
831 | COBL | cordon-bleu homolog (mouse) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
832 | COCH | coagulation factor C homolog, cochlin (Limulus polyphemus) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
833 | COG3 | component of oligomeric golgi complex 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
834 | COG5 | component of oligomeric golgi complex 5 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
835 | COG6 | component of oligomeric golgi complex 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
836 | COL11A1 | collagen, type XI, alpha 1 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
837 | COL11A2 | collagen, type XI, alpha 2 | 6 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
838 | COL14A1 | collagen, type XIV, alpha 1 | 7 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 |
839 | COL18A1 | collagen, type XVIII, alpha 1 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
840 | COL19A1 | collagen, type XIX, alpha 1 | 11 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
841 | COL1A1 | collagen, type I, alpha 1 | 4 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
842 | COL1A2 | collagen, type I, alpha 2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
843 | COL23A1 | collagen, type XXIII, alpha 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
844 | COL24A1 | collagen, type XXIV, alpha 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
845 | COL3A1 | collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) | 0 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 |
846 | COL4A1 | collagen, type IV, alpha 1 | 6 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 |
847 | COL4A2 | collagen, type IV, alpha 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
848 | COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
849 | COL4A3BP | collagen, type IV, alpha 3 (Goodpasture antigen) binding protein | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
850 | COL4A4 | collagen, type IV, alpha 4 | 6 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
851 | COL4A5 | collagen, type IV, alpha 5 (Alport syndrome) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
852 | COL4A6 | collagen, type IV, alpha 6 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
853 | COL5A1 | collagen, type V, alpha 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
854 | COL5A3 | collagen, type V, alpha 3 | 7 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
855 | COL6A2 | collagen, type VI, alpha 2 | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
856 | COL6A3 | collagen, type VI, alpha 3 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
857 | COL7A1 | collagen, type VII, alpha 1 (epidermolysis bullosa, dystrophic, dominant and recessive) | 3 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
858 | COL8A2 | collagen, type VIII, alpha 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
859 | COPB1 | coatomer protein complex, subunit beta 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
860 | COPS2 | COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
861 | COPS3 | COP9 constitutive photomorphogenic homolog subunit 3 (Arabidopsis) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
862 | COPS4 | COP9 constitutive photomorphogenic homolog subunit 4 (Arabidopsis) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
863 | COPS7B | COP9 constitutive photomorphogenic homolog subunit 7B (Arabidopsis) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
864 | CORO1B | coronin, actin binding protein, 1B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
865 | CORO1C | coronin, actin binding protein, 1C | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
866 | CORO2B | coronin, actin binding protein, 2B | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
867 | COTL1 | coactosin-like 1 (Dictyostelium) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
868 | COX4I1 | cytochrome c oxidase subunit IV isoform 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
869 | CPA3 | carboxypeptidase A3 (mast cell) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
870 | CPB1 | carboxypeptidase B1 (tissue) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
871 | CPB2 | carboxypeptidase B2 (plasma) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
872 | CPE | carboxypeptidase E | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
873 | CPN1 | carboxypeptidase N, polypeptide 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
874 | CPNE2 | copine II | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
875 | CPNE4 | copine IV | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
876 | CPNE5 | copine V | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
877 | CPO | carboxypeptidase O | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
878 | CPS1 | carbamoyl-phosphate synthetase 1, mitochondrial | 9 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
879 | CPSF3 | cleavage and polyadenylation specific factor 3, 73kDa | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
880 | CPSF4 | cleavage and polyadenylation specific factor 4, 30kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
881 | CPSF7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
882 | CPT1B | carnitine palmitoyltransferase 1B (muscle) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
883 | CPT1C | carnitine palmitoyltransferase 1C | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
884 | CR2 | complement component (3d/Epstein Barr virus) receptor 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
885 | CRAT | carnitine acetyltransferase | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
886 | CRB1 | crumbs homolog 1 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
887 | CREB1 | cAMP responsive element binding protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
888 | CREBBP | CREB binding protein (Rubinstein-Taybi syndrome) | 10 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
889 | CRISP3 | cysteine-rich secretory protein 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
890 | CRISPLD1 | cysteine-rich secretory protein LCCL domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
891 | CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
892 | CRLF1 | cytokine receptor-like factor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
893 | CROT | carnitine O-octanoyltransferase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
894 | CRTC1 | CREB regulated transcription coactivator 1 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
895 | CRX | cone-rod homeobox | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
896 | CRY2 | cryptochrome 2 (photolyase-like) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
897 | CRYAA | crystallin, alpha A | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
898 | CSDA | cold shock domain protein A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
899 | CSE1L | CSE1 chromosome segregation 1-like (yeast) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
900 | CSF1R | colony stimulating factor 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog | 2 | 20 | 0 | 2,700 | 0 | 1.00 | 1.00 |
901 | CSF3R | colony stimulating factor 3 receptor (granulocyte) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
902 | CSK | c-src tyrosine kinase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
903 | CSMD3 | CUB and Sushi multiple domains 3 | 52 | 27 | 0 | 3,645 | 0 | 1.00 | 1.00 |
904 | CSN3 | casein kappa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
905 | CSNK1A1L | casein kinase 1, alpha 1-like | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
906 | CSNK1D | casein kinase 1, delta | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
907 | CSNK1E | casein kinase 1, epsilon | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
908 | CSNK2A2 | casein kinase 2, alpha prime polypeptide | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
909 | CSPG5 | chondroitin sulfate proteoglycan 5 (neuroglycan C) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
910 | CSRNP1 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
911 | CSRNP3 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
912 | CST4 | cystatin S | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
913 | CSTF1 | cleavage stimulation factor, 3' pre-RNA, subunit 1, 50kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
914 | CTCFL | CCCTC-binding factor (zinc finger protein)-like | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
915 | CTDSP2 | CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
916 | CTH | cystathionase (cystathionine gamma-lyase) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
917 | CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
918 | CTNNA3 | catenin (cadherin-associated protein), alpha 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
919 | CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0 | 109 | 0 | 14,715 | 0 | 1.00 | 1.00 |
920 | CTNND1 | catenin (cadherin-associated protein), delta 1 | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
921 | CTNND2 | catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein) | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
922 | CTSH | cathepsin H | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
923 | CTSW | cathepsin W | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
924 | CTSZ | cathepsin Z | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
925 | CTTNBP2NL | CTTNBP2 N-terminal like | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
926 | CTU2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
927 | CUBN | cubilin (intrinsic factor-cobalamin receptor) | 18 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
928 | CUL1 | cullin 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
929 | CUL3 | cullin 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
930 | CUL4A | cullin 4A | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
931 | CUL4B | cullin 4B | 1 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
932 | CUL7 | cullin 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
933 | CUL9 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
934 | CUTC | cutC copper transporter homolog (E. coli) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
935 | CXCL3 | chemokine (C-X-C motif) ligand 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
936 | CXCR2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
937 | CXCR3 | chemokine (C-X-C motif) receptor 3 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
938 | CXCR4 | chemokine (C-X-C motif) receptor 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
939 | CXCR5 | chemokine (C-X-C motif) receptor 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
940 | CXCR6 | chemokine (C-X-C motif) receptor 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
941 | CXCR7 | chemokine (C-X-C motif) receptor 7 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
942 | CXXC1 | CXXC finger 1 (PHD domain) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
943 | CXXC5 | CXXC finger 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
944 | CXorf22 | chromosome X open reading frame 22 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
945 | CXorf23 | chromosome X open reading frame 23 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
946 | CXorf30 | chromosome X open reading frame 30 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
947 | CXorf36 | chromosome X open reading frame 36 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
948 | CXorf57 | chromosome X open reading frame 57 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
949 | CXorf59 | chromosome X open reading frame 59 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
950 | CXorf65 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
951 | CYB561D2 | cytochrome b-561 domain containing 2 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
952 | CYB5D2 | cytochrome b5 domain containing 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
953 | CYB5R4 | cytochrome b5 reductase 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
954 | CYBB | cytochrome b-245, beta polypeptide (chronic granulomatous disease) | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
955 | CYCS | cytochrome c, somatic | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
956 | CYLC1 | cylicin, basic protein of sperm head cytoskeleton 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
957 | CYLC2 | cylicin, basic protein of sperm head cytoskeleton 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
958 | CYLD | cylindromatosis (turban tumor syndrome) | 0 | 20 | 0 | 2,700 | 0 | 1.00 | 1.00 |
959 | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
960 | CYP1B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
961 | CYP24A1 | cytochrome P450, family 24, subfamily A, polypeptide 1 | 0 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 |
962 | CYP26A1 | cytochrome P450, family 26, subfamily A, polypeptide 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
963 | CYP26C1 | cytochrome P450, family 26, subfamily C, polypeptide 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
964 | CYP27B1 | cytochrome P450, family 27, subfamily B, polypeptide 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
965 | CYP2A13 | cytochrome P450, family 2, subfamily A, polypeptide 13 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
966 | CYP2C18 | cytochrome P450, family 2, subfamily C, polypeptide 18 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
967 | CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 | 6 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
968 | CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
969 | CYP2R1 | cytochrome P450, family 2, subfamily R, polypeptide 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
970 | CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
971 | CYP4F12 | cytochrome P450, family 4, subfamily F, polypeptide 12 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
972 | CYP4F2 | cytochrome P450, family 4, subfamily F, polypeptide 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
973 | CYSLTR2 | cysteinyl leukotriene receptor 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
974 | DAAM2 | dishevelled associated activator of morphogenesis 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
975 | DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
976 | DAB2IP | DAB2 interacting protein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
977 | DACT1 | dapper, antagonist of beta-catenin, homolog 1 (Xenopus laevis) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
978 | DAGLA | diacylglycerol lipase, alpha | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
979 | DAO | D-amino-acid oxidase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
980 | DAPK1 | death-associated protein kinase 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
981 | DAPK2 | death-associated protein kinase 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
982 | DAPK3 | death-associated protein kinase 3 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
983 | DARC | Duffy blood group, chemokine receptor | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
984 | DARS2 | aspartyl-tRNA synthetase 2, mitochondrial | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
985 | DAXX | death-associated protein 6 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
986 | DAZAP1 | DAZ associated protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
987 | DBC1 | deleted in bladder cancer 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
988 | DBF4 | DBF4 homolog (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
989 | DBH | dopamine beta-hydroxylase (dopamine beta-monooxygenase) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
990 | DBN1 | drebrin 1 | 4 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
991 | DCAF10 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
992 | DCAF12L1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 | |
993 | DCAF12L2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 | |
994 | DCAF15 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
995 | DCAF4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
996 | DCAF5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
997 | DCAF6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
998 | DCBLD2 | discoidin, CUB and LCCL domain containing 2 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
999 | DCC | deleted in colorectal carcinoma | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1000 | DCLK1 | doublecortin-like kinase 1 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1001 | DCLK3 | doublecortin-like kinase 3 | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
1002 | DCLRE1A | DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1003 | DCN | decorin | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1004 | DCP1B | DCP1 decapping enzyme homolog B (S. cerevisiae) | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1005 | DCST2 | DC-STAMP domain containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1006 | DCT | dopachrome tautomerase (dopachrome delta-isomerase, tyrosine-related protein 2) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1007 | DCTN4 | dynactin 4 (p62) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1008 | DCTN5 | dynactin 5 (p25) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1009 | DCX | doublecortex; lissencephaly, X-linked (doublecortin) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1010 | DDB1 | damage-specific DNA binding protein 1, 127kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1011 | DDB2 | damage-specific DNA binding protein 2, 48kDa | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1012 | DDIT3 | DNA-damage-inducible transcript 3 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1013 | DDO | D-aspartate oxidase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1014 | DDR1 | discoidin domain receptor tyrosine kinase 1 | 0 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 |
1015 | DDR2 | discoidin domain receptor tyrosine kinase 2 | 4 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1016 | DDX1 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1017 | DDX10 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 10 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1018 | DDX17 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 17 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1019 | DDX18 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 18 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1020 | DDX19B | DEAD (Asp-Glu-Ala-As) box polypeptide 19B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1021 | DDX20 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 20 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1022 | DDX21 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 21 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1023 | DDX23 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 23 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1024 | DDX24 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 24 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1025 | DDX27 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 27 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1026 | DDX28 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 28 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1027 | DDX31 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 31 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1028 | DDX3X | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked | 3 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1029 | DDX4 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1030 | DDX42 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 42 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1031 | DDX43 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 43 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1032 | DDX5 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1033 | DDX51 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 51 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1034 | DDX54 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 54 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1035 | DDX59 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 59 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1036 | DEFA4 | defensin, alpha 4, corticostatin | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1037 | DEFB112 | defensin, beta 112 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1038 | DEFB125 | defensin, beta 125 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1039 | DEK | DEK oncogene (DNA binding) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1040 | DENND4A | DENN/MADD domain containing 4A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1041 | DEPDC5 | DEP domain containing 5 | 5 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1042 | DES | desmin | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1043 | DET1 | de-etiolated homolog 1 (Arabidopsis) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1044 | DFNB31 | deafness, autosomal recessive 31 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1045 | DGCR6 | DiGeorge syndrome critical region gene 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1046 | DGKB | diacylglycerol kinase, beta 90kDa | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
1047 | DGKD | diacylglycerol kinase, delta 130kDa | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1048 | DGKE | diacylglycerol kinase, epsilon 64kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1049 | DGKG | diacylglycerol kinase, gamma 90kDa | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1050 | DGKI | diacylglycerol kinase, iota | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1051 | DGKK | diacylglycerol kinase, kappa | 7 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1052 | DGKQ | diacylglycerol kinase, theta 110kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1053 | DGKZ | diacylglycerol kinase, zeta 104kDa | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1054 | DHPS | deoxyhypusine synthase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1055 | DHRS2 | dehydrogenase/reductase (SDR family) member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1056 | DHTKD1 | dehydrogenase E1 and transketolase domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1057 | DHX16 | DEAH (Asp-Glu-Ala-His) box polypeptide 16 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1058 | DHX29 | DEAH (Asp-Glu-Ala-His) box polypeptide 29 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1059 | DHX30 | DEAH (Asp-Glu-Ala-His) box polypeptide 30 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1060 | DHX32 | DEAH (Asp-Glu-Ala-His) box polypeptide 32 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1061 | DHX35 | DEAH (Asp-Glu-Ala-His) box polypeptide 35 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1062 | DHX36 | DEAH (Asp-Glu-Ala-His) box polypeptide 36 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1063 | DHX57 | DEAH (Asp-Glu-Ala-Asp/His) box polypeptide 57 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1064 | DHX8 | DEAH (Asp-Glu-Ala-His) box polypeptide 8 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1065 | DIAPH2 | diaphanous homolog 2 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1066 | DICER1 | dicer 1, ribonuclease type III | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1067 | DIMT1L | DIM1 dimethyladenosine transferase 1-like (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1068 | DIO3 | deiodinase, iodothyronine, type III | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1069 | DIP2C | DIP2 disco-interacting protein 2 homolog C (Drosophila) | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
1070 | DIS3L2 | DIS3 mitotic control homolog (S. cerevisiae)-like 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1071 | DKK1 | dickkopf homolog 1 (Xenopus laevis) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1072 | DKK2 | dickkopf homolog 2 (Xenopus laevis) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1073 | DKK3 | dickkopf homolog 3 (Xenopus laevis) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1074 | DLC1 | deleted in liver cancer 1 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1075 | DLD | dihydrolipoamide dehydrogenase | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1076 | DLEC1 | deleted in lung and esophageal cancer 1 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1077 | DLG3 | discs, large homolog 3 (neuroendocrine-dlg, Drosophila) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1078 | DLGAP1 | discs, large (Drosophila) homolog-associated protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1079 | DLGAP4 | discs, large (Drosophila) homolog-associated protein 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1080 | DLL3 | delta-like 3 (Drosophila) | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1081 | DMBT1 | deleted in malignant brain tumors 1 | 6 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
1082 | DMKN | dermokine | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1083 | DMPK | dystrophia myotonica-protein kinase | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1084 | DMRT3 | doublesex and mab-3 related transcription factor 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1085 | DMRTA1 | DMRT-like family A1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1086 | DMTF1 | cyclin D binding myb-like transcription factor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1087 | DNAH10 | dynein, axonemal, heavy chain 10 | 14 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1088 | DNAH11 | dynein, axonemal, heavy chain 11 | 16 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1089 | DNAH17 | dynein, axonemal, heavy chain 17 | 7 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1090 | DNAH2 | dynein, axonemal, heavy chain 2 | 7 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1091 | DNAH3 | dynein, axonemal, heavy chain 3 | 11 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1092 | DNAH5 | dynein, axonemal, heavy chain 5 | 19 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1093 | DNAH8 | dynein, axonemal, heavy chain 8 | 26 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 |
1094 | DNAH9 | dynein, axonemal, heavy chain 9 | 18 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
1095 | DNAI2 | dynein, axonemal, intermediate chain 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1096 | DNAJA2 | DnaJ (Hsp40) homolog, subfamily A, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1097 | DNAJA3 | DnaJ (Hsp40) homolog, subfamily A, member 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1098 | DNAJA4 | DnaJ (Hsp40) homolog, subfamily A, member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1099 | DNAJB11 | DnaJ (Hsp40) homolog, subfamily B, member 11 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1100 | DNAJC1 | DnaJ (Hsp40) homolog, subfamily C, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1101 | DNAJC14 | DnaJ (Hsp40) homolog, subfamily C, member 14 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1102 | DNAJC16 | DnaJ (Hsp40) homolog, subfamily C, member 16 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1103 | DNAJC18 | DnaJ (Hsp40) homolog, subfamily C, member 18 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1104 | DNAJC2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1105 | DNAJC21 | DnaJ (Hsp40) homolog, subfamily C, member 21 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1106 | DNAJC24 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 | |
1107 | DNAJC5G | DnaJ (Hsp40) homolog, subfamily C, member 5 gamma | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1108 | DNAJC6 | DnaJ (Hsp40) homolog, subfamily C, member 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1109 | DNALI1 | dynein, axonemal, light intermediate chain 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1110 | DNASE1L3 | deoxyribonuclease I-like 3 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1111 | DNM2 | dynamin 2 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1112 | DNMT1 | DNA (cytosine-5-)-methyltransferase 1 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1113 | DNMT3B | DNA (cytosine-5-)-methyltransferase 3 beta | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1114 | DNTTIP1 | deoxynucleotidyltransferase, terminal, interacting protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1115 | DOCK1 | dedicator of cytokinesis 1 | 3 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
1116 | DOCK6 | dedicator of cytokinesis 6 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1117 | DOCK8 | dedicator of cytokinesis 8 | 3 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1118 | DOCK9 | dedicator of cytokinesis 9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1119 | DOK6 | docking protein 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1120 | DONSON | downstream neighbor of SON | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1121 | DOPEY1 | dopey family member 1 | 5 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1122 | DOPEY2 | dopey family member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1123 | DOT1L | DOT1-like, histone H3 methyltransferase (S. cerevisiae) | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1124 | DPAGT1 | dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1125 | DPEP1 | dipeptidase 1 (renal) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1126 | DPEP2 | dipeptidase 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1127 | DPP10 | dipeptidyl-peptidase 10 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1128 | DPP9 | dipeptidyl-peptidase 9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1129 | DPY19L2 | dpy-19-like 2 (C. elegans) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1130 | DPYSL2 | dihydropyrimidinase-like 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1131 | DPYSL4 | dihydropyrimidinase-like 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1132 | DRD3 | dopamine receptor D3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1133 | DRG1 | developmentally regulated GTP binding protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1134 | DSCAML1 | Down syndrome cell adhesion molecule like 1 | 9 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1135 | DSCR6 | Down syndrome critical region gene 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1136 | DSEL | dermatan sulfate epimerase-like | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1137 | DSG1 | desmoglein 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1138 | DSG2 | desmoglein 2 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
1139 | DSG3 | desmoglein 3 (pemphigus vulgaris antigen) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1140 | DSG4 | desmoglein 4 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
1141 | DSP | desmoplakin | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
1142 | DSPP | dentin sialophosphoprotein | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1143 | DST | dystonin | 16 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
1144 | DSTN | destrin (actin depolymerizing factor) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1145 | DSTYK | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1146 | DTX1 | deltex homolog 1 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1147 | DTX3 | deltex 3 homolog (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1148 | DTX3L | deltex 3-like (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1149 | DULLARD | dullard homolog (Xenopus laevis) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1150 | DUSP12 | dual specificity phosphatase 12 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1151 | DUSP21 | dual specificity phosphatase 21 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1152 | DUSP22 | dual specificity phosphatase 22 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1153 | DUSP23 | dual specificity phosphatase 23 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1154 | DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1155 | DYNC1H1 | dynein, cytoplasmic 1, heavy chain 1 | 7 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1156 | DYNC1LI2 | dynein, cytoplasmic 1, light intermediate chain 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1157 | DYRK1B | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1158 | DYRK2 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1159 | DYRK3 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1160 | DYRK4 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1161 | DYSF | dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive) | 6 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1162 | DZIP3 | DAZ interacting protein 3, zinc finger | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1163 | E2F2 | E2F transcription factor 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1164 | E2F3 | E2F transcription factor 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1165 | E2F4 | E2F transcription factor 4, p107/p130-binding | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1166 | E2F6 | E2F transcription factor 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1167 | E2F7 | E2F transcription factor 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1168 | EAF1 | ELL associated factor 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1169 | EBF1 | early B-cell factor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1170 | EBF3 | early B-cell factor 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1171 | ECEL1 | endothelin converting enzyme-like 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1172 | ECHDC2 | enoyl Coenzyme A hydratase domain containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1173 | ECM2 | extracellular matrix protein 2, female organ and adipocyte specific | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1174 | ECT2 | epithelial cell transforming sequence 2 oncogene | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1175 | EDA | ectodysplasin A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1176 | EDA2R | ectodysplasin A2 receptor | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1177 | EDC4 | enhancer of mRNA decapping 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1178 | EDEM3 | ER degradation enhancer, mannosidase alpha-like 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1179 | EDIL3 | EGF-like repeats and discoidin I-like domains 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1180 | EDNRA | endothelin receptor type A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1181 | EED | embryonic ectoderm development | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1182 | EEF1D | eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1183 | EEF2K | eukaryotic elongation factor-2 kinase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1184 | EFCAB5 | EF-hand calcium binding domain 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1185 | EFHC2 | EF-hand domain (C-terminal) containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1186 | EFR3A | EFR3 homolog A (S. cerevisiae) | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1187 | EFS | embryonal Fyn-associated substrate | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1188 | EGF | epidermal growth factor (beta-urogastrone) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1189 | EGFL6 | EGF-like-domain, multiple 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1190 | EGFR | epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) | 2 | 235 | 0 | 31,725 | 0 | 1.00 | 1.00 |
1191 | EHBP1 | EH domain binding protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1192 | EHMT1 | euchromatic histone-lysine N-methyltransferase 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1193 | EIF2AK1 | eukaryotic translation initiation factor 2-alpha kinase 1 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
1194 | EIF2AK2 | eukaryotic translation initiation factor 2-alpha kinase 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1195 | EIF2AK4 | eukaryotic translation initiation factor 2 alpha kinase 4 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1196 | EIF2C1 | eukaryotic translation initiation factor 2C, 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1197 | EIF2S2 | eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1198 | EIF2S3 | eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1199 | EIF3E | eukaryotic translation initiation factor 3, subunit E | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1200 | EIF3M | eukaryotic translation initiation factor 3, subunit M | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1201 | EIF4A2 | eukaryotic translation initiation factor 4A, isoform 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1202 | EIF4E | eukaryotic translation initiation factor 4E | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1203 | EIF4G1 | eukaryotic translation initiation factor 4 gamma, 1 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1204 | EIF4G2 | eukaryotic translation initiation factor 4 gamma, 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1205 | EIF5 | eukaryotic translation initiation factor 5 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1206 | ELAVL2 | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1207 | ELP2 | elongation protein 2 homolog (S. cerevisiae) | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
1208 | EME2 | essential meiotic endonuclease 1 homolog 2 (S. pombe) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1209 | EML2 | echinoderm microtubule associated protein like 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1210 | EML4 | echinoderm microtubule associated protein like 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1211 | EN1 | engrailed homeobox 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1212 | EN2 | engrailed homeobox 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1213 | ENC1 | ectodermal-neural cortex (with BTB-like domain) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1214 | ENO1 | enolase 1, (alpha) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1215 | ENPEP | glutamyl aminopeptidase (aminopeptidase A) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1216 | ENPP2 | ectonucleotide pyrophosphatase/phosphodiesterase 2 (autotaxin) | 3 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1217 | ENPP6 | ectonucleotide pyrophosphatase/phosphodiesterase 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1218 | ENPP7 | ectonucleotide pyrophosphatase/phosphodiesterase 7 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1219 | ENSA | endosulfine alpha | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1220 | EOMES | eomesodermin homolog (Xenopus laevis) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1221 | EP300 | E1A binding protein p300 | 4 | 8 | 0 | 1,080 | 0 | 1.00 | 1.00 |
1222 | EP400 | E1A binding protein p400 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1223 | EPAS1 | endothelial PAS domain protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1224 | EPB41L2 | erythrocyte membrane protein band 4.1-like 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1225 | EPB41L4B | erythrocyte membrane protein band 4.1 like 4B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1226 | EPB49 | erythrocyte membrane protein band 4.9 (dematin) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1227 | EPC1 | enhancer of polycomb homolog 1 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1228 | EPHA1 | EPH receptor A1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1229 | EPHA10 | EPH receptor A10 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1230 | EPHA2 | EPH receptor A2 | 2 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1231 | EPHA3 | EPH receptor A3 | 5 | 22 | 0 | 2,970 | 0 | 1.00 | 1.00 |
1232 | EPHA4 | EPH receptor A4 | 0 | 8 | 0 | 1,080 | 0 | 1.00 | 1.00 |
1233 | EPHA5 | EPH receptor A5 | 0 | 13 | 0 | 1,755 | 0 | 1.00 | 1.00 |
1234 | EPHA6 | EPH receptor A6 | 7 | 10 | 0 | 1,350 | 0 | 1.00 | 1.00 |
1235 | EPHA7 | EPH receptor A7 | 0 | 13 | 0 | 1,755 | 0 | 1.00 | 1.00 |
1236 | EPHA8 | EPH receptor A8 | 0 | 8 | 0 | 1,080 | 0 | 1.00 | 1.00 |
1237 | EPHB1 | EPH receptor B1 | 0 | 12 | 0 | 1,620 | 0 | 1.00 | 1.00 |
1238 | EPHB2 | EPH receptor B2 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1239 | EPHB3 | EPH receptor B3 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1240 | EPHB4 | EPH receptor B4 | 0 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 |
1241 | EPHB6 | EPH receptor B6 | 0 | 13 | 0 | 1,755 | 0 | 1.00 | 1.00 |
1242 | EPHX1 | epoxide hydrolase 1, microsomal (xenobiotic) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1243 | EPHX4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1244 | EPO | erythropoietin | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1245 | EPS15 | epidermal growth factor receptor pathway substrate 15 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1246 | EPS8L3 | EPS8-like 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1247 | ERAS | ES cell expressed Ras | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1248 | ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0 | 46 | 0 | 6,210 | 0 | 1.00 | 1.00 |
1249 | ERBB2IP | erbb2 interacting protein | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1250 | ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 2 | 8 | 0 | 1,080 | 0 | 1.00 | 1.00 |
1251 | ERBB4 | v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) | 0 | 13 | 0 | 1,755 | 0 | 1.00 | 1.00 |
1252 | ERC1 | ELKS/RAB6-interacting/CAST family member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1253 | ERCC2 | excision repair cross-complementing rodent repair deficiency, complementation group 2 (xeroderma pigmentosum D) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1254 | ERCC3 | excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1255 | ERCC5 | excision repair cross-complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1256 | ERCC6 | excision repair cross-complementing rodent repair deficiency, complementation group 6 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
1257 | EREG | epiregulin | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1258 | ERF | Ets2 repressor factor | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1259 | ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1260 | ERGIC3 | ERGIC and golgi 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1261 | ERI2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1262 | ERICH1 | glutamate-rich 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1263 | ERN1 | endoplasmic reticulum to nucleus signaling 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1264 | ERN2 | endoplasmic reticulum to nucleus signaling 2 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1265 | ESCO2 | establishment of cohesion 1 homolog 2 (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1266 | ESPL1 | extra spindle pole bodies homolog 1 (S. cerevisiae) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1267 | ESR1 | estrogen receptor 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1268 | ESR2 | estrogen receptor 2 (ER beta) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1269 | ESRRG | estrogen-related receptor gamma | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1270 | ETAA1 | Ewing tumor-associated antigen 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1271 | ETFDH | electron-transferring-flavoprotein dehydrogenase | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1272 | ETNK2 | ethanolamine kinase 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1273 | ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1274 | ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1275 | ETV1 | ets variant gene 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1276 | ETV3L | ets variant gene 3-like | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1277 | ETV5 | ets variant gene 5 (ets-related molecule) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1278 | ETV7 | ets variant gene 7 (TEL2 oncogene) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1279 | EVC2 | Ellis van Creveld syndrome 2 (limbin) | 9 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1280 | EVL | Enah/Vasp-like | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1281 | EVPL | envoplakin | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1282 | EXO1 | exonuclease 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1283 | EXOC1 | exocyst complex component 1 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1284 | EXOC2 | exocyst complex component 2 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1285 | EXOC3L | exocyst complex component 3-like | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1286 | EXOC4 | exocyst complex component 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1287 | EXOC6B | exocyst complex component 6B | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1288 | EXT1 | exostoses (multiple) 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1289 | EXTL1 | exostoses (multiple)-like 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1290 | EYA1 | eyes absent homolog 1 (Drosophila) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1291 | EYA4 | eyes absent homolog 4 (Drosophila) | 3 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1292 | EZH2 | enhancer of zeste homolog 2 (Drosophila) | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
1293 | F13A1 | coagulation factor XIII, A1 polypeptide | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1294 | F13B | coagulation factor XIII, B polypeptide | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1295 | F2RL1 | coagulation factor II (thrombin) receptor-like 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1296 | F2RL2 | coagulation factor II (thrombin) receptor-like 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1297 | F3 | coagulation factor III (thromboplastin, tissue factor) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1298 | F5 | coagulation factor V (proaccelerin, labile factor) | 5 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1299 | F8 | coagulation factor VIII, procoagulant component (hemophilia A) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1300 | F9 | coagulation factor IX (plasma thromboplastic component, Christmas disease, hemophilia B) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1301 | FAAH | fatty acid amide hydrolase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1302 | FABP4 | fatty acid binding protein 4, adipocyte | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1303 | FADS1 | fatty acid desaturase 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1304 | FAF1 | Fas (TNFRSF6) associated factor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1305 | FAIM2 | Fas apoptotic inhibitory molecule 2 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1306 | FAIM3 | Fas apoptotic inhibitory molecule 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1307 | FAM100B | family with sequence similarity 100, member B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1308 | FAM107B | family with sequence similarity 107, member B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1309 | FAM110B | family with sequence similarity 110, member B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1310 | FAM120C | family with sequence similarity 120C | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1311 | FAM123A | family with sequence similarity 123A | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1312 | FAM123B | family with sequence similarity 123B | 0 | 23 | 0 | 3,105 | 0 | 1.00 | 1.00 |
1313 | FAM124A | family with sequence similarity 124A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1314 | FAM126A | family with sequence similarity 126, member A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1315 | FAM131A | family with sequence similarity 131, member A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1316 | FAM134A | family with sequence similarity 134, member A | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1317 | FAM135A | family with sequence similarity 135, member A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1318 | FAM160B1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1319 | FAM171B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1320 | FAM173B | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1321 | FAM175A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1322 | FAM179A | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1323 | FAM184A | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 | |
1324 | FAM189B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1325 | FAM194A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1326 | FAM194B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1327 | FAM22G | family with sequence similarity 22, member G | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1328 | FAM43A | family with sequence similarity 43, member A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1329 | FAM46B | family with sequence similarity 46, member B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1330 | FAM46D | family with sequence similarity 46, member D | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1331 | FAM47A | family with sequence similarity 47, member A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1332 | FAM47B | family with sequence similarity 47, member B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1333 | FAM48B1 | family with sequence similarity 48, member B1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1334 | FAM5C | family with sequence similarity 5, member C | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1335 | FAM63B | family with sequence similarity 63, member B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1336 | FAM65A | family with sequence similarity 65, member A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1337 | FAM70A | family with sequence similarity 70, member A | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1338 | FAM71A | family with sequence similarity 71, member A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1339 | FAM78B | family with sequence similarity 78, member B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1340 | FAM83A | family with sequence similarity 83, member A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1341 | FAM83F | family with sequence similarity 83, member F | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1342 | FAM83H | family with sequence similarity 83, member H | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1343 | FAM91A1 | family with sequence similarity 91, member A1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1344 | FAM92B | family with sequence similarity 92, member B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1345 | FANCA | Fanconi anemia, complementation group A | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1346 | FANCD2 | Fanconi anemia, complementation group D2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1347 | FANCF | Fanconi anemia, complementation group F | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1348 | FANCG | Fanconi anemia, complementation group G | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1349 | FARP1 | FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1350 | FAS | Fas (TNF receptor superfamily, member 6) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1351 | FASN | fatty acid synthase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1352 | FASTK | Fas-activated serine/threonine kinase | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1353 | FASTKD3 | FAST kinase domains 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1354 | FBLN1 | fibulin 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1355 | FBLN5 | fibulin 5 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1356 | FBN3 | fibrillin 3 | 11 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1357 | FBXL12 | F-box and leucine-rich repeat protein 12 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1358 | FBXL15 | F-box and leucine-rich repeat protein 15 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1359 | FBXL18 | F-box and leucine-rich repeat protein 18 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1360 | FBXL19 | F-box and leucine-rich repeat protein 19 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1361 | FBXL2 | F-box and leucine-rich repeat protein 2 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1362 | FBXL21 | F-box and leucine-rich repeat protein 21 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1363 | FBXL4 | F-box and leucine-rich repeat protein 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1364 | FBXL7 | F-box and leucine-rich repeat protein 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1365 | FBXO18 | F-box protein, helicase, 18 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1366 | FBXO21 | F-box protein 21 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1367 | FBXO24 | F-box protein 24 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1368 | FBXO25 | F-box protein 25 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1369 | FBXO28 | F-box protein 28 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1370 | FBXO30 | F-box protein 30 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1371 | FBXO31 | F-box protein 31 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1372 | FBXO32 | F-box protein 32 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1373 | FBXO34 | F-box protein 34 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1374 | FBXO38 | F-box protein 38 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1375 | FBXO40 | F-box protein 40 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1376 | FBXO43 | F-box protein 43 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1377 | FBXO45 | F-box protein 45 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1378 | FBXO46 | F-box protein 46 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1379 | FBXO6 | F-box protein 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1380 | FBXO8 | F-box protein 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1381 | FBXW2 | F-box and WD repeat domain containing 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1382 | FBXW4 | F-box and WD repeat domain containing 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1383 | FBXW7 | F-box and WD repeat domain containing 7 | 0 | 91 | 0 | 12,285 | 0 | 1.00 | 1.00 |
1384 | FCGBP | Fc fragment of IgG binding protein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1385 | FCHSD1 | FCH and double SH3 domains 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1386 | FCN1 | ficolin (collagen/fibrinogen domain containing) 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1387 | FCN2 | ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1388 | FCRL3 | Fc receptor-like 3 | 5 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1389 | FCRL4 | Fc receptor-like 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1390 | FCRL5 | Fc receptor-like 5 | 7 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1391 | FECH | ferrochelatase (protoporphyria) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1392 | FEM1C | fem-1 homolog c (C. elegans) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1393 | FER | fer (fps/fes related) tyrosine kinase | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1394 | FER1L6 | fer-1-like 6 (C. elegans) | 8 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1395 | FERD3L | Fer3-like (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1396 | FES | feline sarcoma oncogene | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1397 | FETUB | fetuin B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1398 | FEZ1 | fasciculation and elongation protein zeta 1 (zygin I) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1399 | FEZF2 | FEZ family zinc finger 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1400 | FFAR1 | free fatty acid receptor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1401 | FFAR2 | free fatty acid receptor 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1402 | FGD1 | FYVE, RhoGEF and PH domain containing 1 (faciogenital dysplasia) | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1403 | FGD2 | FYVE, RhoGEF and PH domain containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1404 | FGD4 | FYVE, RhoGEF and PH domain containing 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1405 | FGD5 | FYVE, RhoGEF and PH domain containing 5 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1406 | FGF13 | fibroblast growth factor 13 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1407 | FGF14 | fibroblast growth factor 14 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1408 | FGF19 | fibroblast growth factor 19 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1409 | FGF2 | fibroblast growth factor 2 (basic) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1410 | FGF23 | fibroblast growth factor 23 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1411 | FGF3 | fibroblast growth factor 3 (murine mammary tumor virus integration site (v-int-2) oncogene homolog) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1412 | FGFR1 | fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome) | 0 | 10 | 0 | 1,350 | 0 | 1.00 | 1.00 |
1413 | FGFR2 | fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) | 0 | 49 | 0 | 6,615 | 0 | 1.00 | 1.00 |
1414 | FGFR3 | fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism) | 0 | 53 | 0 | 7,155 | 0 | 1.00 | 1.00 |
1415 | FGFR4 | fibroblast growth factor receptor 4 | 0 | 10 | 0 | 1,350 | 0 | 1.00 | 1.00 |
1416 | FGL2 | fibrinogen-like 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1417 | FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1418 | FH | fumarate hydratase | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1419 | FHAD1 | forkhead-associated (FHA) phosphopeptide binding domain 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1420 | FHOD1 | formin homology 2 domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1421 | FIGF | c-fos induced growth factor (vascular endothelial growth factor D) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1422 | FIGN | fidgetin | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1423 | FIP1L1 | FIP1 like 1 (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1424 | FKBP9 | FK506 binding protein 9, 63 kDa | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1425 | FKTN | fukutin | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1426 | FLCN | folliculin | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1427 | FLI1 | Friend leukemia virus integration 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1428 | FLII | flightless I homolog (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1429 | FLJ44635 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1430 | FLNB | filamin B, beta (actin binding protein 278) | 3 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
1431 | FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0 | 14 | 0 | 1,890 | 0 | 1.00 | 1.00 |
1432 | FLT3 | fms-related tyrosine kinase 3 | 0 | 117 | 0 | 15,795 | 0 | 1.00 | 1.00 |
1433 | FLT4 | fms-related tyrosine kinase 4 | 1 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
1434 | FMN2 | formin 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1435 | FMNL2 | formin-like 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1436 | FMNL3 | formin-like 3 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1437 | FMO4 | flavin containing monooxygenase 4 | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1438 | FN1 | fibronectin 1 | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
1439 | FNDC1 | fibronectin type III domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1440 | FNDC3A | fibronectin type III domain containing 3A | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1441 | FNDC3B | fibronectin type III domain containing 3B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1442 | FOLH1 | folate hydrolase (prostate-specific membrane antigen) 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1443 | FOLH1B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1444 | FOLR2 | folate receptor 2 (fetal) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1445 | FOS | v-fos FBJ murine osteosarcoma viral oncogene homolog | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1446 | FOXA2 | forkhead box A2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1447 | FOXA3 | forkhead box A3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1448 | FOXB1 | forkhead box B1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1449 | FOXG1 | forkhead box G1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1450 | FOXI1 | forkhead box I1 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1451 | FOXJ2 | forkhead box J2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1452 | FOXL2 | forkhead box L2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1453 | FOXM1 | forkhead box M1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1454 | FOXN1 | forkhead box N1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1455 | FOXN3 | forkhead box N3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1456 | FOXN4 | forkhead box N4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1457 | FOXO1 | forkhead box O1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1458 | FOXO3 | forkhead box O3 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
1459 | FOXO4 | forkhead box O4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1460 | FOXP1 | forkhead box P1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1461 | FOXP2 | forkhead box P2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1462 | FOXP4 | forkhead box P4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1463 | FOXR2 | forkhead box R2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1464 | FOXRED2 | FAD-dependent oxidoreductase domain containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1465 | FREM2 | FRAS1 related extracellular matrix protein 2 | 6 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1466 | FRK | fyn-related kinase | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
1467 | FRMD3 | FERM domain containing 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1468 | FRMD6 | FERM domain containing 6 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1469 | FRMD8 | FERM domain containing 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1470 | FRMPD1 | FERM and PDZ domain containing 1 | 5 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1471 | FRMPD2 | FERM and PDZ domain containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1472 | FRMPD4 | FERM and PDZ domain containing 4 | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
1473 | FRS2 | fibroblast growth factor receptor substrate 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1474 | FRYL | FRY-like | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1475 | FRZB | frizzled-related protein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1476 | FSCB | fibrous sheath CABYR binding protein | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1477 | FSD2 | fibronectin type III and SPRY domain containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1478 | FSTL1 | follistatin-like 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1479 | FSTL4 | follistatin-like 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1480 | FSTL5 | follistatin-like 5 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1481 | FTSJD2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1482 | FUBP1 | far upstream element (FUSE) binding protein 1 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1483 | FUCA1 | fucosidase, alpha-L- 1, tissue | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1484 | FURIN | furin (paired basic amino acid cleaving enzyme) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1485 | FUS | fusion (involved in t(12;16) in malignant liposarcoma) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1486 | FUT2 | fucosyltransferase 2 (secretor status included) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1487 | FXR1 | fragile X mental retardation, autosomal homolog 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1488 | FXYD6 | FXYD domain containing ion transport regulator 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1489 | FYCO1 | FYVE and coiled-coil domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1490 | FYN | FYN oncogene related to SRC, FGR, YES | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
1491 | FZD10 | frizzled homolog 10 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1492 | FZD3 | frizzled homolog 3 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1493 | FZD4 | frizzled homolog 4 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1494 | FZD6 | frizzled homolog 6 (Drosophila) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1495 | FZD7 | frizzled homolog 7 (Drosophila) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1496 | FZD9 | frizzled homolog 9 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1497 | FZR1 | fizzy/cell division cycle 20 related 1 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1498 | G2E3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1499 | G3BP2 | GTPase activating protein (SH3 domain) binding protein 2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1500 | G6PC | glucose-6-phosphatase, catalytic subunit | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1501 | GAB1 | GRB2-associated binding protein 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1502 | GAB2 | GRB2-associated binding protein 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1503 | GABPA | GA binding protein transcription factor, alpha subunit 60kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1504 | GABPB1 | GA binding protein transcription factor, beta subunit 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1505 | GABRA4 | gamma-aminobutyric acid (GABA) A receptor, alpha 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1506 | GABRA6 | gamma-aminobutyric acid (GABA) A receptor, alpha 6 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1507 | GABRB3 | gamma-aminobutyric acid (GABA) A receptor, beta 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1508 | GABRD | gamma-aminobutyric acid (GABA) A receptor, delta | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1509 | GABRP | gamma-aminobutyric acid (GABA) A receptor, pi | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1510 | GAD2 | glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1511 | GAK | cyclin G associated kinase | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1512 | GALNS | galactosamine (N-acetyl)-6-sulfate sulfatase (Morquio syndrome, mucopolysaccharidosis type IVA) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1513 | GALNT13 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1514 | GALNT3 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1515 | GALNT5 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1516 | GALNT7 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7) | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1517 | GALNTL1 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 1 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1518 | GANAB | glucosidase, alpha; neutral AB | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1519 | GAPVD1 | GTPase activating protein and VPS9 domains 1 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1520 | GARNL3 | GTPase activating Rap/RanGAP domain-like 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1521 | GAS2L2 | growth arrest-specific 2 like 2 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1522 | GAS6 | growth arrest-specific 6 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1523 | GATA1 | GATA binding protein 1 (globin transcription factor 1) | 0 | 119 | 0 | 16,065 | 0 | 1.00 | 1.00 |
1524 | GATA2 | GATA binding protein 2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1525 | GATA3 | GATA binding protein 3 | 0 | 34 | 0 | 4,590 | 0 | 1.00 | 1.00 |
1526 | GATA4 | GATA binding protein 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1527 | GATA6 | GATA binding protein 6 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1528 | GBAS | glioblastoma amplified sequence | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1529 | GBF1 | golgi-specific brefeldin A resistance factor 1 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1530 | GCK | glucokinase (hexokinase 4) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1531 | GCLC | glutamate-cysteine ligase, catalytic subunit | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1532 | GCM1 | glial cells missing homolog 1 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1533 | GCM2 | glial cells missing homolog 2 (Drosophila) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1534 | GCNT3 | glucosaminyl (N-acetyl) transferase 3, mucin type | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1535 | GCNT4 | glucosaminyl (N-acetyl) transferase 4, core 2 (beta-1,6-N-acetylglucosaminyltransferase) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1536 | GDA | guanine deaminase | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1537 | GDAP1L1 | ganglioside-induced differentiation-associated protein 1-like 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1538 | GDF10 | growth differentiation factor 10 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1539 | GDF11 | growth differentiation factor 11 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1540 | GDF15 | growth differentiation factor 15 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1541 | GDF3 | growth differentiation factor 3 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1542 | GEFT | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 | |
1543 | GEMIN4 | gem (nuclear organelle) associated protein 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1544 | GEMIN5 | gem (nuclear organelle) associated protein 5 | 3 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1545 | GEN1 | Gen homolog 1, endonuclease (Drosophila) | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
1546 | GFI1B | growth factor independent 1B transcription repressor | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1547 | GFM1 | G elongation factor, mitochondrial 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1548 | GFRAL | GDNF family receptor alpha like | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1549 | GGA1 | golgi associated, gamma adaptin ear containing, ARF binding protein 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1550 | GGA2 | golgi associated, gamma adaptin ear containing, ARF binding protein 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1551 | GGA3 | golgi associated, gamma adaptin ear containing, ARF binding protein 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1552 | GGPS1 | geranylgeranyl diphosphate synthase 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1553 | GHR | growth hormone receptor | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1554 | GHRHR | growth hormone releasing hormone receptor | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1555 | GHSR | growth hormone secretagogue receptor | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1556 | GIMAP1 | GTPase, IMAP family member 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1557 | GIMAP5 | GTPase, IMAP family member 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1558 | GIMAP8 | GTPase, IMAP family member 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1559 | GIT2 | G protein-coupled receptor kinase interactor 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1560 | GJA4 | gap junction protein, alpha 4, 37kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1561 | GJB1 | gap junction protein, beta 1, 32kDa | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1562 | GJB4 | gap junction protein, beta 4, 30.3kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1563 | GJD4 | gap junction protein, delta 4, 40.1kDa | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1564 | GK | glycerol kinase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1565 | GKN1 | gastrokine 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1566 | GLI1 | glioma-associated oncogene homolog 1 (zinc finger protein) | 1 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
1567 | GLI2 | GLI-Kruppel family member GLI2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1568 | GLI3 | GLI-Kruppel family member GLI3 (Greig cephalopolysyndactyly syndrome) | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
1569 | GLIPR2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1570 | GLP1R | glucagon-like peptide 1 receptor | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1571 | GLRA1 | glycine receptor, alpha 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1572 | GLRA2 | glycine receptor, alpha 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1573 | GLT25D2 | glycosyltransferase 25 domain containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1574 | GLTSCR2 | glioma tumor suppressor candidate region gene 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1575 | GMDS | GDP-mannose 4,6-dehydratase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1576 | GML | glycosylphosphatidylinositol anchored molecule like protein | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1577 | GMPS | guanine monphosphate synthetase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1578 | GNA11 | guanine nucleotide binding protein (G protein), alpha 11 (Gq class) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1579 | GNAI1 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1580 | GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1581 | GNAQ | guanine nucleotide binding protein (G protein), q polypeptide | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1582 | GNAS | GNAS complex locus | 2 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
1583 | GNAT1 | guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1584 | GNAZ | guanine nucleotide binding protein (G protein), alpha z polypeptide | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1585 | GNB1L | guanine nucleotide binding protein (G protein), beta polypeptide 1-like | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1586 | GNB4 | guanine nucleotide binding protein (G protein), beta polypeptide 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1587 | GNB5 | guanine nucleotide binding protein (G protein), beta 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1588 | GNG11 | guanine nucleotide binding protein (G protein), gamma 11 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1589 | GNL2 | guanine nucleotide binding protein-like 2 (nucleolar) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1590 | GNPAT | glyceronephosphate O-acyltransferase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1591 | GNPTG | N-acetylglucosamine-1-phosphate transferase, gamma subunit | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1592 | GNS | glucosamine (N-acetyl)-6-sulfatase (Sanfilippo disease IIID) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1593 | GOLGA3 | golgi autoantigen, golgin subfamily a, 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1594 | GOLGA4 | golgi autoantigen, golgin subfamily a, 4 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1595 | GOLGA5 | golgi autoantigen, golgin subfamily a, 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1596 | GOLGB1 | golgin B1, golgi integral membrane protein | 10 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1597 | GOLIM4 | golgi integral membrane protein 4 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1598 | GORASP2 | golgi reassembly stacking protein 2, 55kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1599 | GOT2 | glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1600 | GP5 | glycoprotein V (platelet) | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1601 | GPBP1 | GC-rich promoter binding protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1602 | GPC1 | glypican 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1603 | GPC2 | glypican 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1604 | GPC3 | glypican 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1605 | GPLD1 | glycosylphosphatidylinositol specific phospholipase D1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1606 | GPNMB | glycoprotein (transmembrane) nmb | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1607 | GPR101 | G protein-coupled receptor 101 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1608 | GPR111 | G protein-coupled receptor 111 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1609 | GPR112 | G protein-coupled receptor 112 | 11 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1610 | GPR114 | G protein-coupled receptor 114 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1611 | GPR115 | G protein-coupled receptor 115 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1612 | GPR116 | G protein-coupled receptor 116 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1613 | GPR124 | G protein-coupled receptor 124 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1614 | GPR132 | G protein-coupled receptor 132 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1615 | GPR142 | G protein-coupled receptor 142 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1616 | GPR162 | G protein-coupled receptor 162 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1617 | GPR173 | G protein-coupled receptor 173 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1618 | GPR174 | G protein-coupled receptor 174 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1619 | GPR176 | G protein-coupled receptor 176 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1620 | GPR180 | G protein-coupled receptor 180 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1621 | GPR35 | G protein-coupled receptor 35 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1622 | GPR37 | G protein-coupled receptor 37 (endothelin receptor type B-like) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1623 | GPR37L1 | G protein-coupled receptor 37 like 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1624 | GPR45 | G protein-coupled receptor 45 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1625 | GPR61 | G protein-coupled receptor 61 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1626 | GPR78 | G protein-coupled receptor 78 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1627 | GPR81 | G protein-coupled receptor 81 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1628 | GPR83 | G protein-coupled receptor 83 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1629 | GPR85 | G protein-coupled receptor 85 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1630 | GPR87 | G protein-coupled receptor 87 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1631 | GPR98 | G protein-coupled receptor 98 | 23 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1632 | GPRASP1 | G protein-coupled receptor associated sorting protein 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1633 | GPRC5C | G protein-coupled receptor, family C, group 5, member C | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1634 | GPS1 | G protein pathway suppressor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1635 | GPSM2 | G-protein signaling modulator 2 (AGS3-like, C. elegans) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1636 | GPT | glutamic-pyruvate transaminase (alanine aminotransferase) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1637 | GRAMD3 | GRAM domain containing 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1638 | GRAP2 | GRB2-related adaptor protein 2 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1639 | GRASP | GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1640 | GRB10 | growth factor receptor-bound protein 10 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1641 | GRB14 | growth factor receptor-bound protein 14 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1642 | GRB7 | growth factor receptor-bound protein 7 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1643 | GRHL2 | grainyhead-like 2 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1644 | GRIA1 | glutamate receptor, ionotropic, AMPA 1 | 5 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1645 | GRIA2 | glutamate receptor, ionotropic, AMPA 2 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
1646 | GRIA4 | glutamate receptor, ionotrophic, AMPA 4 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1647 | GRID2 | glutamate receptor, ionotropic, delta 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1648 | GRIK2 | glutamate receptor, ionotropic, kainate 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1649 | GRIK3 | glutamate receptor, ionotropic, kainate 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1650 | GRIK4 | glutamate receptor, ionotropic, kainate 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1651 | GRIN2A | glutamate receptor, ionotropic, N-methyl D-aspartate 2A | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1652 | GRIN2B | glutamate receptor, ionotropic, N-methyl D-aspartate 2B | 11 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
1653 | GRIN2C | glutamate receptor, ionotropic, N-methyl D-aspartate 2C | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1654 | GRIN2D | glutamate receptor, ionotropic, N-methyl D-aspartate 2D | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1655 | GRIN3A | glutamate receptor, ionotropic, N-methyl-D-aspartate 3A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1656 | GRINA | glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1657 | GRIPAP1 | GRIP1 associated protein 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1658 | GRK4 | G protein-coupled receptor kinase 4 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1659 | GRK5 | G protein-coupled receptor kinase 5 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1660 | GRK6 | G protein-coupled receptor kinase 6 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1661 | GRK7 | G protein-coupled receptor kinase 7 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1662 | GRLF1 | glucocorticoid receptor DNA binding factor 1 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1663 | GRM1 | glutamate receptor, metabotropic 1 | 8 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1664 | GRM3 | glutamate receptor, metabotropic 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1665 | GRM5 | glutamate receptor, metabotropic 5 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1666 | GRM6 | glutamate receptor, metabotropic 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1667 | GRN | granulin | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1668 | GSDMB | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1669 | GSK3A | glycogen synthase kinase 3 alpha | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1670 | GSK3B | glycogen synthase kinase 3 beta | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1671 | GSN | gelsolin (amyloidosis, Finnish type) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1672 | GSPT1 | G1 to S phase transition 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1673 | GSR | glutathione reductase | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1674 | GSTM5 | glutathione S-transferase M5 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1675 | GSTO2 | glutathione S-transferase omega 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1676 | GTF2A1 | general transcription factor IIA, 1, 19/37kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1677 | GTF2A2 | general transcription factor IIA, 2, 12kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1678 | GTF2B | general transcription factor IIB | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1679 | GTF3C4 | general transcription factor IIIC, polypeptide 4, 90kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1680 | GUCA1B | guanylate cyclase activator 1B (retina) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1681 | GUCY1A2 | guanylate cyclase 1, soluble, alpha 2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1682 | GUCY1A3 | guanylate cyclase 1, soluble, alpha 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1683 | GUCY2C | guanylate cyclase 2C (heat stable enterotoxin receptor) | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1684 | GUCY2F | guanylate cyclase 2F, retinal | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
1685 | GYPA | glycophorin A (MNS blood group) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1686 | GYPC | glycophorin C (Gerbich blood group) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1687 | GZMH | granzyme H (cathepsin G-like 2, protein h-CCPX) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1688 | HACE1 | HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1 | 7 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1689 | HADHB | hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1690 | HAMP | hepcidin antimicrobial peptide | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1691 | HAPLN1 | hyaluronan and proteoglycan link protein 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1692 | HAT1 | histone acetyltransferase 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1693 | HBB | hemoglobin, beta | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1694 | HBXIP | hepatitis B virus x interacting protein | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1695 | HCFC2 | host cell factor C2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1696 | HCK | hemopoietic cell kinase | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
1697 | HCN3 | hyperpolarization activated cyclic nucleotide-gated potassium channel 3 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1698 | HDAC2 | histone deacetylase 2 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1699 | HDAC4 | histone deacetylase 4 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1700 | HDAC7 | histone deacetylase 7 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1701 | HDAC9 | histone deacetylase 9 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1702 | HDC | histidine decarboxylase | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1703 | HDGF | hepatoma-derived growth factor (high-mobility group protein 1-like) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1704 | HDLBP | high density lipoprotein binding protein (vigilin) | 2 | 12 | 0 | 1,620 | 0 | 1.00 | 1.00 |
1705 | HEATR6 | HEAT repeat containing 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1706 | HECTD2 | HECT domain containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1707 | HECW1 | HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
1708 | HECW2 | HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1709 | HELB | helicase (DNA) B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1710 | HELQ | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1711 | HEMK1 | HemK methyltransferase family member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1712 | HEPACAM2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1713 | HEPH | hephaestin | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
1714 | HERC1 | hect (homologous to the E6-AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1715 | HERC2 | hect domain and RLD 2 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
1716 | HERC4 | hect domain and RLD 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1717 | HERC5 | hect domain and RLD 5 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1718 | HES1 | hairy and enhancer of split 1, (Drosophila) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1719 | HES6 | hairy and enhancer of split 6 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1720 | HEY1 | hairy/enhancer-of-split related with YRPW motif 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1721 | HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1722 | HGFAC | HGF activator | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1723 | HHIP | hedgehog interacting protein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1724 | HIF1A | hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1725 | HIF3A | hypoxia inducible factor 3, alpha subunit | 3 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1726 | HIP1 | huntingtin interacting protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1727 | HIPK1 | homeodomain interacting protein kinase 1 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1728 | HIPK2 | homeodomain interacting protein kinase 2 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1729 | HIPK3 | homeodomain interacting protein kinase 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1730 | HIST1H1B | histone cluster 1, H1b | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1731 | HIST1H1E | histone cluster 1, H1e | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1732 | HIST1H2BA | histone cluster 1, H2ba | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1733 | HIST1H2BM | histone cluster 1, H2bm | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1734 | HIST1H4I | histone cluster 1, H4i | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1735 | HIST1H4L | histone cluster 1, H4l | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1736 | HIST2H2AB | histone cluster 2, H2ab | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1737 | HIVEP1 | human immunodeficiency virus type I enhancer binding protein 1 | 8 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1738 | HIVEP2 | human immunodeficiency virus type I enhancer binding protein 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1739 | HIVEP3 | human immunodeficiency virus type I enhancer binding protein 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1740 | HK2 | hexokinase 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1741 | HK3 | hexokinase 3 (white cell) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1742 | HLA-E | major histocompatibility complex, class I, E | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1743 | HLA-G | major histocompatibility complex, class I, G | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1744 | HLCS | holocarboxylase synthetase (biotin-(proprionyl-Coenzyme A-carboxylase (ATP-hydrolysing)) ligase) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1745 | HM13 | histocompatibility (minor) 13 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1746 | HMG20A | high-mobility group 20A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1747 | HMGCL | 3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase (hydroxymethylglutaricaciduria) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1748 | HMGN5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1749 | HMHA1 | histocompatibility (minor) HA-1 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1750 | HMP19 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1751 | HNF1A | HNF1 homeobox A | 0 | 98 | 0 | 13,230 | 0 | 1.00 | 1.00 |
1752 | HNF4A | hepatocyte nuclear factor 4, alpha | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1753 | HNRNPK | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1754 | HOOK1 | hook homolog 1 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1755 | HOOK3 | hook homolog 3 (Drosophila) | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1756 | HORMAD1 | HORMA domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1757 | HOXA3 | homeobox A3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1758 | HOXA4 | homeobox A4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1759 | HOXA6 | homeobox A6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1760 | HOXA9 | homeobox A9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1761 | HOXC9 | homeobox C9 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1762 | HP1BP3 | heterochromatin protein 1, binding protein 3 | 1 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
1763 | HPCAL4 | hippocalcin like 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1764 | HPN | hepsin (transmembrane protease, serine 1) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1765 | HPS3 | Hermansky-Pudlak syndrome 3 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1766 | HR | hairless homolog (mouse) | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1767 | HRAS | v-Ha-ras Harvey rat sarcoma viral oncogene homolog | 0 | 21 | 0 | 2,835 | 0 | 1.00 | 1.00 |
1768 | HRG | histidine-rich glycoprotein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1769 | HRH1 | histamine receptor H1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1770 | HS2ST1 | heparan sulfate 2-O-sulfotransferase 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1771 | HS3ST3A1 | heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1772 | HSCB | HscB iron-sulfur cluster co-chaperone homolog (E. coli) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1773 | HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1774 | HSD17B2 | hydroxysteroid (17-beta) dehydrogenase 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1775 | HSD17B8 | hydroxysteroid (17-beta) dehydrogenase 8 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1776 | HSP90AA1 | heat shock protein 90kDa alpha (cytosolic), class A member 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1777 | HSPA13 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1778 | HSPA14 | heat shock 70kDa protein 14 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1779 | HSPA1L | heat shock 70kDa protein 1-like | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1780 | HSPA2 | heat shock 70kDa protein 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1781 | HSPA4 | heat shock 70kDa protein 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1782 | HSPA4L | heat shock 70kDa protein 4-like | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1783 | HSPA6 | heat shock 70kDa protein 6 (HSP70B') | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1784 | HSPA8 | heat shock 70kDa protein 8 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
1785 | HSPB2 | heat shock 27kDa protein 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1786 | HSPB8 | heat shock 22kDa protein 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1787 | HSPBAP1 | HSPB (heat shock 27kDa) associated protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1788 | HSPG2 | heparan sulfate proteoglycan 2 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1789 | HTATSF1 | HIV-1 Tat specific factor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1790 | HTR2A | 5-hydroxytryptamine (serotonin) receptor 2A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1791 | HTR3C | 5-hydroxytryptamine (serotonin) receptor 3, family member C | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1792 | HTR3E | 5-hydroxytryptamine (serotonin) receptor 3, family member E | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1793 | HTR5A | 5-hydroxytryptamine (serotonin) receptor 5A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1794 | HTT | huntingtin | 5 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1795 | HUS1 | HUS1 checkpoint homolog (S. pombe) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1796 | HUWE1 | HECT, UBA and WWE domain containing 1 | 4 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1797 | HYAL1 | hyaluronoglucosaminidase 1 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1798 | IBTK | inhibitor of Bruton agammaglobulinemia tyrosine kinase | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1799 | ICA1 | islet cell autoantigen 1, 69kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1800 | ICAM3 | intercellular adhesion molecule 3 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1801 | ICAM4 | intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1802 | ICAM5 | intercellular adhesion molecule 5, telencephalin | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1803 | ICK | intestinal cell (MAK-like) kinase | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1804 | ID3 | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1805 | IDE | insulin-degrading enzyme | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1806 | IDH1 | isocitrate dehydrogenase 1 (NADP+), soluble | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1807 | IDH2 | isocitrate dehydrogenase 2 (NADP+), mitochondrial | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
1808 | IDO1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 | |
1809 | IFI44 | interferon-induced protein 44 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1810 | IFIT3 | interferon-induced protein with tetratricopeptide repeats 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1811 | IFITM3 | interferon induced transmembrane protein 3 (1-8U) | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
1812 | IFLTD1 | intermediate filament tail domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1813 | IFNA2 | interferon, alpha 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1814 | IFNA21 | interferon, alpha 21 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1815 | IFNAR1 | interferon (alpha, beta and omega) receptor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1816 | IFNB1 | interferon, beta 1, fibroblast | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1817 | IFRD1 | interferon-related developmental regulator 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1818 | IFT172 | intraflagellar transport 172 homolog (Chlamydomonas) | 5 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1819 | IFT57 | intraflagellar transport 57 homolog (Chlamydomonas) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1820 | IGBP1 | immunoglobulin (CD79A) binding protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1821 | IGF1 | insulin-like growth factor 1 (somatomedin C) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1822 | IGF1R | insulin-like growth factor 1 receptor | 0 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 |
1823 | IGF2 | insulin-like growth factor 2 (somatomedin A) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1824 | IGFBP3 | insulin-like growth factor binding protein 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1825 | IGFBP7 | insulin-like growth factor binding protein 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1826 | IGSF1 | immunoglobulin superfamily, member 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1827 | IGSF10 | immunoglobulin superfamily, member 10 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1828 | IGSF21 | immunoglobin superfamily, member 21 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1829 | IGSF9 | immunoglobulin superfamily, member 9 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1830 | IKBKAP | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein | 0 | 11 | 0 | 1,485 | 0 | 1.00 | 1.00 |
1831 | IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1832 | IKBKE | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1833 | IKZF1 | IKAROS family zinc finger 1 (Ikaros) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1834 | IKZF3 | IKAROS family zinc finger 3 (Aiolos) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1835 | IL12RB2 | interleukin 12 receptor, beta 2 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1836 | IL13RA2 | interleukin 13 receptor, alpha 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1837 | IL16 | interleukin 16 (lymphocyte chemoattractant factor) | 4 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1838 | IL17B | interleukin 17B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1839 | IL17RE | interleukin 17 receptor E | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1840 | IL1F9 | interleukin 1 family, member 9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1841 | IL1RAPL1 | interleukin 1 receptor accessory protein-like 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1842 | IL1RAPL2 | interleukin 1 receptor accessory protein-like 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1843 | IL1RL1 | interleukin 1 receptor-like 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1844 | IL1RN | interleukin 1 receptor antagonist | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1845 | IL3 | interleukin 3 (colony-stimulating factor, multiple) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1846 | IL31 | interleukin 31 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1847 | IL34 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1848 | IL3RA | interleukin 3 receptor, alpha (low affinity) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1849 | IL4R | interleukin 4 receptor | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1850 | IL6R | interleukin 6 receptor | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1851 | IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1852 | IL7R | interleukin 7 receptor | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1853 | ILK | integrin-linked kinase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1854 | IMMT | inner membrane protein, mitochondrial (mitofilin) | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1855 | IMP4 | IMP4, U3 small nucleolar ribonucleoprotein, homolog (yeast) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1856 | IMPA1 | inositol(myo)-1(or 4)-monophosphatase 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1857 | IMPA2 | inositol(myo)-1(or 4)-monophosphatase 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1858 | IMPDH1 | IMP (inosine monophosphate) dehydrogenase 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1859 | IMPDH2 | IMP (inosine monophosphate) dehydrogenase 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1860 | IMPG2 | interphotoreceptor matrix proteoglycan 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1861 | INA | internexin neuronal intermediate filament protein, alpha | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1862 | ING4 | inhibitor of growth family, member 4 | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1863 | INHBA | inhibin, beta A | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
1864 | INHBE | inhibin, beta E | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1865 | INO80B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1866 | INPP1 | inositol polyphosphate-1-phosphatase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1867 | INPP4A | inositol polyphosphate-4-phosphatase, type I, 107kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1868 | INPP4B | inositol polyphosphate-4-phosphatase, type II, 105kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1869 | INPP5B | inositol polyphosphate-5-phosphatase, 75kDa | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1870 | INPP5D | inositol polyphosphate-5-phosphatase, 145kDa | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1871 | INPP5E | inositol polyphosphate-5-phosphatase, 72 kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1872 | INPP5J | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1873 | INPPL1 | inositol polyphosphate phosphatase-like 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1874 | INSIG2 | insulin induced gene 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1875 | INSM2 | insulinoma-associated 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1876 | INSR | insulin receptor | 2 | 8 | 0 | 1,080 | 0 | 1.00 | 1.00 |
1877 | INSRR | insulin receptor-related receptor | 0 | 10 | 0 | 1,350 | 0 | 1.00 | 1.00 |
1878 | INTS2 | integrator complex subunit 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1879 | INTS6 | integrator complex subunit 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1880 | IPO11 | importin 11 | 4 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1881 | IPO13 | importin 13 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1882 | IPO4 | importin 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1883 | IPO5 | importin 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1884 | IPO7 | importin 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1885 | IPO8 | importin 8 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1886 | IQGAP1 | IQ motif containing GTPase activating protein 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1887 | IQGAP2 | IQ motif containing GTPase activating protein 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1888 | IQSEC3 | IQ motif and Sec7 domain 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1889 | IQUB | IQ motif and ubiquitin domain containing | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1890 | IRAK1 | interleukin-1 receptor-associated kinase 1 | 4 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
1891 | IRAK2 | interleukin-1 receptor-associated kinase 2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1892 | IRAK3 | interleukin-1 receptor-associated kinase 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1893 | IRF8 | interferon regulatory factor 8 | 3 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1894 | IRS1 | insulin receptor substrate 1 | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
1895 | IRS2 | insulin receptor substrate 2 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
1896 | IRS4 | insulin receptor substrate 4 | 3 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
1897 | IRX2 | iroquois homeobox 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1898 | IRX6 | iroquois homeobox 6 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1899 | ISG20L2 | interferon stimulated exonuclease gene 20kDa-like 2 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1900 | ISL1 | ISL LIM homeobox 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1901 | ISLR | immunoglobulin superfamily containing leucine-rich repeat | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1902 | ITFG1 | integrin alpha FG-GAP repeat containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1903 | ITFG3 | integrin alpha FG-GAP repeat containing 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1904 | ITGA1 | integrin, alpha 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1905 | ITGA10 | integrin, alpha 10 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
1906 | ITGA11 | integrin, alpha 11 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1907 | ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 5 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1908 | ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1909 | ITGA4 | integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1910 | ITGA6 | integrin, alpha 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1911 | ITGA7 | integrin, alpha 7 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1912 | ITGA8 | integrin, alpha 8 | 8 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1913 | ITGA9 | integrin, alpha 9 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1914 | ITGAD | integrin, alpha D | 7 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1915 | ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1916 | ITGAM | integrin, alpha M (complement component 3 receptor 3 subunit) | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1917 | ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1918 | ITGAX | integrin, alpha X (complement component 3 receptor 4 subunit) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1919 | ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1920 | ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
1921 | ITGB4 | integrin, beta 4 | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1922 | ITGB6 | integrin, beta 6 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1923 | ITGB7 | integrin, beta 7 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1924 | ITGB8 | integrin, beta 8 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1925 | ITIH5 | inter-alpha (globulin) inhibitor H5 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1926 | ITIH5L | inter-alpha (globulin) inhibitor H5-like | 9 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1927 | ITK | IL2-inducible T-cell kinase | 0 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 |
1928 | ITLN1 | intelectin 1 (galactofuranose binding) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1929 | ITM2A | integral membrane protein 2A | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1930 | ITPKB | inositol 1,4,5-trisphosphate 3-kinase B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1931 | ITPR1 | inositol 1,4,5-triphosphate receptor, type 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1932 | ITPR2 | inositol 1,4,5-triphosphate receptor, type 2 | 5 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 |
1933 | ITPR3 | inositol 1,4,5-triphosphate receptor, type 3 | 3 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
1934 | ITPRIPL1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1935 | ITSN2 | intersectin 2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1936 | IVNS1ABP | influenza virus NS1A binding protein | 3 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1937 | JAG1 | jagged 1 (Alagille syndrome) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1938 | JAG2 | jagged 2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1939 | JAK1 | Janus kinase 1 (a protein tyrosine kinase) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1940 | JAK2 | Janus kinase 2 (a protein tyrosine kinase) | 3 | 70 | 0 | 9,450 | 0 | 1.00 | 1.00 |
1941 | JAK3 | Janus kinase 3 (a protein tyrosine kinase, leukocyte) | 0 | 18 | 0 | 2,430 | 0 | 1.00 | 1.00 |
1942 | JAKMIP1 | janus kinase and microtubule interacting protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1943 | JAKMIP2 | janus kinase and microtubule interacting protein 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1944 | JARID2 | jumonji, AT rich interactive domain 2 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1945 | JUNB | jun B proto-oncogene | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1946 | JUP | junction plakoglobin | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1947 | KALRN | kalirin, RhoGEF kinase | 6 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1948 | KANK1 | KN motif and ankyrin repeat domains 1 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1949 | KANK4 | KN motif and ankyrin repeat domains 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1950 | KAT2B | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1951 | KATNA1 | katanin p60 (ATPase-containing) subunit A 1 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1952 | KATNAL2 | katanin p60 subunit A-like 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1953 | KBTBD3 | kelch repeat and BTB (POZ) domain containing 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1954 | KBTBD4 | kelch repeat and BTB (POZ) domain containing 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1955 | KBTBD8 | kelch repeat and BTB (POZ) domain containing 8 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1956 | KCNA10 | potassium voltage-gated channel, shaker-related subfamily, member 10 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1957 | KCNA4 | potassium voltage-gated channel, shaker-related subfamily, member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1958 | KCNA5 | potassium voltage-gated channel, shaker-related subfamily, member 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1959 | KCNA6 | potassium voltage-gated channel, shaker-related subfamily, member 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1960 | KCNA7 | potassium voltage-gated channel, shaker-related subfamily, member 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1961 | KCNB2 | potassium voltage-gated channel, Shab-related subfamily, member 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1962 | KCNC2 | potassium voltage-gated channel, Shaw-related subfamily, member 2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
1963 | KCNC4 | potassium voltage-gated channel, Shaw-related subfamily, member 4 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
1964 | KCND1 | potassium voltage-gated channel, Shal-related subfamily, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1965 | KCND2 | potassium voltage-gated channel, Shal-related subfamily, member 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1966 | KCND3 | potassium voltage-gated channel, Shal-related subfamily, member 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1967 | KCNG1 | potassium voltage-gated channel, subfamily G, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1968 | KCNG3 | potassium voltage-gated channel, subfamily G, member 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1969 | KCNH1 | potassium voltage-gated channel, subfamily H (eag-related), member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1970 | KCNH2 | potassium voltage-gated channel, subfamily H (eag-related), member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1971 | KCNH4 | potassium voltage-gated channel, subfamily H (eag-related), member 4 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1972 | KCNH5 | potassium voltage-gated channel, subfamily H (eag-related), member 5 | 7 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1973 | KCNIP3 | Kv channel interacting protein 3, calsenilin | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1974 | KCNJ1 | potassium inwardly-rectifying channel, subfamily J, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1975 | KCNJ15 | potassium inwardly-rectifying channel, subfamily J, member 15 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1976 | KCNJ16 | potassium inwardly-rectifying channel, subfamily J, member 16 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1977 | KCNK1 | potassium channel, subfamily K, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1978 | KCNK17 | potassium channel, subfamily K, member 17 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1979 | KCNK5 | potassium channel, subfamily K, member 5 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1980 | KCNK9 | potassium channel, subfamily K, member 9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1981 | KCNN3 | potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1982 | KCNQ3 | potassium voltage-gated channel, KQT-like subfamily, member 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1983 | KCNQ4 | potassium voltage-gated channel, KQT-like subfamily, member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1984 | KCNQ5 | potassium voltage-gated channel, KQT-like subfamily, member 5 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1985 | KCNT2 | potassium channel, subfamily T, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1986 | KCNV1 | potassium channel, subfamily V, member 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1987 | KCNV2 | potassium channel, subfamily V, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1988 | KCP | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1989 | KCTD7 | potassium channel tetramerisation domain containing 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1990 | KCTD8 | potassium channel tetramerisation domain containing 8 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
1991 | KDELR2 | KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
1992 | KDM1A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1993 | KDM2A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1994 | KDM3A | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 | |
1995 | KDM3B | 1 | 6 | 0 | 810 | 0 | 1.00 | 1.00 | |
1996 | KDM4B | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1997 | KDM5A | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 | |
1998 | KDM5B | 7 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
1999 | KDM5C | 6 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 | |
2000 | KDM5D | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2001 | KDM6A | 4 | 52 | 0 | 7,020 | 0 | 1.00 | 1.00 | |
2002 | KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0 | 18 | 0 | 2,430 | 0 | 1.00 | 1.00 |
2003 | KEAP1 | kelch-like ECH-associated protein 1 | 13 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2004 | KEL | Kell blood group, metallo-endopeptidase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2005 | KHDC1 | KH homology domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2006 | KHDRBS2 | KH domain containing, RNA binding, signal transduction associated 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2007 | KHSRP | KH-type splicing regulatory protein | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2008 | KIAA0101 | KIAA0101 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2009 | KIAA0182 | KIAA0182 | 1 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2010 | KIAA0317 | KIAA0317 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2011 | KIAA0319L | KIAA0319-like | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2012 | KIAA0406 | KIAA0406 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2013 | KIAA0415 | KIAA0415 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2014 | KIAA0427 | KIAA0427 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2015 | KIAA0528 | KIAA0528 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2016 | KIAA0564 | KIAA0564 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2017 | KIAA0649 | KIAA0649 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2018 | KIAA0652 | 1 | 5 | 0 | 675 | 0 | 1.00 | 1.00 | |
2019 | KIAA0748 | KIAA0748 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2020 | KIAA0802 | KIAA0802 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2021 | KIAA0831 | KIAA0831 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2022 | KIAA1012 | KIAA1012 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2023 | KIAA1024 | KIAA1024 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2024 | KIAA1033 | KIAA1033 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2025 | KIAA1210 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2026 | KIAA1211 | 6 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2027 | KIAA1244 | KIAA1244 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2028 | KIAA1274 | KIAA1274 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2029 | KIAA1324 | KIAA1324 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2030 | KIAA1328 | KIAA1328 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2031 | KIAA1377 | KIAA1377 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2032 | KIAA1409 | KIAA1409 | 8 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2033 | KIAA1467 | KIAA1467 | 3 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2034 | KIAA1468 | KIAA1468 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2035 | KIAA1524 | KIAA1524 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
2036 | KIAA1632 | KIAA1632 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
2037 | KIAA1671 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2038 | KIAA1804 | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 | |
2039 | KIAA1967 | KIAA1967 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2040 | KIAA2022 | KIAA2022 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2041 | KIAA2026 | KIAA2026 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2042 | KIDINS220 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2043 | KIF16B | kinesin family member 16B | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
2044 | KIF1A | kinesin family member 1A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2045 | KIF21A | kinesin family member 21A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2046 | KIF3B | kinesin family member 3B | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2047 | KIF5C | kinesin family member 5C | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2048 | KIF6 | kinesin family member 6 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2049 | KIFC2 | kinesin family member C2 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2050 | KIFC3 | kinesin family member C3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2051 | KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0 | 201 | 0 | 27,135 | 0 | 1.00 | 1.00 |
2052 | KL | klotho | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2053 | KLB | klotho beta | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2054 | KLC4 | kinesin light chain 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2055 | KLF15 | Kruppel-like factor 15 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2056 | KLF3 | Kruppel-like factor 3 (basic) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2057 | KLF4 | Kruppel-like factor 4 (gut) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2058 | KLF5 | Kruppel-like factor 5 (intestinal) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2059 | KLF6 | Kruppel-like factor 6 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2060 | KLHDC5 | kelch domain containing 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2061 | KLHDC7B | kelch domain containing 7B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2062 | KLHL10 | kelch-like 10 (Drosophila) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2063 | KLHL21 | kelch-like 21 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2064 | KLHL22 | kelch-like 22 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2065 | KLHL29 | kelch-like 29 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2066 | KLHL4 | kelch-like 4 (Drosophila) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2067 | KLK10 | kallikrein-related peptidase 10 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2068 | KLK14 | kallikrein-related peptidase 14 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2069 | KLK15 | kallikrein-related peptidase 15 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2070 | KLK2 | kallikrein-related peptidase 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2071 | KLK3 | kallikrein-related peptidase 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2072 | KLK8 | kallikrein-related peptidase 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2073 | KLK9 | kallikrein-related peptidase 9 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2074 | KLRG1 | killer cell lectin-like receptor subfamily G, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2075 | KLRG2 | killer cell lectin-like receptor subfamily G, member 2 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2076 | KNTC1 | kinetochore associated 1 | 2 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 |
2077 | KPNA2 | karyopherin alpha 2 (RAG cohort 1, importin alpha 1) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2078 | KPNA5 | karyopherin alpha 5 (importin alpha 6) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2079 | KPNA7 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 | |
2080 | KRAS | v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog | 2 | 53 | 0 | 7,155 | 0 | 1.00 | 1.00 |
2081 | KRBA1 | KRAB-A domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2082 | KREMEN1 | kringle containing transmembrane protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2083 | KREMEN2 | kringle containing transmembrane protein 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2084 | KRIT1 | KRIT1, ankyrin repeat containing | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2085 | KRT17 | keratin 17 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2086 | KRT20 | keratin 20 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2087 | KRT222 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2088 | KRT34 | keratin 34 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2089 | KRT73 | keratin 73 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2090 | KRT76 | keratin 76 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2091 | KRT9 | keratin 9 (epidermolytic palmoplantar keratoderma) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2092 | KRTAP10-8 | keratin associated protein 10-8 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2093 | KRTAP12-3 | keratin associated protein 12-3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2094 | KRTAP13-3 | keratin associated protein 13-3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2095 | KRTAP20-1 | keratin associated protein 20-1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2096 | KRTAP20-2 | keratin associated protein 20-2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2097 | KRTAP21-1 | keratin associated protein 21-1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2098 | KRTAP5-5 | keratin associated protein 5-5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2099 | KSR1 | kinase suppressor of ras 1 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2100 | KSR2 | kinase suppressor of ras 2 | 1 | 8 | 0 | 1,080 | 0 | 1.00 | 1.00 |
2101 | KTI12 | KTI12 homolog, chromatin associated (S. cerevisiae) | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2102 | KTN1 | kinectin 1 (kinesin receptor) | 3 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2103 | KYNU | kynureninase (L-kynurenine hydrolase) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2104 | L1CAM | L1 cell adhesion molecule | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2105 | L3MBTL | l(3)mbt-like (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2106 | L3MBTL2 | l(3)mbt-like 2 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2107 | LACE1 | lactation elevated 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2108 | LACRT | lacritin | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2109 | LAMA1 | laminin, alpha 1 | 7 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2110 | LAMA2 | laminin, alpha 2 (merosin, congenital muscular dystrophy) | 10 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2111 | LAMA3 | laminin, alpha 3 | 6 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2112 | LAMA4 | laminin, alpha 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2113 | LAMB3 | laminin, beta 3 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2114 | LAMC1 | laminin, gamma 1 (formerly LAMB2) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2115 | LAMP1 | lysosomal-associated membrane protein 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2116 | LAMP3 | lysosomal-associated membrane protein 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2117 | LARGE | like-glycosyltransferase | 5 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2118 | LARP4B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2119 | LAS1L | LAS1-like (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2120 | LATS1 | LATS, large tumor suppressor, homolog 1 (Drosophila) | 2 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2121 | LATS2 | LATS, large tumor suppressor, homolog 2 (Drosophila) | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
2122 | LAX1 | lymphocyte transmembrane adaptor 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2123 | LBP | lipopolysaccharide binding protein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2124 | LCK | lymphocyte-specific protein tyrosine kinase | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2125 | LCT | lactase | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2126 | LDB1 | LIM domain binding 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2127 | LDHA | lactate dehydrogenase A | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2128 | LDHB | lactate dehydrogenase B | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2129 | LDLRAD3 | low density lipoprotein receptor class A domain containing 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2130 | LEF1 | lymphoid enhancer-binding factor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2131 | LEMD2 | LEM domain containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2132 | LEMD3 | LEM domain containing 3 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2133 | LENG8 | leukocyte receptor cluster (LRC) member 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2134 | LEPRE1 | leucine proline-enriched proteoglycan (leprecan) 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2135 | LEPREL1 | leprecan-like 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2136 | LETM1 | leucine zipper-EF-hand containing transmembrane protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2137 | LETMD1 | LETM1 domain containing 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2138 | LGALS2 | lectin, galactoside-binding, soluble, 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2139 | LGALS3BP | lectin, galactoside-binding, soluble, 3 binding protein | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2140 | LGI1 | leucine-rich, glioma inactivated 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2141 | LGR6 | leucine-rich repeat-containing G protein-coupled receptor 6 | 1 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2142 | LGSN | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2143 | LHCGR | luteinizing hormone/choriogonadotropin receptor | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2144 | LHFP | lipoma HMGIC fusion partner | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2145 | LHX3 | LIM homeobox 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2146 | LIFR | leukemia inhibitory factor receptor alpha | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2147 | LIG1 | ligase I, DNA, ATP-dependent | 4 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2148 | LIG3 | ligase III, DNA, ATP-dependent | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2149 | LILRA4 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2150 | LIMK1 | LIM domain kinase 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2151 | LINGO1 | leucine rich repeat and Ig domain containing 1 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2152 | LINGO2 | leucine rich repeat and Ig domain containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2153 | LIPE | lipase, hormone-sensitive | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2154 | LLGL1 | lethal giant larvae homolog 1 (Drosophila) | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2155 | LMF2 | lipase maturation factor 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2156 | LMNB1 | lamin B1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2157 | LMNB2 | lamin B2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2158 | LMO7 | LIM domain 7 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2159 | LMOD1 | leiomodin 1 (smooth muscle) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2160 | LMTK2 | lemur tyrosine kinase 2 | 0 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 |
2161 | LMTK3 | lemur tyrosine kinase 3 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
2162 | LMX1A | LIM homeobox transcription factor 1, alpha | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2163 | LNPEP | leucyl/cystinyl aminopeptidase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2164 | LNX1 | ligand of numb-protein X 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2165 | LNX2 | ligand of numb-protein X 2 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2166 | LONRF2 | LON peptidase N-terminal domain and ring finger 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2167 | LONRF3 | LON peptidase N-terminal domain and ring finger 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2168 | LOX | lysyl oxidase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2169 | LOXL4 | lysyl oxidase-like 4 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2170 | LPHN1 | latrophilin 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2171 | LPHN2 | latrophilin 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2172 | LPIN1 | lipin 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2173 | LPIN2 | lipin 2 | 5 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2174 | LPIN3 | lipin 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2175 | LPL | lipoprotein lipase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2176 | LPPR2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2177 | LRAT | lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2178 | LRBA | LPS-responsive vesicle trafficking, beach and anchor containing | 4 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2179 | LRCH1 | leucine-rich repeats and calponin homology (CH) domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2180 | LRFN5 | leucine rich repeat and fibronectin type III domain containing 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2181 | LRGUK | leucine-rich repeats and guanylate kinase domain containing | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2182 | LRIG1 | leucine-rich repeats and immunoglobulin-like domains 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2183 | LRIG3 | leucine-rich repeats and immunoglobulin-like domains 3 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2184 | LRP1 | low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor) | 8 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2185 | LRP10 | low density lipoprotein receptor-related protein 10 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2186 | LRP1B | low density lipoprotein-related protein 1B (deleted in tumors) | 52 | 19 | 0 | 2,565 | 0 | 1.00 | 1.00 |
2187 | LRP2 | low density lipoprotein-related protein 2 | 22 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
2188 | LRP5 | low density lipoprotein receptor-related protein 5 | 3 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2189 | LRP6 | low density lipoprotein receptor-related protein 6 | 1 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2190 | LRRC14B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2191 | LRRC16A | leucine rich repeat containing 16A | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2192 | LRRC33 | leucine rich repeat containing 33 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2193 | LRRC4 | leucine rich repeat containing 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2194 | LRRC41 | leucine rich repeat containing 41 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2195 | LRRC47 | leucine rich repeat containing 47 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2196 | LRRC4B | leucine rich repeat containing 4B | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2197 | LRRC4C | leucine rich repeat containing 4C | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2198 | LRRC59 | leucine rich repeat containing 59 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2199 | LRRC66 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2200 | LRRC7 | leucine rich repeat containing 7 | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
2201 | LRRC8C | leucine rich repeat containing 8 family, member C | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2202 | LRRC8E | leucine rich repeat containing 8 family, member E | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2203 | LRRFIP1 | leucine rich repeat (in FLII) interacting protein 1 | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2204 | LRRIQ1 | leucine-rich repeats and IQ motif containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2205 | LRRK1 | leucine-rich repeat kinase 1 | 0 | 8 | 0 | 1,080 | 0 | 1.00 | 1.00 |
2206 | LRRK2 | leucine-rich repeat kinase 2 | 6 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 |
2207 | LRRN1 | leucine rich repeat neuronal 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2208 | LRRN2 | leucine rich repeat neuronal 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2209 | LRRN3 | leucine rich repeat neuronal 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2210 | LTA4H | leukotriene A4 hydrolase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2211 | LTBP1 | latent transforming growth factor beta binding protein 1 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2212 | LTBP3 | latent transforming growth factor beta binding protein 3 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2213 | LTBP4 | latent transforming growth factor beta binding protein 4 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2214 | LTF | lactotransferrin | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2215 | LTK | leukocyte receptor tyrosine kinase | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
2216 | LUC7L | LUC7-like (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2217 | LUM | lumican | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2218 | LY6G6F | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2219 | LY6K | lymphocyte antigen 6 complex, locus K | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2220 | LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2221 | LYPLA1 | lysophospholipase I | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2222 | LYST | lysosomal trafficking regulator | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2223 | LYVE1 | lymphatic vessel endothelial hyaluronan receptor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2224 | LYZL4 | lysozyme-like 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2225 | LZTR1 | leucine-zipper-like transcription regulator 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2226 | LZTS2 | leucine zipper, putative tumor suppressor 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2227 | MACF1 | microtubule-actin crosslinking factor 1 | 15 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
2228 | MAD1L1 | MAD1 mitotic arrest deficient-like 1 (yeast) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2229 | MADD | MAP-kinase activating death domain | 2 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2230 | MAEA | macrophage erythroblast attacher | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2231 | MAEL | maelstrom homolog (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2232 | MAFG | v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2233 | MAG | myelin associated glycoprotein | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2234 | MAGEA1 | melanoma antigen family A, 1 (directs expression of antigen MZ2-E) | 2 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 |
2235 | MAGEA4 | melanoma antigen family A, 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2236 | MAGEB10 | melanoma antigen family B, 10 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2237 | MAGEB16 | melanoma antigen family B, 16 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2238 | MAGEB18 | melanoma antigen family B, 18 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2239 | MAGEC1 | melanoma antigen family C, 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2240 | MAGEC2 | melanoma antigen family C, 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2241 | MAGEC3 | melanoma antigen family C, 3 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2242 | MAGED2 | melanoma antigen family D, 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2243 | MAGEE1 | melanoma antigen family E, 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2244 | MAGEH1 | melanoma antigen family H, 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2245 | MAGI1 | membrane associated guanylate kinase, WW and PDZ domain containing 1 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2246 | MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2247 | MAGOHB | mago-nashi homolog B (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2248 | MAK | male germ cell-associated kinase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2249 | MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2250 | MAMDC2 | MAM domain containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2251 | MAMDC4 | MAM domain containing 4 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2252 | MAML1 | mastermind-like 1 (Drosophila) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2253 | MAML2 | mastermind-like 2 (Drosophila) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2254 | MAN1A1 | mannosidase, alpha, class 1A, member 1 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2255 | MAN1B1 | mannosidase, alpha, class 1B, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2256 | MAN2A1 | mannosidase, alpha, class 2A, member 1 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2257 | MAN2B1 | mannosidase, alpha, class 2B, member 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2258 | MANEA | mannosidase, endo-alpha | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2259 | MAOA | monoamine oxidase A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2260 | MAOB | monoamine oxidase B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2261 | MAP1B | microtubule-associated protein 1B | 4 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2262 | MAP1S | microtubule-associated protein 1S | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2263 | MAP2 | microtubule-associated protein 2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2264 | MAP2K4 | mitogen-activated protein kinase kinase 4 | 0 | 15 | 0 | 2,025 | 0 | 1.00 | 1.00 |
2265 | MAP2K5 | mitogen-activated protein kinase kinase 5 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2266 | MAP2K6 | mitogen-activated protein kinase kinase 6 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2267 | MAP2K7 | mitogen-activated protein kinase kinase 7 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
2268 | MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | 4 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2269 | MAP3K10 | mitogen-activated protein kinase kinase kinase 10 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2270 | MAP3K11 | mitogen-activated protein kinase kinase kinase 11 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2271 | MAP3K12 | mitogen-activated protein kinase kinase kinase 12 | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2272 | MAP3K13 | mitogen-activated protein kinase kinase kinase 13 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2273 | MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 1 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
2274 | MAP3K15 | mitogen-activated protein kinase kinase kinase 15 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2275 | MAP3K2 | mitogen-activated protein kinase kinase kinase 2 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
2276 | MAP3K3 | mitogen-activated protein kinase kinase kinase 3 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2277 | MAP3K4 | mitogen-activated protein kinase kinase kinase 4 | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
2278 | MAP3K6 | mitogen-activated protein kinase kinase kinase 6 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
2279 | MAP3K7 | mitogen-activated protein kinase kinase kinase 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2280 | MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2281 | MAP3K9 | mitogen-activated protein kinase kinase kinase 9 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2282 | MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
2283 | MAP4K3 | mitogen-activated protein kinase kinase kinase kinase 3 | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2284 | MAP4K4 | mitogen-activated protein kinase kinase kinase kinase 4 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2285 | MAP4K5 | mitogen-activated protein kinase kinase kinase kinase 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2286 | MAP7D2 | MAP7 domain containing 2 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2287 | MAP7D3 | MAP7 domain containing 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2288 | MAP9 | microtubule-associated protein 9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2289 | MAPK10 | mitogen-activated protein kinase 10 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2290 | MAPK11 | mitogen-activated protein kinase 11 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2291 | MAPK13 | mitogen-activated protein kinase 13 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2292 | MAPK14 | mitogen-activated protein kinase 14 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2293 | MAPK15 | mitogen-activated protein kinase 15 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2294 | MAPK4 | mitogen-activated protein kinase 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2295 | MAPK6 | mitogen-activated protein kinase 6 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2296 | MAPK7 | mitogen-activated protein kinase 7 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
2297 | MAPK8 | mitogen-activated protein kinase 8 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
2298 | MAPK8IP2 | mitogen-activated protein kinase 8 interacting protein 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2299 | MAPK8IP3 | mitogen-activated protein kinase 8 interacting protein 3 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2300 | MAPK9 | mitogen-activated protein kinase 9 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2301 | MAPKAP1 | mitogen-activated protein kinase associated protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2302 | MAPKAPK3 | mitogen-activated protein kinase-activated protein kinase 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2303 | MAPKBP1 | mitogen-activated protein kinase binding protein 1 | 3 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2304 | MARCH1 | membrane-associated ring finger (C3HC4) 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2305 | MARCH5 | membrane-associated ring finger (C3HC4) 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2306 | MARCO | macrophage receptor with collagenous structure | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2307 | MARK1 | MAP/microtubule affinity-regulating kinase 1 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
2308 | MARK2 | MAP/microtubule affinity-regulating kinase 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2309 | MARK3 | MAP/microtubule affinity-regulating kinase 3 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2310 | MARK4 | MAP/microtubule affinity-regulating kinase 4 | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2311 | MARS | methionyl-tRNA synthetase | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2312 | MARS2 | methionyl-tRNA synthetase 2, mitochondrial | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2313 | MAST1 | microtubule associated serine/threonine kinase 1 | 4 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2314 | MAST2 | microtubule associated serine/threonine kinase 2 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
2315 | MAST3 | microtubule associated serine/threonine kinase 3 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2316 | MAST4 | microtubule associated serine/threonine kinase family member 4 | 3 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2317 | MASTL | microtubule associated serine/threonine kinase-like | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2318 | MATK | megakaryocyte-associated tyrosine kinase | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2319 | MATN1 | matrilin 1, cartilage matrix protein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2320 | MBD4 | methyl-CpG binding domain protein 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2321 | MBD6 | methyl-CpG binding domain protein 6 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2322 | MCART1 | mitochondrial carrier triple repeat 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2323 | MCCC1 | methylcrotonoyl-Coenzyme A carboxylase 1 (alpha) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2324 | MCF2 | MCF.2 cell line derived transforming sequence | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2325 | MCF2L | MCF.2 cell line derived transforming sequence-like | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2326 | MCF2L2 | MCF.2 cell line derived transforming sequence-like 2 | 3 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2327 | MCFD2 | multiple coagulation factor deficiency 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2328 | MCHR2 | melanin-concentrating hormone receptor 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2329 | MCM10 | minichromosome maintenance complex component 10 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2330 | MCM2 | minichromosome maintenance complex component 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2331 | MCM3 | minichromosome maintenance complex component 3 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2332 | MCM3AP | minichromosome maintenance complex component 3 associated protein | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
2333 | MCM4 | minichromosome maintenance complex component 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2334 | MCM8 | minichromosome maintenance complex component 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2335 | MCOLN1 | mucolipin 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2336 | MCPH1 | microcephalin 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2337 | MCRS1 | microspherule protein 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2338 | MDC1 | mediator of DNA damage checkpoint 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2339 | MDGA1 | MAM domain containing glycosylphosphatidylinositol anchor 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2340 | MDH1 | malate dehydrogenase 1, NAD (soluble) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2341 | MDH2 | malate dehydrogenase 2, NAD (mitochondrial) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2342 | MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2343 | MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2344 | MEA1 | male-enhanced antigen 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2345 | MECOM | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 | |
2346 | MED1 | mediator complex subunit 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2347 | MED12 | mediator complex subunit 12 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2348 | MED13L | mediator complex subunit 13-like | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2349 | MED14 | mediator complex subunit 14 | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2350 | MEF2C | myocyte enhancer factor 2C | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2351 | MEFV | Mediterranean fever | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2352 | MEI1 | meiosis inhibitor 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2353 | MELK | maternal embryonic leucine zipper kinase | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2354 | MEN1 | multiple endocrine neoplasia I | 1 | 208 | 0 | 28,080 | 0 | 1.00 | 1.00 |
2355 | MEOX2 | mesenchyme homeobox 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2356 | MEPE | matrix, extracellular phosphoglycoprotein with ASARM motif (bone) | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2357 | MERTK | c-mer proto-oncogene tyrosine kinase | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
2358 | MET | met proto-oncogene (hepatocyte growth factor receptor) | 2 | 36 | 0 | 4,860 | 0 | 1.00 | 1.00 |
2359 | METT10D | methyltransferase 10 domain containing | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2360 | METTL4 | methyltransferase like 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2361 | METTL5 | methyltransferase like 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2362 | MEX3B | mex-3 homolog B (C. elegans) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2363 | MEX3C | mex-3 homolog C (C. elegans) | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2364 | MEX3D | mex-3 homolog D (C. elegans) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2365 | MFAP1 | microfibrillar-associated protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2366 | MFAP5 | microfibrillar associated protein 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2367 | MFF | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2368 | MFN1 | mitofusin 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2369 | MFSD4 | major facilitator superfamily domain containing 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2370 | MFSD9 | major facilitator superfamily domain containing 9 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2371 | MGA | MAX gene associated | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
2372 | MGC42105 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 | |
2373 | MIA2 | melanoma inhibitory activity 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2374 | MICAL1 | microtubule associated monoxygenase, calponin and LIM domain containing 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2375 | MICALL1 | MICAL-like 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2376 | MICALL2 | MICAL-like 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2377 | MINK1 | misshapen-like kinase 1 (zebrafish) | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2378 | MINPP1 | multiple inositol polyphosphate histidine phosphatase, 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2379 | MIPEP | mitochondrial intermediate peptidase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2380 | MITD1 | MIT, microtubule interacting and transport, domain containing 1 | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2381 | MKI67 | antigen identified by monoclonal antibody Ki-67 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2382 | MKL1 | megakaryoblastic leukemia (translocation) 1 | 5 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2383 | MKNK1 | MAP kinase interacting serine/threonine kinase 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2384 | MKNK2 | MAP kinase interacting serine/threonine kinase 2 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2385 | MKRN3 | makorin, ring finger protein, 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2386 | MLF2 | myeloid leukemia factor 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2387 | MLH1 | mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) | 2 | 49 | 0 | 6,615 | 0 | 1.00 | 1.00 |
2388 | MLH3 | mutL homolog 3 (E. coli) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2389 | MLKL | mixed lineage kinase domain-like | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2390 | MLL | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) | 2 | 11 | 0 | 1,485 | 0 | 1.00 | 1.00 |
2391 | MLL2 | myeloid/lymphoid or mixed-lineage leukemia 2 | 0 | 25 | 0 | 3,375 | 0 | 1.00 | 1.00 |
2392 | MLL3 | myeloid/lymphoid or mixed-lineage leukemia 3 | 0 | 11 | 0 | 1,485 | 0 | 1.00 | 1.00 |
2393 | MLL4 | 3 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 | |
2394 | MLLT1 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2395 | MLLT10 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2396 | MLLT3 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2397 | MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2398 | MLLT6 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2399 | MMADHC | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2400 | MMD2 | monocyte to macrophage differentiation-associated 2 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2401 | MME | membrane metallo-endopeptidase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2402 | MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2403 | MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2404 | MMP11 | matrix metallopeptidase 11 (stromelysin 3) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2405 | MMP15 | matrix metallopeptidase 15 (membrane-inserted) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2406 | MMP16 | matrix metallopeptidase 16 (membrane-inserted) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2407 | MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
2408 | MMP20 | matrix metallopeptidase 20 (enamelysin) | 3 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2409 | MMP28 | matrix metallopeptidase 28 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2410 | MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2411 | MMP8 | matrix metallopeptidase 8 (neutrophil collagenase) | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2412 | MMRN2 | multimerin 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2413 | MN1 | meningioma (disrupted in balanced translocation) 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2414 | MOBKL2A | MOB1, Mps One Binder kinase activator-like 2A (yeast) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2415 | MOBKL2B | MOB1, Mps One Binder kinase activator-like 2B (yeast) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2416 | MOBP | myelin-associated oligodendrocyte basic protein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2417 | MOCS1 | molybdenum cofactor synthesis 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2418 | MOCS3 | molybdenum cofactor synthesis 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2419 | MON2 | MON2 homolog (S. cerevisiae) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2420 | MORN1 | MORN repeat containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2421 | MOS | v-mos Moloney murine sarcoma viral oncogene homolog | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2422 | MOSPD1 | motile sperm domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2423 | MOSPD2 | motile sperm domain containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2424 | MPDU1 | mannose-P-dolichol utilization defect 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2425 | MPDZ | multiple PDZ domain protein | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2426 | MPG | N-methylpurine-DNA glycosylase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2427 | MPL | myeloproliferative leukemia virus oncogene | 0 | 24 | 0 | 3,240 | 0 | 1.00 | 1.00 |
2428 | MPO | myeloperoxidase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2429 | MPP1 | membrane protein, palmitoylated 1, 55kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2430 | MPPED2 | metallophosphoesterase domain containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2431 | MPZ | myelin protein zero (Charcot-Marie-Tooth neuropathy 1B) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2432 | MRAS | muscle RAS oncogene homolog | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2433 | MRC2 | mannose receptor, C type 2 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2434 | MRE11A | MRE11 meiotic recombination 11 homolog A (S. cerevisiae) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2435 | MRGPRX1 | MAS-related GPR, member X1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2436 | MRPL13 | mitochondrial ribosomal protein L13 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2437 | MRPL16 | mitochondrial ribosomal protein L16 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2438 | MRPL44 | mitochondrial ribosomal protein L44 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2439 | MRPL46 | mitochondrial ribosomal protein L46 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2440 | MRPL55 | mitochondrial ribosomal protein L55 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2441 | MRPS5 | mitochondrial ribosomal protein S5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2442 | MRPS6 | mitochondrial ribosomal protein S6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2443 | MRPS7 | mitochondrial ribosomal protein S7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2444 | MS4A15 | membrane-spanning 4-domains, subfamily A, member 15 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2445 | MS4A5 | membrane-spanning 4-domains, subfamily A, member 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2446 | MSH2 | mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) | 0 | 45 | 0 | 6,075 | 0 | 1.00 | 1.00 |
2447 | MSH4 | mutS homolog 4 (E. coli) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2448 | MSH5 | mutS homolog 5 (E. coli) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2449 | MSH6 | mutS homolog 6 (E. coli) | 0 | 53 | 0 | 7,155 | 0 | 1.00 | 1.00 |
2450 | MSI1 | musashi homolog 1 (Drosophila) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2451 | MSI2 | musashi homolog 2 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2452 | MSL2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2453 | MSRB3 | methionine sulfoxide reductase B3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2454 | MST1 | macrophage stimulating 1 (hepatocyte growth factor-like) | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2455 | MST1R | macrophage stimulating 1 receptor (c-met-related tyrosine kinase) | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2456 | MST4 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 | |
2457 | MSTN | myostatin | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2458 | MTA1 | metastasis associated 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2459 | MTAP | methylthioadenosine phosphorylase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2460 | MTBP | Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2461 | MTDH | metadherin | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2462 | MTHFD1L | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2463 | MTHFD2L | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2464 | MTL5 | metallothionein-like 5, testis-specific (tesmin) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2465 | MTM1 | myotubularin 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2466 | MTMR11 | myotubularin related protein 11 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2467 | MTMR3 | myotubularin related protein 3 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2468 | MTMR4 | myotubularin related protein 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2469 | MTMR8 | myotubularin related protein 8 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2470 | MTNR1B | melatonin receptor 1B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2471 | MTOR | 3 | 14 | 0 | 1,890 | 0 | 1.00 | 1.00 | |
2472 | MTR | 5-methyltetrahydrofolate-homocysteine methyltransferase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2473 | MTSS1L | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2474 | MTTP | microsomal triglyceride transfer protein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2475 | MTUS1 | mitochondrial tumor suppressor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2476 | MTX2 | metaxin 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2477 | MUC1 | mucin 1, cell surface associated | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2478 | MUC15 | mucin 15, cell surface associated | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2479 | MUC16 | mucin 16, cell surface associated | 68 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2480 | MUC17 | mucin 17, cell surface associated | 19 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2481 | MUC2 | mucin 2, oligomeric mucus/gel-forming | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2482 | MUC7 | mucin 7, secreted | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2483 | MUM1L1 | melanoma associated antigen (mutated) 1-like 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2484 | MUSK | muscle, skeletal, receptor tyrosine kinase | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2485 | MVP | major vault protein | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2486 | MXRA5 | matrix-remodelling associated 5 | 10 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2487 | MYB | v-myb myeloblastosis viral oncogene homolog (avian) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2488 | MYBBP1A | MYB binding protein (P160) 1a | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2489 | MYBL2 | v-myb myeloblastosis viral oncogene homolog (avian)-like 2 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2490 | MYBPC3 | myosin binding protein C, cardiac | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2491 | MYBPHL | myosin binding protein H-like | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2492 | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
2493 | MYCBPAP | MYCBP associated protein | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2494 | MYCL1 | v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived (avian) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2495 | MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2496 | MYF6 | myogenic factor 6 (herculin) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2497 | MYH1 | myosin, heavy chain 1, skeletal muscle, adult | 9 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2498 | MYH11 | myosin, heavy chain 11, smooth muscle | 6 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2499 | MYH15 | myosin, heavy chain 15 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2500 | MYH2 | myosin, heavy chain 2, skeletal muscle, adult | 14 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2501 | MYH3 | myosin, heavy chain 3, skeletal muscle, embryonic | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2502 | MYH4 | myosin, heavy chain 4, skeletal muscle | 11 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2503 | MYH9 | myosin, heavy chain 9, non-muscle | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
2504 | MYLK | myosin light chain kinase | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2505 | MYLK2 | myosin light chain kinase 2 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2506 | MYLK3 | myosin light chain kinase 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2507 | MYO15A | myosin XVA | 4 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2508 | MYO16 | myosin XVI | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2509 | MYO18B | myosin XVIIIB | 9 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2510 | MYO1A | myosin IA | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2511 | MYO1B | myosin IB | 1 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
2512 | MYO1D | myosin ID | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2513 | MYO1E | myosin IE | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2514 | MYO3A | myosin IIIA | 8 | 15 | 0 | 2,025 | 0 | 1.00 | 1.00 |
2515 | MYO3B | myosin IIIB | 0 | 11 | 0 | 1,485 | 0 | 1.00 | 1.00 |
2516 | MYO5A | myosin VA (heavy chain 12, myoxin) | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2517 | MYO5C | myosin VC | 1 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2518 | MYO9A | myosin IXA | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2519 | MYOC | myocilin, trabecular meshwork inducible glucocorticoid response | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2520 | MYOCD | myocardin | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2521 | MYOD1 | myogenic differentiation 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2522 | MYOG | myogenin (myogenic factor 4) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2523 | MYOM1 | myomesin 1, 185kDa | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2524 | MYOM2 | myomesin (M-protein) 2, 165kDa | 8 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2525 | MYOT | myotilin | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2526 | MYRIP | myosin VIIA and Rab interacting protein | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2527 | MYST2 | MYST histone acetyltransferase 2 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2528 | MYST3 | MYST histone acetyltransferase (monocytic leukemia) 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2529 | MYST4 | MYST histone acetyltransferase (monocytic leukemia) 4 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
2530 | MYT1L | myelin transcription factor 1-like | 13 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2531 | N4BP2 | NEDD4 binding protein 2 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
2532 | NAA16 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2533 | NAA25 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2534 | NAA35 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2535 | NAGA | N-acetylgalactosaminidase, alpha- | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2536 | NAIP | NLR family, apoptosis inhibitory protein | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2537 | NALCN | sodium leak channel, non-selective | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2538 | NAMPT | nicotinamide phosphoribosyltransferase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2539 | NAP1L2 | nucleosome assembly protein 1-like 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2540 | NAP1L3 | nucleosome assembly protein 1-like 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2541 | NARF | nuclear prelamin A recognition factor | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2542 | NARG2 | NMDA receptor regulated 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2543 | NAT10 | N-acetyltransferase 10 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2544 | NAT14 | N-acetyltransferase 14 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2545 | NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2546 | NAT6 | N-acetyltransferase 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2547 | NAV1 | neuron navigator 1 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2548 | NAV3 | neuron navigator 3 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2549 | NBN | nibrin | 0 | 10 | 0 | 1,350 | 0 | 1.00 | 1.00 |
2550 | NBR1 | neighbor of BRCA1 gene 1 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2551 | NCAPD2 | non-SMC condensin I complex, subunit D2 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2552 | NCAPD3 | non-SMC condensin II complex, subunit D3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2553 | NCAPG | non-SMC condensin I complex, subunit G | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2554 | NCAPG2 | non-SMC condensin II complex, subunit G2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2555 | NCAPH | non-SMC condensin I complex, subunit H | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2556 | NCBP1 | nuclear cap binding protein subunit 1, 80kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2557 | NCDN | neurochondrin | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2558 | NCKAP1L | NCK-associated protein 1-like | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2559 | NCOA1 | nuclear receptor coactivator 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2560 | NCOA2 | nuclear receptor coactivator 2 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2561 | NCOA3 | nuclear receptor coactivator 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2562 | NCOA4 | nuclear receptor coactivator 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2563 | NCOA5 | nuclear receptor coactivator 5 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2564 | NCOA6 | nuclear receptor coactivator 6 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2565 | NCOA7 | nuclear receptor coactivator 7 | 4 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2566 | NCOR1 | nuclear receptor co-repressor 1 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2567 | NCR1 | natural cytotoxicity triggering receptor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2568 | NDRG2 | NDRG family member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2569 | NDST3 | N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2570 | NDUFA1 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2571 | NDUFA10 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2572 | NDUFA11 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2573 | NDUFA2 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2574 | NDUFA3 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2575 | NDUFA8 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8, 19kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2576 | NDUFB2 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2577 | NDUFB9 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2578 | NDUFS6 | NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2579 | NEB | nebulin | 9 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2580 | NECAB3 | N-terminal EF-hand calcium binding protein 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2581 | NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2582 | NEIL3 | nei endonuclease VIII-like 3 (E. coli) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2583 | NEK1 | NIMA (never in mitosis gene a)-related kinase 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2584 | NEK10 | NIMA (never in mitosis gene a)- related kinase 10 | 1 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
2585 | NEK11 | NIMA (never in mitosis gene a)- related kinase 11 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
2586 | NEK4 | NIMA (never in mitosis gene a)-related kinase 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2587 | NEK6 | NIMA (never in mitosis gene a)-related kinase 6 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2588 | NEK7 | NIMA (never in mitosis gene a)-related kinase 7 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2589 | NEK8 | NIMA (never in mitosis gene a)- related kinase 8 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2590 | NEK9 | NIMA (never in mitosis gene a)- related kinase 9 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2591 | NELL1 | NEL-like 1 (chicken) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2592 | NELL2 | NEL-like 2 (chicken) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2593 | NET1 | neuroepithelial cell transforming gene 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2594 | NEUROG2 | neurogenin 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2595 | NF1 | neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease) | 14 | 289 | 0 | 39,015 | 0 | 1.00 | 1.00 |
2596 | NF2 | neurofibromin 2 (merlin) | 0 | 546 | 0 | 73,710 | 0 | 1.00 | 1.00 |
2597 | NFATC1 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2598 | NFATC3 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2599 | NFATC4 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2600 | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2601 | NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2602 | NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2603 | NFYC | nuclear transcription factor Y, gamma | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2604 | NGEF | neuronal guanine nucleotide exchange factor | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2605 | NGF | nerve growth factor (beta polypeptide) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2606 | NGRN | neugrin, neurite outgrowth associated | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2607 | NHEJ1 | nonhomologous end-joining factor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2608 | NHS | Nance-Horan syndrome (congenital cataracts and dental anomalies) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2609 | NID1 | nidogen 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2610 | NID2 | nidogen 2 (osteonidogen) | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
2611 | NIN | ninein (GSK3B interacting protein) | 3 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
2612 | NINJ1 | ninjurin 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2613 | NINL | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2614 | NIP7 | nuclear import 7 homolog (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2615 | NIPBL | Nipped-B homolog (Drosophila) | 1 | 8 | 0 | 1,080 | 0 | 1.00 | 1.00 |
2616 | NISCH | nischarin | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2617 | NKG7 | natural killer cell group 7 sequence | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2618 | NKRF | NFKB repressing factor | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2619 | NKX2-1 | NK2 homeobox 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2620 | NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2621 | NLE1 | notchless homolog 1 (Drosophila) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2622 | NLGN1 | neuroligin 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2623 | NLGN2 | neuroligin 2 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2624 | NLGN4X | neuroligin 4, X-linked | 7 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2625 | NLK | nemo-like kinase | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2626 | NLN | neurolysin (metallopeptidase M3 family) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2627 | NLRC3 | NLR family, CARD domain containing 3 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2628 | NLRC4 | NLR family, CARD domain containing 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2629 | NLRC5 | NLR family, CARD domain containing 5 | 6 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2630 | NLRP1 | NLR family, pyrin domain containing 1 | 2 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
2631 | NLRP10 | NLR family, pyrin domain containing 10 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
2632 | NLRP12 | NLR family, pyrin domain containing 12 | 8 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2633 | NLRP13 | NLR family, pyrin domain containing 13 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2634 | NLRP14 | NLR family, pyrin domain containing 14 | 5 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2635 | NLRP3 | NLR family, pyrin domain containing 3 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
2636 | NLRP4 | NLR family, pyrin domain containing 4 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2637 | NLRP5 | NLR family, pyrin domain containing 5 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2638 | NLRP6 | NLR family, pyrin domain containing 6 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2639 | NLRP7 | NLR family, pyrin domain containing 7 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2640 | NLRP8 | NLR family, pyrin domain containing 8 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
2641 | NLRP9 | NLR family, pyrin domain containing 9 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2642 | NMBR | neuromedin B receptor | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2643 | NME2 | non-metastatic cells 2, protein (NM23B) expressed in | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2644 | NME7 | non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2645 | NMUR1 | neuromedin U receptor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2646 | NNT | nicotinamide nucleotide transhydrogenase | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2647 | NOC2L | nucleolar complex associated 2 homolog (S. cerevisiae) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2648 | NODAL | nodal homolog (mouse) | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2649 | NOP16 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2650 | NOS1AP | nitric oxide synthase 1 (neuronal) adaptor protein | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2651 | NOS2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2652 | NOS3 | nitric oxide synthase 3 (endothelial cell) | 1 | 8 | 0 | 1,080 | 0 | 1.00 | 1.00 |
2653 | NOTCH1 | Notch homolog 1, translocation-associated (Drosophila) | 6 | 283 | 0 | 38,205 | 0 | 1.00 | 1.00 |
2654 | NOTCH2 | Notch homolog 2 (Drosophila) | 2 | 12 | 0 | 1,620 | 0 | 1.00 | 1.00 |
2655 | NOTCH3 | Notch homolog 3 (Drosophila) | 3 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2656 | NOTCH4 | Notch homolog 4 (Drosophila) | 4 | 10 | 0 | 1,350 | 0 | 1.00 | 1.00 |
2657 | NOV | nephroblastoma overexpressed gene | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2658 | NOVA1 | neuro-oncological ventral antigen 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2659 | NOX4 | NADPH oxidase 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2660 | NPBWR1 | neuropeptides B/W receptor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2661 | NPBWR2 | neuropeptides B/W receptor 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2662 | NPC1L1 | NPC1 (Niemann-Pick disease, type C1, gene)-like 1 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2663 | NPFFR2 | neuropeptide FF receptor 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2664 | NPL | N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2665 | NPM1 | nucleophosmin (nucleolar phosphoprotein B23, numatrin) | 0 | 29 | 0 | 3,915 | 0 | 1.00 | 1.00 |
2666 | NPPA | natriuretic peptide precursor A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2667 | NPR1 | natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2668 | NPR3 | natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2669 | NPSR1 | neuropeptide S receptor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2670 | NPTX2 | neuronal pentraxin II | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2671 | NPTXR | neuronal pentraxin receptor | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2672 | NR0B1 | nuclear receptor subfamily 0, group B, member 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2673 | NR1D1 | nuclear receptor subfamily 1, group D, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2674 | NR1D2 | nuclear receptor subfamily 1, group D, member 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2675 | NR1H3 | nuclear receptor subfamily 1, group H, member 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2676 | NR1H4 | nuclear receptor subfamily 1, group H, member 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2677 | NR2E1 | nuclear receptor subfamily 2, group E, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2678 | NR2F1 | nuclear receptor subfamily 2, group F, member 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2679 | NR2F2 | nuclear receptor subfamily 2, group F, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2680 | NR3C2 | nuclear receptor subfamily 3, group C, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2681 | NR5A2 | nuclear receptor subfamily 5, group A, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2682 | NRAP | nebulin-related anchoring protein | 7 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2683 | NRAS | neuroblastoma RAS viral (v-ras) oncogene homolog | 0 | 29 | 0 | 3,915 | 0 | 1.00 | 1.00 |
2684 | NRBP1 | nuclear receptor binding protein 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2685 | NRBP2 | nuclear receptor binding protein 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2686 | NRCAM | neuronal cell adhesion molecule | 3 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2687 | NRK | Nik related kinase | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
2688 | NRN1L | neuritin 1-like | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2689 | NRP1 | neuropilin 1 | 4 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2690 | NRP2 | neuropilin 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2691 | NRXN2 | neurexin 2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2692 | NRXN3 | neurexin 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2693 | NSD1 | nuclear receptor binding SET domain protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2694 | NSMCE2 | non-SMC element 2, MMS21 homolog (S. cerevisiae) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2695 | NT5DC3 | 5'-nucleotidase domain containing 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2696 | NT5E | 5'-nucleotidase, ecto (CD73) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2697 | NTHL1 | nth endonuclease III-like 1 (E. coli) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2698 | NTM | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2699 | NTN3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2700 | NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 5 | 11 | 0 | 1,485 | 0 | 1.00 | 1.00 |
2701 | NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 | 0 | 10 | 0 | 1,350 | 0 | 1.00 | 1.00 |
2702 | NTRK3 | neurotrophic tyrosine kinase, receptor, type 3 | 0 | 17 | 0 | 2,295 | 0 | 1.00 | 1.00 |
2703 | NUAK1 | NUAK family, SNF1-like kinase, 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2704 | NUAK2 | NUAK family, SNF1-like kinase, 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2705 | NUDCD1 | NudC domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2706 | NUDT14 | nudix (nucleoside diphosphate linked moiety X)-type motif 14 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2707 | NUMA1 | nuclear mitotic apparatus protein 1 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2708 | NUMB | numb homolog (Drosophila) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2709 | NUP133 | nucleoporin 133kDa | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2710 | NUP153 | nucleoporin 153kDa | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2711 | NUP160 | nucleoporin 160kDa | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2712 | NUP188 | nucleoporin 188kDa | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2713 | NUP205 | nucleoporin 205kDa | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2714 | NUP210 | nucleoporin 210kDa | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2715 | NUP210L | nucleoporin 210kDa-like | 7 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2716 | NUP214 | nucleoporin 214kDa | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
2717 | NUP54 | nucleoporin 54kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2718 | NUP88 | nucleoporin 88kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2719 | NUP93 | nucleoporin 93kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2720 | NUP98 | nucleoporin 98kDa | 3 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
2721 | NUPL2 | nucleoporin like 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2722 | NUS1 | nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2723 | NXF1 | nuclear RNA export factor 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2724 | NXF3 | nuclear RNA export factor 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2725 | NXF5 | nuclear RNA export factor 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2726 | NXN | nucleoredoxin | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2727 | NXPH1 | neurexophilin 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2728 | NXPH2 | neurexophilin 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2729 | NYX | nyctalopin | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2730 | OBSCN | obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF | 11 | 16 | 0 | 2,160 | 0 | 1.00 | 1.00 |
2731 | OC90 | otoconin 90 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2732 | OCA2 | oculocutaneous albinism II | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2733 | OCEL1 | occludin/ELL domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2734 | OCRL | oculocerebrorenal syndrome of Lowe | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2735 | ODAM | odontogenic, ameloblast asssociated | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2736 | ODZ1 | odz, odd Oz/ten-m homolog 1(Drosophila) | 0 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 |
2737 | OLA1 | Obg-like ATPase 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2738 | OLFM2 | olfactomedin 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2739 | OLFM3 | olfactomedin 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2740 | OLIG1 | oligodendrocyte transcription factor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2741 | OLIG2 | oligodendrocyte lineage transcription factor 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2742 | OMA1 | OMA1 homolog, zinc metallopeptidase (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2743 | OMG | oligodendrocyte myelin glycoprotein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2744 | ONECUT2 | one cut homeobox 2 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2745 | OPRD1 | opioid receptor, delta 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2746 | OPRL1 | opiate receptor-like 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2747 | OR10G3 | olfactory receptor, family 10, subfamily G, member 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2748 | OR10G4 | olfactory receptor, family 10, subfamily G, member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2749 | OR10H2 | olfactory receptor, family 10, subfamily H, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2750 | OR10P1 | olfactory receptor, family 10, subfamily P, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2751 | OR10T2 | olfactory receptor, family 10, subfamily T, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2752 | OR12D3 | olfactory receptor, family 12, subfamily D, member 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2753 | OR13J1 | olfactory receptor, family 13, subfamily J, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2754 | OR1E2 | olfactory receptor, family 1, subfamily E, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2755 | OR1J1 | olfactory receptor, family 1, subfamily J, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2756 | OR1J2 | olfactory receptor, family 1, subfamily J, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2757 | OR1L8 | olfactory receptor, family 1, subfamily L, member 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2758 | OR1N1 | olfactory receptor, family 1, subfamily N, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2759 | OR2A12 | olfactory receptor, family 2, subfamily A, member 12 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2760 | OR2AG1 | olfactory receptor, family 2, subfamily AG, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2761 | OR2AG2 | olfactory receptor, family 2, subfamily AG, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2762 | OR2D2 | olfactory receptor, family 2, subfamily D, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2763 | OR2G3 | olfactory receptor, family 2, subfamily G, member 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2764 | OR2L13 | olfactory receptor, family 2, subfamily L, member 13 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2765 | OR2L2 | olfactory receptor, family 2, subfamily L, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2766 | OR2S2 | olfactory receptor, family 2, subfamily S, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2767 | OR2T11 | olfactory receptor, family 2, subfamily T, member 11 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2768 | OR2T4 | olfactory receptor, family 2, subfamily T, member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2769 | OR2V2 | olfactory receptor, family 2, subfamily V, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2770 | OR2Y1 | olfactory receptor, family 2, subfamily Y, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2771 | OR2Z1 | olfactory receptor, family 2, subfamily Z, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2772 | OR3A1 | olfactory receptor, family 3, subfamily A, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2773 | OR4A5 | olfactory receptor, family 4, subfamily A, member 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2774 | OR4D11 | olfactory receptor, family 4, subfamily D, member 11 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2775 | OR4L1 | olfactory receptor, family 4, subfamily L, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2776 | OR4N2 | olfactory receptor, family 4, subfamily N, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2777 | OR4P4 | olfactory receptor, family 4, subfamily P, member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2778 | OR4S2 | olfactory receptor, family 4, subfamily S, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2779 | OR51B4 | olfactory receptor, family 51, subfamily B, member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2780 | OR52A5 | olfactory receptor, family 52, subfamily A, member 5 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2781 | OR52D1 | olfactory receptor, family 52, subfamily D, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2782 | OR52E6 | olfactory receptor, family 52, subfamily E, member 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2783 | OR52J3 | olfactory receptor, family 52, subfamily J, member 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2784 | OR56A4 | olfactory receptor, family 56, subfamily A, member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2785 | OR56B1 | olfactory receptor, family 56, subfamily B, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2786 | OR56B4 | olfactory receptor, family 56, subfamily B, member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2787 | OR5A1 | olfactory receptor, family 5, subfamily A, member 1 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2788 | OR5AP2 | olfactory receptor, family 5, subfamily AP, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2789 | OR5AU1 | olfactory receptor, family 5, subfamily AU, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2790 | OR5D14 | olfactory receptor, family 5, subfamily D, member 14 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2791 | OR5H6 | olfactory receptor, family 5, subfamily H, member 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2792 | OR5K4 | olfactory receptor, family 5, subfamily K, member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2793 | OR5M1 | olfactory receptor, family 5, subfamily M, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2794 | OR5M8 | olfactory receptor, family 5, subfamily M, member 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2795 | OR5M9 | olfactory receptor, family 5, subfamily M, member 9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2796 | OR5P2 | olfactory receptor, family 5, subfamily P, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2797 | OR6C74 | olfactory receptor, family 6, subfamily C, member 74 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2798 | OR6K3 | olfactory receptor, family 6, subfamily K, member 3 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2799 | OR7A5 | olfactory receptor, family 7, subfamily A, member 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2800 | OR7D4 | olfactory receptor, family 7, subfamily D, member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2801 | OR8D2 | olfactory receptor, family 8, subfamily D, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2802 | OR8K3 | olfactory receptor, family 8, subfamily K, member 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2803 | OR9K2 | olfactory receptor, family 9, subfamily K, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2804 | OR9Q2 | olfactory receptor, family 9, subfamily Q, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2805 | ORAI2 | ORAI calcium release-activated calcium modulator 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2806 | ORC6L | origin recognition complex, subunit 6 like (yeast) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2807 | OSBP | oxysterol binding protein | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2808 | OSBPL11 | oxysterol binding protein-like 11 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2809 | OSBPL2 | oxysterol binding protein-like 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2810 | OSBPL3 | oxysterol binding protein-like 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2811 | OSBPL5 | oxysterol binding protein-like 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2812 | OSBPL9 | oxysterol binding protein-like 9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2813 | OSMR | oncostatin M receptor | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2814 | OSTC | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2815 | OSTM1 | osteopetrosis associated transmembrane protein 1 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2816 | OTC | ornithine carbamoyltransferase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2817 | OTOF | otoferlin | 4 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2818 | OTOP2 | otopetrin 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2819 | OTOR | otoraplin | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2820 | OTUD4 | OTU domain containing 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2821 | OVCH1 | ovochymase 1 | 4 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2822 | OVGP1 | oviductal glycoprotein 1, 120kDa (mucin 9, oviductin) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2823 | OVOL1 | ovo-like 1(Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2824 | OVOL2 | ovo-like 2 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2825 | OXA1L | oxidase (cytochrome c) assembly 1-like | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2826 | OXCT1 | 3-oxoacid CoA transferase 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2827 | OXGR1 | oxoglutarate (alpha-ketoglutarate) receptor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2828 | OXSM | 3-oxoacyl-ACP synthase, mitochondrial | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2829 | OXSR1 | oxidative-stress responsive 1 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2830 | P2RX7 | purinergic receptor P2X, ligand-gated ion channel, 7 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2831 | P2RY10 | purinergic receptor P2Y, G-protein coupled, 10 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2832 | P2RY14 | purinergic receptor P2Y, G-protein coupled, 14 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2833 | P4HTM | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 | |
2834 | PABPC3 | poly(A) binding protein, cytoplasmic 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2835 | PABPC5 | poly(A) binding protein, cytoplasmic 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2836 | PADI2 | peptidyl arginine deiminase, type II | 3 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2837 | PADI3 | peptidyl arginine deiminase, type III | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2838 | PAFAH1B2 | platelet-activating factor acetylhydrolase, isoform Ib, beta subunit 30kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2839 | PAK1 | p21/Cdc42/Rac1-activated kinase 1 (STE20 homolog, yeast) | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2840 | PAK3 | p21 (CDKN1A)-activated kinase 3 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
2841 | PAK4 | p21(CDKN1A)-activated kinase 4 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2842 | PAK6 | p21(CDKN1A)-activated kinase 6 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
2843 | PAK7 | p21(CDKN1A)-activated kinase 7 | 0 | 12 | 0 | 1,620 | 0 | 1.00 | 1.00 |
2844 | PALB2 | partner and localizer of BRCA2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2845 | PALM2-AKAP2 | PALM2-AKAP2 | 5 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2846 | PAN2 | PAN2 polyA specific ribonuclease subunit homolog (S. cerevisiae) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2847 | PANK4 | pantothenate kinase 4 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2848 | PANX2 | pannexin 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2849 | PAPLN | papilin, proteoglycan-like sulfated glycoprotein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2850 | PAPOLG | poly(A) polymerase gamma | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2851 | PAPPA2 | pappalysin 2 | 24 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
2852 | PAPSS2 | 3'-phosphoadenosine 5'-phosphosulfate synthase 2 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2853 | PARP1 | poly (ADP-ribose) polymerase family, member 1 | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2854 | PARP11 | poly (ADP-ribose) polymerase family, member 11 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2855 | PARP8 | poly (ADP-ribose) polymerase family, member 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2856 | PASK | PAS domain containing serine/threonine kinase | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2857 | PAX1 | paired box 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2858 | PAX5 | paired box 5 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2859 | PAX7 | paired box 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2860 | PAX9 | paired box 9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2861 | PAXIP1 | PAX interacting (with transcription-activation domain) protein 1 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2862 | PBX4 | pre-B-cell leukemia homeobox 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2863 | PBXIP1 | pre-B-cell leukemia homeobox interacting protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2864 | PC | pyruvate carboxylase | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2865 | PCCA | propionyl Coenzyme A carboxylase, alpha polypeptide | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2866 | PCDH11X | protocadherin 11 X-linked | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2867 | PCDH19 | protocadherin 19 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
2868 | PCDH20 | protocadherin 20 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2869 | PCDH7 | protocadherin 7 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2870 | PCDH8 | protocadherin 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2871 | PCDHA13 | protocadherin alpha 13 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2872 | PCDHA6 | protocadherin alpha 6 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2873 | PCDHB15 | protocadherin beta 15 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2874 | PCDHB7 | protocadherin beta 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2875 | PCGF2 | polycomb group ring finger 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2876 | PCGF5 | polycomb group ring finger 5 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2877 | PCGF6 | polycomb group ring finger 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2878 | PCNA | proliferating cell nuclear antigen | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2879 | PCNXL2 | pecanex-like 2 (Drosophila) | 5 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2880 | PCSK2 | proprotein convertase subtilisin/kexin type 2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2881 | PCSK5 | proprotein convertase subtilisin/kexin type 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2882 | PCTP | phosphatidylcholine transfer protein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2883 | PCYOX1 | prenylcysteine oxidase 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2884 | PDCD10 | programmed cell death 10 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2885 | PDCD11 | programmed cell death 11 | 4 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2886 | PDCD4 | programmed cell death 4 (neoplastic transformation inhibitor) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2887 | PDCD5 | programmed cell death 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2888 | PDCD6 | programmed cell death 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2889 | PDCD6IP | programmed cell death 6 interacting protein | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2890 | PDE1C | phosphodiesterase 1C, calmodulin-dependent 70kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2891 | PDE2A | phosphodiesterase 2A, cGMP-stimulated | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2892 | PDE4A | phosphodiesterase 4A, cAMP-specific (phosphodiesterase E2 dunce homolog, Drosophila) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2893 | PDE4B | phosphodiesterase 4B, cAMP-specific (phosphodiesterase E4 dunce homolog, Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2894 | PDE4C | phosphodiesterase 4C, cAMP-specific (phosphodiesterase E1 dunce homolog, Drosophila) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2895 | PDE4D | phosphodiesterase 4D, cAMP-specific (phosphodiesterase E3 dunce homolog, Drosophila) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2896 | PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2897 | PDGFC | platelet derived growth factor C | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2898 | PDGFD | platelet derived growth factor D | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2899 | PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0 | 70 | 0 | 9,450 | 0 | 1.00 | 1.00 |
2900 | PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 5 | 10 | 0 | 1,350 | 0 | 1.00 | 1.00 |
2901 | PDHA2 | pyruvate dehydrogenase (lipoamide) alpha 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2902 | PDHB | pyruvate dehydrogenase (lipoamide) beta | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2903 | PDHX | pyruvate dehydrogenase complex, component X | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2904 | PDIA2 | protein disulfide isomerase family A, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2905 | PDILT | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2906 | PDK1 | pyruvate dehydrogenase kinase, isozyme 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2907 | PDK2 | pyruvate dehydrogenase kinase, isozyme 2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2908 | PDK3 | pyruvate dehydrogenase kinase, isozyme 3 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2909 | PDLIM4 | PDZ and LIM domain 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2910 | PDLIM7 | PDZ and LIM domain 7 (enigma) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2911 | PDP1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2912 | PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2913 | PDS5B | PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2914 | PDZD2 | PDZ domain containing 2 | 7 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2915 | PDZD3 | PDZ domain containing 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2916 | PDZD4 | PDZ domain containing 4 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2917 | PDZD7 | PDZ domain containing 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2918 | PDZRN4 | PDZ domain containing RING finger 4 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
2919 | PEG3 | paternally expressed 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2920 | PENK | proenkephalin | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2921 | PER1 | period homolog 1 (Drosophila) | 4 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
2922 | PER2 | period homolog 2 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2923 | PEX1 | peroxisome biogenesis factor 1 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2924 | PEX10 | peroxisome biogenesis factor 10 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2925 | PEX5L | peroxisomal biogenesis factor 5-like | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2926 | PFAS | phosphoribosylformylglycinamidine synthase (FGAR amidotransferase) | 5 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2927 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2928 | PFKFB4 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2929 | PFKM | phosphofructokinase, muscle | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2930 | PFKP | phosphofructokinase, platelet | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2931 | PGAP1 | post-GPI attachment to proteins 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2932 | PGBD3 | piggyBac transposable element derived 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2933 | PGBD5 | piggyBac transposable element derived 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2934 | PGM1 | phosphoglucomutase 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2935 | PGR | progesterone receptor | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2936 | PHC1 | polyhomeotic homolog 1 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2937 | PHC3 | polyhomeotic homolog 3 (Drosophila) | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2938 | PHEX | phosphate regulating endopeptidase homolog, X-linked (hypophosphatemia, vitamin D resistant rickets) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2939 | PHF10 | PHD finger protein 10 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2940 | PHF14 | PHD finger protein 14 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2941 | PHF21A | PHD finger protein 21A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2942 | PHF21B | PHD finger protein 21B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2943 | PHF3 | PHD finger protein 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2944 | PHF7 | PHD finger protein 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2945 | PHIP | pleckstrin homology domain interacting protein | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2946 | PHKA2 | phosphorylase kinase, alpha 2 (liver) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2947 | PHKB | phosphorylase kinase, beta | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2948 | PHKG1 | phosphorylase kinase, gamma 1 (muscle) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2949 | PHLPP2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2950 | PHOX2B | paired-like homeobox 2b | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
2951 | PI15 | peptidase inhibitor 15 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2952 | PI4K2A | phosphatidylinositol 4-kinase type 2 alpha | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2953 | PI4K2B | phosphatidylinositol 4-kinase type 2 beta | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2954 | PI4KA | phosphatidylinositol 4-kinase, catalytic, alpha | 3 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2955 | PI4KB | phosphatidylinositol 4-kinase, catalytic, beta | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2956 | PICALM | phosphatidylinositol binding clathrin assembly protein | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2957 | PIGC | phosphatidylinositol glycan anchor biosynthesis, class C | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2958 | PIGG | phosphatidylinositol glycan anchor biosynthesis, class G | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2959 | PIGM | phosphatidylinositol glycan anchor biosynthesis, class M | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2960 | PIGN | phosphatidylinositol glycan anchor biosynthesis, class N | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2961 | PIGO | phosphatidylinositol glycan anchor biosynthesis, class O | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2962 | PIGQ | phosphatidylinositol glycan anchor biosynthesis, class Q | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2963 | PIGR | polymeric immunoglobulin receptor | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2964 | PIGS | phosphatidylinositol glycan anchor biosynthesis, class S | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2965 | PIK3C2A | phosphoinositide-3-kinase, class 2, alpha polypeptide | 1 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
2966 | PIK3C2B | phosphoinositide-3-kinase, class 2, beta polypeptide | 5 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2967 | PIK3C2G | phosphoinositide-3-kinase, class 2, gamma polypeptide | 1 | 10 | 0 | 1,350 | 0 | 1.00 | 1.00 |
2968 | PIK3C3 | phosphoinositide-3-kinase, class 3 | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
2969 | PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 0 | 193 | 0 | 26,055 | 0 | 1.00 | 1.00 |
2970 | PIK3CB | phosphoinositide-3-kinase, catalytic, beta polypeptide | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2971 | PIK3CD | phosphoinositide-3-kinase, catalytic, delta polypeptide | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2972 | PIK3CG | phosphoinositide-3-kinase, catalytic, gamma polypeptide | 0 | 16 | 0 | 2,160 | 0 | 1.00 | 1.00 |
2973 | PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0 | 34 | 0 | 4,590 | 0 | 1.00 | 1.00 |
2974 | PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
2975 | PIK3R4 | phosphoinositide-3-kinase, regulatory subunit 4 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2976 | PIK3R5 | phosphoinositide-3-kinase, regulatory subunit 5 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2977 | PIKFYVE | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 | |
2978 | PIM1 | pim-1 oncogene | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2979 | PIM2 | pim-2 oncogene | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2980 | PINK1 | PTEN induced putative kinase 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2981 | PINX1 | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 | |
2982 | PION | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
2983 | PIP4K2A | phosphatidylinositol-5-phosphate 4-kinase, type II, alpha | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2984 | PIP4K2C | phosphatidylinositol-5-phosphate 4-kinase, type II, gamma | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2985 | PIP5K1A | phosphatidylinositol-4-phosphate 5-kinase, type I, alpha | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2986 | PIP5KL1 | phosphatidylinositol-4-phosphate 5-kinase-like 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2987 | PISD | phosphatidylserine decarboxylase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2988 | PITPNB | phosphatidylinositol transfer protein, beta | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2989 | PITPNC1 | phosphatidylinositol transfer protein, cytoplasmic 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2990 | PITPNM1 | phosphatidylinositol transfer protein, membrane-associated 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
2991 | PITPNM2 | phosphatidylinositol transfer protein, membrane-associated 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2992 | PITPNM3 | PITPNM family member 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2993 | PIWIL3 | piwi-like 3 (Drosophila) | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2994 | PKD1 | polycystic kidney disease 1 (autosomal dominant) | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2995 | PKD1L2 | polycystic kidney disease 1-like 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
2996 | PKDREJ | polycystic kidney disease (polycystin) and REJ homolog (sperm receptor for egg jelly homolog, sea urchin) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2997 | PKHD1 | polycystic kidney and hepatic disease 1 (autosomal recessive) | 20 | 8 | 0 | 1,080 | 0 | 1.00 | 1.00 |
2998 | PKHD1L1 | polycystic kidney and hepatic disease 1 (autosomal recessive)-like 1 | 29 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
2999 | PKIA | protein kinase (cAMP-dependent, catalytic) inhibitor alpha | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3000 | PKLR | pyruvate kinase, liver and RBC | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3001 | PKN1 | protein kinase N1 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3002 | PKN2 | protein kinase N2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3003 | PKN3 | protein kinase N3 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3004 | PKNOX1 | PBX/knotted 1 homeobox 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3005 | PKP3 | plakophilin 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3006 | PLA1A | phospholipase A1 member A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3007 | PLA2G4A | phospholipase A2, group IVA (cytosolic, calcium-dependent) | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3008 | PLAG1 | pleiomorphic adenoma gene 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3009 | PLAGL2 | pleiomorphic adenoma gene-like 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3010 | PLAT | plasminogen activator, tissue | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3011 | PLCB1 | phospholipase C, beta 1 (phosphoinositide-specific) | 6 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3012 | PLCB2 | phospholipase C, beta 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3013 | PLCB4 | phospholipase C, beta 4 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3014 | PLCD1 | phospholipase C, delta 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3015 | PLCD3 | phospholipase C, delta 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3016 | PLCE1 | phospholipase C, epsilon 1 | 6 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3017 | PLCG1 | phospholipase C, gamma 1 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3018 | PLCG2 | phospholipase C, gamma 2 (phosphatidylinositol-specific) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3019 | PLCH2 | phospholipase C, eta 2 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3020 | PLCL2 | phospholipase C-like 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3021 | PLCXD3 | phosphatidylinositol-specific phospholipase C, X domain containing 3 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3022 | PLCZ1 | phospholipase C, zeta 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3023 | PLD2 | phospholipase D2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3024 | PLD3 | phospholipase D family, member 3 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3025 | PLD4 | phospholipase D family, member 4 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3026 | PLEC | 7 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
3027 | PLEKHA1 | pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3028 | PLEKHA3 | pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3029 | PLEKHA4 | pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3030 | PLEKHA5 | pleckstrin homology domain containing, family A member 5 | 4 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3031 | PLEKHA7 | pleckstrin homology domain containing, family A member 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3032 | PLEKHA8 | pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 8 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3033 | PLEKHB1 | pleckstrin homology domain containing, family B (evectins) member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3034 | PLEKHG2 | pleckstrin homology domain containing, family G (with RhoGef domain) member 2 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3035 | PLEKHG4B | pleckstrin homology domain containing, family G (with RhoGef domain) member 4B | 6 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3036 | PLEKHH2 | pleckstrin homology domain containing, family H (with MyTH4 domain) member 2 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3037 | PLEKHO1 | pleckstrin homology domain containing, family O member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3038 | PLEKHO2 | pleckstrin homology domain containing, family O member 2 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3039 | PLIN1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 | |
3040 | PLK1 | polo-like kinase 1 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3041 | PLK2 | polo-like kinase 2 (Drosophila) | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3042 | PLOD1 | procollagen-lysine 1, 2-oxoglutarate 5-dioxygenase 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3043 | PLOD3 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3044 | PLS3 | plastin 3 (T isoform) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3045 | PLXDC2 | plexin domain containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3046 | PLXNA3 | plexin A3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3047 | PLXNB1 | plexin B1 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3048 | PLXNB3 | plexin B3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3049 | PLXNC1 | plexin C1 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3050 | PML | promyelocytic leukemia | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3051 | PMS1 | PMS1 postmeiotic segregation increased 1 (S. cerevisiae) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3052 | PMS2 | PMS2 postmeiotic segregation increased 2 (S. cerevisiae) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3053 | PNCK | pregnancy upregulated non-ubiquitously expressed CaM kinase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3054 | PNKP | polynucleotide kinase 3'-phosphatase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3055 | PNLIP | pancreatic lipase | 5 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3056 | PNLIPRP1 | pancreatic lipase-related protein 1 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3057 | PNMA3 | paraneoplastic antigen MA3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3058 | PNMA5 | paraneoplastic antigen like 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3059 | PNOC | prepronociceptin | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3060 | PODNL1 | podocan-like 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3061 | PODXL2 | podocalyxin-like 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3062 | POFUT1 | protein O-fucosyltransferase 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3063 | POLA1 | polymerase (DNA directed), alpha 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3064 | POLD1 | polymerase (DNA directed), delta 1, catalytic subunit 125kDa | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3065 | POLE | polymerase (DNA directed), epsilon | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3066 | POLG | polymerase (DNA directed), gamma | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3067 | POLG2 | polymerase (DNA directed), gamma 2, accessory subunit | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3068 | POLH | polymerase (DNA directed), eta | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3069 | POLI | polymerase (DNA directed) iota | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3070 | POLK | polymerase (DNA directed) kappa | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3071 | POLM | polymerase (DNA directed), mu | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3072 | POLN | polymerase (DNA directed) nu | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3073 | POLQ | polymerase (DNA directed), theta | 6 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3074 | POLR2F | polymerase (RNA) II (DNA directed) polypeptide F | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3075 | POLR3B | polymerase (RNA) III (DNA directed) polypeptide B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3076 | POLR3E | polymerase (RNA) III (DNA directed) polypeptide E (80kD) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3077 | POP1 | processing of precursor 1, ribonuclease P/MRP subunit (S. cerevisiae) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3078 | POPDC2 | popeye domain containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3079 | POPDC3 | popeye domain containing 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3080 | POT1 | POT1 protection of telomeres 1 homolog (S. pombe) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3081 | POTEF | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
3082 | POU1F1 | POU class 1 homeobox 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3083 | POU2AF1 | POU class 2 associating factor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3084 | POU2F1 | POU class 2 homeobox 1 | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3085 | POU2F2 | POU class 2 homeobox 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3086 | POU5F1 | POU class 5 homeobox 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3087 | POU6F2 | POU class 6 homeobox 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3088 | PPA1 | pyrophosphatase (inorganic) 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3089 | PPAP2C | phosphatidic acid phosphatase type 2C | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3090 | PPAPDC3 | phosphatidic acid phosphatase type 2 domain containing 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3091 | PPARA | peroxisome proliferator-activated receptor alpha | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3092 | PPARG | peroxisome proliferator-activated receptor gamma | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3093 | PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3094 | PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3095 | PPEF2 | protein phosphatase, EF-hand calcium binding domain 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3096 | PPFIA1 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3097 | PPFIA2 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3098 | PPFIA3 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3099 | PPFIA4 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3100 | PPFIBP1 | PTPRF interacting protein, binding protein 1 (liprin beta 1) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3101 | PPFIBP2 | PTPRF interacting protein, binding protein 2 (liprin beta 2) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3102 | PPHLN1 | periphilin 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3103 | PPIG | peptidylprolyl isomerase G (cyclophilin G) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3104 | PPIL5 | peptidylprolyl isomerase (cyclophilin)-like 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3105 | PPL | periplakin | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3106 | PPM1B | protein phosphatase 1B (formerly 2C), magnesium-dependent, beta isoform | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3107 | PPM1E | protein phosphatase 1E (PP2C domain containing) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3108 | PPM1F | protein phosphatase 1F (PP2C domain containing) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3109 | PPM1J | protein phosphatase 1J (PP2C domain containing) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3110 | PPP1CB | protein phosphatase 1, catalytic subunit, beta isoform | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3111 | PPP1CC | protein phosphatase 1, catalytic subunit, gamma isoform | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3112 | PPP1R10 | protein phosphatase 1, regulatory (inhibitor) subunit 10 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3113 | PPP1R12A | protein phosphatase 1, regulatory (inhibitor) subunit 12A | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3114 | PPP1R12C | protein phosphatase 1, regulatory (inhibitor) subunit 12C | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3115 | PPP1R15A | protein phosphatase 1, regulatory (inhibitor) subunit 15A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3116 | PPP1R16B | protein phosphatase 1, regulatory (inhibitor) subunit 16B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3117 | PPP1R2 | protein phosphatase 1, regulatory (inhibitor) subunit 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3118 | PPP1R3A | protein phosphatase 1, regulatory (inhibitor) subunit 3A | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3119 | PPP1R3G | protein phosphatase 1, regulatory (inhibitor) subunit 3G | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3120 | PPP1R9A | protein phosphatase 1, regulatory (inhibitor) subunit 9A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3121 | PPP2R1A | protein phosphatase 2 (formerly 2A), regulatory subunit A , alpha isoform | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3122 | PPP2R2A | protein phosphatase 2 (formerly 2A), regulatory subunit B, alpha isoform | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3123 | PPP2R2C | protein phosphatase 2 (formerly 2A), regulatory subunit B, gamma isoform | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3124 | PPP2R5C | protein phosphatase 2, regulatory subunit B', gamma isoform | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3125 | PPP2R5D | protein phosphatase 2, regulatory subunit B', delta isoform | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3126 | PPP3CA | protein phosphatase 3 (formerly 2B), catalytic subunit, alpha isoform | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3127 | PPP3CB | protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3128 | PPP3R2 | protein phosphatase 3 (formerly 2B), regulatory subunit B, beta isoform | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3129 | PPP4C | protein phosphatase 4 (formerly X), catalytic subunit | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3130 | PPP4R2 | protein phosphatase 4, regulatory subunit 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3131 | PPP5C | protein phosphatase 5, catalytic subunit | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3132 | PPP6C | protein phosphatase 6, catalytic subunit | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3133 | PPRC1 | peroxisome proliferator-activated receptor gamma, coactivator-related 1 | 4 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3134 | PQBP1 | polyglutamine binding protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3135 | PQLC1 | PQ loop repeat containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3136 | PRAME | preferentially expressed antigen in melanoma | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3137 | PRC1 | protein regulator of cytokinesis 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3138 | PRCC | papillary renal cell carcinoma (translocation-associated) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3139 | PRDM16 | PR domain containing 16 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3140 | PRDM4 | PR domain containing 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3141 | PRDM5 | PR domain containing 5 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3142 | PRDX5 | peroxiredoxin 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3143 | PRELP | proline/arginine-rich end leucine-rich repeat protein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3144 | PREX1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 | |
3145 | PREX2 | 0 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 | |
3146 | PRF1 | perforin 1 (pore forming protein) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3147 | PRIC285 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 | |
3148 | PRICKLE3 | prickle homolog 3 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3149 | PRIMA1 | proline rich membrane anchor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3150 | PRKAA1 | protein kinase, AMP-activated, alpha 1 catalytic subunit | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3151 | PRKAA2 | protein kinase, AMP-activated, alpha 2 catalytic subunit | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3152 | PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3153 | PRKACB | protein kinase, cAMP-dependent, catalytic, beta | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3154 | PRKAG1 | protein kinase, AMP-activated, gamma 1 non-catalytic subunit | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3155 | PRKAG2 | protein kinase, AMP-activated, gamma 2 non-catalytic subunit | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3156 | PRKAR1A | protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) | 0 | 8 | 0 | 1,080 | 0 | 1.00 | 1.00 |
3157 | PRKCA | protein kinase C, alpha | 3 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3158 | PRKCB | 1 | 7 | 0 | 945 | 0 | 1.00 | 1.00 | |
3159 | PRKCD | protein kinase C, delta | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3160 | PRKCE | protein kinase C, epsilon | 2 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3161 | PRKCG | protein kinase C, gamma | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3162 | PRKCH | protein kinase C, eta | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3163 | PRKCI | protein kinase C, iota | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3164 | PRKCQ | protein kinase C, theta | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3165 | PRKCZ | protein kinase C, zeta | 1 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3166 | PRKD1 | protein kinase D1 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3167 | PRKD2 | protein kinase D2 | 1 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3168 | PRKD3 | protein kinase D3 | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3169 | PRKDC | protein kinase, DNA-activated, catalytic polypeptide | 4 | 25 | 0 | 3,375 | 0 | 1.00 | 1.00 |
3170 | PRKG1 | protein kinase, cGMP-dependent, type I | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3171 | PRKG2 | protein kinase, cGMP-dependent, type II | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3172 | PRKRA | protein kinase, interferon-inducible double stranded RNA dependent activator | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3173 | PRKX | protein kinase, X-linked | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3174 | PRMT10 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
3175 | PRNP | prion protein (p27-30) (Creutzfeldt-Jakob disease, Gerstmann-Strausler-Scheinker syndrome, fatal familial insomnia) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3176 | PRODH | proline dehydrogenase (oxidase) 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3177 | PROKR2 | prokineticin receptor 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3178 | PROM1 | prominin 1 | 3 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3179 | PROS1 | protein S (alpha) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3180 | PROSC | proline synthetase co-transcribed homolog (bacterial) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3181 | PROX1 | prospero homeobox 1 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3182 | PRPF18 | PRP18 pre-mRNA processing factor 18 homolog (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3183 | PRPF4B | PRP4 pre-mRNA processing factor 4 homolog B (yeast) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3184 | PRPF8 | PRP8 pre-mRNA processing factor 8 homolog (S. cerevisiae) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3185 | PRPH2 | peripherin 2 (retinal degeneration, slow) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3186 | PRPS1 | phosphoribosyl pyrophosphate synthetase 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3187 | PRR23C | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
3188 | PRRG1 | proline rich Gla (G-carboxyglutamic acid) 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3189 | PRRT1 | proline-rich transmembrane protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3190 | PRSS1 | protease, serine, 1 (trypsin 1) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3191 | PRSS16 | protease, serine, 16 (thymus) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3192 | PRSS22 | protease, serine, 22 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3193 | PRSS23 | protease, serine, 23 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3194 | PSD | pleckstrin and Sec7 domain containing | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3195 | PSKH2 | protein serine kinase H2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3196 | PSMA2 | proteasome (prosome, macropain) subunit, alpha type, 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3197 | PSMA8 | proteasome (prosome, macropain) subunit, alpha type, 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3198 | PSMC5 | proteasome (prosome, macropain) 26S subunit, ATPase, 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3199 | PSMC6 | proteasome (prosome, macropain) 26S subunit, ATPase, 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3200 | PSMD6 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3201 | PSMD8 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3202 | PSME4 | proteasome (prosome, macropain) activator subunit 4 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3203 | PSPH | phosphoserine phosphatase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3204 | PTBP1 | polypyrimidine tract binding protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3205 | PTCH1 | patched homolog 1 (Drosophila) | 0 | 263 | 0 | 35,505 | 0 | 1.00 | 1.00 |
3206 | PTCH2 | patched homolog 2 (Drosophila) | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
3207 | PTCHD1 | patched domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3208 | PTCHD2 | patched domain containing 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3209 | PTCHD3 | patched domain containing 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3210 | PTEN | phosphatase and tensin homolog (mutated in multiple advanced cancers 1) | 0 | 736 | 0 | 99,360 | 0 | 1.00 | 1.00 |
3211 | PTGDR | prostaglandin D2 receptor (DP) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3212 | PTGES | prostaglandin E synthase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3213 | PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3214 | PTHLH | parathyroid hormone-like hormone | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3215 | PTK2 | PTK2 protein tyrosine kinase 2 | 2 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3216 | PTK2B | PTK2B protein tyrosine kinase 2 beta | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3217 | PTK6 | PTK6 protein tyrosine kinase 6 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3218 | PTK7 | PTK7 protein tyrosine kinase 7 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3219 | PTPLA | protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3220 | PTPLB | protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3221 | PTPMT1 | protein tyrosine phosphatase, mitochondrial 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3222 | PTPN11 | protein tyrosine phosphatase, non-receptor type 11 (Noonan syndrome 1) | 0 | 33 | 0 | 4,455 | 0 | 1.00 | 1.00 |
3223 | PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3224 | PTPN13 | protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3225 | PTPN14 | protein tyrosine phosphatase, non-receptor type 14 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3226 | PTPN18 | protein tyrosine phosphatase, non-receptor type 18 (brain-derived) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3227 | PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 3 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3228 | PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3229 | PTPN9 | protein tyrosine phosphatase, non-receptor type 9 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3230 | PTPRB | protein tyrosine phosphatase, receptor type, B | 9 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3231 | PTPRC | protein tyrosine phosphatase, receptor type, C | 4 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
3232 | PTPRD | protein tyrosine phosphatase, receptor type, D | 8 | 14 | 0 | 1,890 | 0 | 1.00 | 1.00 |
3233 | PTPRF | protein tyrosine phosphatase, receptor type, F | 4 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3234 | PTPRG | protein tyrosine phosphatase, receptor type, G | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3235 | PTPRJ | protein tyrosine phosphatase, receptor type, J | 2 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3236 | PTPRK | protein tyrosine phosphatase, receptor type, K | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3237 | PTPRM | protein tyrosine phosphatase, receptor type, M | 5 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3238 | PTPRN | protein tyrosine phosphatase, receptor type, N | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3239 | PTPRN2 | protein tyrosine phosphatase, receptor type, N polypeptide 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3240 | PTPRO | protein tyrosine phosphatase, receptor type, O | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3241 | PTPRR | protein tyrosine phosphatase, receptor type, R | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3242 | PTPRS | protein tyrosine phosphatase, receptor type, S | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3243 | PTPRT | protein tyrosine phosphatase, receptor type, T | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
3244 | PTPRU | protein tyrosine phosphatase, receptor type, U | 3 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3245 | PTPRZ1 | protein tyrosine phosphatase, receptor-type, Z polypeptide 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3246 | PTRF | polymerase I and transcript release factor | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3247 | PTX3 | pentraxin-related gene, rapidly induced by IL-1 beta | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3248 | PUM1 | pumilio homolog 1 (Drosophila) | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3249 | PUS1 | pseudouridylate synthase 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3250 | PUS10 | pseudouridylate synthase 10 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3251 | PYGB | phosphorylase, glycogen; brain | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3252 | PYROXD2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
3253 | PZP | pregnancy-zone protein | 6 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3254 | QKI | quaking homolog, KH domain RNA binding (mouse) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3255 | QPCT | glutaminyl-peptide cyclotransferase (glutaminyl cyclase) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3256 | QRICH2 | glutamine rich 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3257 | QSER1 | glutamine and serine rich 1 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3258 | QSOX1 | quiescin Q6 sulfhydryl oxidase 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3259 | QTRTD1 | queuine tRNA-ribosyltransferase domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3260 | R3HCC1 | R3H domain and coiled-coil containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3261 | RAB28 | RAB28, member RAS oncogene family | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3262 | RAB31 | RAB31, member RAS oncogene family | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3263 | RAB36 | RAB36, member RAS oncogene family | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3264 | RAB38 | RAB38, member RAS oncogene family | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3265 | RAB3C | RAB3C, member RAS oncogene family | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3266 | RAB3GAP1 | RAB3 GTPase activating protein subunit 1 (catalytic) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3267 | RAB3GAP2 | RAB3 GTPase activating protein subunit 2 (non-catalytic) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3268 | RAB3IL1 | RAB3A interacting protein (rabin3)-like 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3269 | RAB41 | RAB41, member RAS oncogene family | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3270 | RAB43 | RAB43, member RAS oncogene family | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3271 | RAB4B | RAB4B, member RAS oncogene family | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3272 | RAB5C | RAB5C, member RAS oncogene family | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3273 | RAB6C | RAB6C, member RAS oncogene family | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3274 | RAB8A | RAB8A, member RAS oncogene family | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3275 | RAB8B | RAB8B, member RAS oncogene family | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3276 | RABGAP1 | RAB GTPase activating protein 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3277 | RABGAP1L | RAB GTPase activating protein 1-like | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3278 | RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3279 | RACGAP1 | Rac GTPase activating protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3280 | RAD18 | RAD18 homolog (S. cerevisiae) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3281 | RAD21 | RAD21 homolog (S. pombe) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3282 | RAD23A | RAD23 homolog A (S. cerevisiae) | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3283 | RAD50 | RAD50 homolog (S. cerevisiae) | 3 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3284 | RAD51L1 | RAD51-like 1 (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3285 | RAD51L3 | RAD51-like 3 (S. cerevisiae) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3286 | RAD52 | RAD52 homolog (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3287 | RAD54B | RAD54 homolog B (S. cerevisiae) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3288 | RAD54L | RAD54-like (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3289 | RAD9B | RAD9 homolog B (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3290 | RADIL | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 | |
3291 | RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3292 | RAG1 | recombination activating gene 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3293 | RAGE | renal tumor antigen | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3294 | RAI1 | retinoic acid induced 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3295 | RAI2 | retinoic acid induced 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3296 | RALA | v-ral simian leukemia viral oncogene homolog A (ras related) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3297 | RALB | v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3298 | RALBP1 | ralA binding protein 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3299 | RALGDS | ral guanine nucleotide dissociation stimulator | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3300 | RANBP1 | RAN binding protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3301 | RANBP17 | RAN binding protein 17 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3302 | RANBP9 | RAN binding protein 9 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3303 | RAP1GAP | RAP1 GTPase activating protein | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3304 | RAP2A | RAP2A, member of RAS oncogene family | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3305 | RAP2B | RAP2B, member of RAS oncogene family | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3306 | RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3307 | RAPGEF2 | Rap guanine nucleotide exchange factor (GEF) 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3308 | RAPGEF4 | Rap guanine nucleotide exchange factor (GEF) 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3309 | RAPGEF6 | Rap guanine nucleotide exchange factor (GEF) 6 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3310 | RAPGEFL1 | Rap guanine nucleotide exchange factor (GEF)-like 1 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3311 | RAPH1 | Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3312 | RARA | retinoic acid receptor, alpha | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3313 | RARB | retinoic acid receptor, beta | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3314 | RARG | retinoic acid receptor, gamma | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3315 | RARS2 | arginyl-tRNA synthetase 2, mitochondrial | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3316 | RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3317 | RASA2 | RAS p21 protein activator 2 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3318 | RASA3 | RAS p21 protein activator 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3319 | RASAL1 | RAS protein activator like 1 (GAP1 like) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3320 | RASAL2 | RAS protein activator like 2 | 4 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3321 | RASD2 | RASD family, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3322 | RASEF | RAS and EF-hand domain containing | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3323 | RASGRF1 | Ras protein-specific guanine nucleotide-releasing factor 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3324 | RASGRF2 | Ras protein-specific guanine nucleotide-releasing factor 2 | 2 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
3325 | RASGRP3 | RAS guanyl releasing protein 3 (calcium and DAG-regulated) | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3326 | RASGRP4 | RAS guanyl releasing protein 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3327 | RASL10B | RAS-like, family 10, member B | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3328 | RASL11B | RAS-like, family 11, member B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3329 | RASL12 | RAS-like, family 12 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3330 | RASSF2 | Ras association (RalGDS/AF-6) domain family member 2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3331 | RASSF4 | Ras association (RalGDS/AF-6) domain family member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3332 | RAX | retina and anterior neural fold homeobox | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3333 | RB1 | retinoblastoma 1 (including osteosarcoma) | 0 | 271 | 0 | 36,585 | 0 | 1.00 | 1.00 |
3334 | RBAK | RB-associated KRAB zinc finger | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3335 | RBBP5 | retinoblastoma binding protein 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3336 | RBBP7 | retinoblastoma binding protein 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3337 | RBBP8 | retinoblastoma binding protein 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3338 | RBL1 | retinoblastoma-like 1 (p107) | 4 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
3339 | RBL2 | retinoblastoma-like 2 (p130) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3340 | RBM10 | RNA binding motif protein 10 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3341 | RBM14 | RNA binding motif protein 14 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3342 | RBM19 | RNA binding motif protein 19 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3343 | RBM25 | RNA binding motif protein 25 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3344 | RBM27 | RNA binding motif protein 27 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3345 | RBM34 | RNA binding motif protein 34 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3346 | RBM39 | RNA binding motif protein 39 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3347 | RBM5 | RNA binding motif protein 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3348 | RBMS3 | RNA binding motif, single stranded interacting protein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3349 | RBP3 | retinol binding protein 3, interstitial | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3350 | RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3351 | RCBTB2 | regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3352 | RCE1 | RCE1 homolog, prenyl protein peptidase (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3353 | RCN1 | reticulocalbin 1, EF-hand calcium binding domain | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3354 | RCSD1 | RCSD domain containing 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3355 | RECQL | RecQ protein-like (DNA helicase Q1-like) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3356 | RECQL4 | RecQ protein-like 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3357 | RECQL5 | RecQ protein-like 5 | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3358 | REG1B | regenerating islet-derived 1 beta (pancreatic stone protein, pancreatic thread protein) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3359 | RELA | v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65 (avian) | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3360 | RELN | reelin | 27 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3361 | REM1 | RAS (RAD and GEM)-like GTP-binding 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3362 | REM2 | RAS (RAD and GEM)-like GTP binding 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3363 | REN | renin | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3364 | REPS2 | RALBP1 associated Eps domain containing 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3365 | RERE | arginine-glutamic acid dipeptide (RE) repeats | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3366 | REST | RE1-silencing transcription factor | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3367 | RET | ret proto-oncogene | 0 | 54 | 0 | 7,290 | 0 | 1.00 | 1.00 |
3368 | REV3L | REV3-like, catalytic subunit of DNA polymerase zeta (yeast) | 4 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3369 | RFC1 | replication factor C (activator 1) 1, 145kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3370 | RFC4 | replication factor C (activator 1) 4, 37kDa | 0 | 8 | 0 | 1,080 | 0 | 1.00 | 1.00 |
3371 | RFNG | RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3372 | RFTN1 | raftlin, lipid raft linker 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3373 | RFX1 | regulatory factor X, 1 (influences HLA class II expression) | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3374 | RFX2 | regulatory factor X, 2 (influences HLA class II expression) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3375 | RFX3 | regulatory factor X, 3 (influences HLA class II expression) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3376 | RG9MTD2 | RNA (guanine-9-) methyltransferase domain containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3377 | RGAG1 | retrotransposon gag domain containing 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3378 | RGAG4 | retrotransposon gag domain containing 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3379 | RGL1 | ral guanine nucleotide dissociation stimulator-like 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3380 | RGL2 | ral guanine nucleotide dissociation stimulator-like 2 | 4 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3381 | RGS11 | regulator of G-protein signaling 11 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3382 | RGS12 | regulator of G-protein signaling 12 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3383 | RGS14 | regulator of G-protein signaling 14 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3384 | RGS22 | regulator of G-protein signaling 22 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3385 | RGS3 | regulator of G-protein signaling 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3386 | RGS4 | regulator of G-protein signaling 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3387 | RGS6 | regulator of G-protein signaling 6 | 3 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3388 | RGS7 | regulator of G-protein signaling 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3389 | RGS9BP | regulator of G protein signaling 9 binding protein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3390 | RGSL1 | regulator of G-protein signaling like 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3391 | RHAG | Rh-associated glycoprotein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3392 | RHCG | Rh family, C glycoprotein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3393 | RHD | Rh blood group, D antigen | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3394 | RHEB | Ras homolog enriched in brain | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3395 | RHEBL1 | Ras homolog enriched in brain like 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3396 | RHOB | ras homolog gene family, member B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3397 | RHOBTB2 | Rho-related BTB domain containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3398 | RHOBTB3 | Rho-related BTB domain containing 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3399 | RHOQ | ras homolog gene family, member Q | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3400 | RHOT1 | ras homolog gene family, member T1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3401 | RHPN2 | rhophilin, Rho GTPase binding protein 2 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3402 | RIC3 | resistance to inhibitors of cholinesterase 3 homolog (C. elegans) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3403 | RICTOR | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 | |
3404 | RIF1 | RAP1 interacting factor homolog (yeast) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3405 | RIMBP2 | RIMS binding protein 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3406 | RIMS2 | regulating synaptic membrane exocytosis 2 | 10 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3407 | RIMS4 | regulating synaptic membrane exocytosis 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3408 | RIN1 | Ras and Rab interactor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3409 | RING1 | ring finger protein 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3410 | RINT1 | RAD50 interactor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3411 | RIOK2 | RIO kinase 2 (yeast) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3412 | RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3413 | RIPK3 | receptor-interacting serine-threonine kinase 3 | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3414 | RIPK4 | receptor-interacting serine-threonine kinase 4 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3415 | RLBP1 | retinaldehyde binding protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3416 | RMND5B | required for meiotic nuclear division 5 homolog B (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3417 | RNASE4 | ribonuclease, RNase A family, 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3418 | RNASEH2A | ribonuclease H2, subunit A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3419 | RNASEL | ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3420 | RNF10 | ring finger protein 10 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3421 | RNF103 | ring finger protein 103 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3422 | RNF113A | ring finger protein 113A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3423 | RNF113B | ring finger protein 113B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3424 | RNF114 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
3425 | RNF123 | ring finger protein 123 | 4 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3426 | RNF128 | ring finger protein 128 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3427 | RNF130 | ring finger protein 130 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3428 | RNF135 | ring finger protein 135 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3429 | RNF139 | ring finger protein 139 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3430 | RNF144A | ring finger protein 144A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3431 | RNF146 | ring finger protein 146 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3432 | RNF149 | ring finger protein 149 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3433 | RNF152 | ring finger protein 152 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3434 | RNF160 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
3435 | RNF182 | ring finger protein 182 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3436 | RNF19A | ring finger protein 19A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3437 | RNF20 | ring finger protein 20 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3438 | RNF213 | ring finger protein 213 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3439 | RNF216 | ring finger protein 216 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3440 | RNF25 | ring finger protein 25 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3441 | RNF38 | ring finger protein 38 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3442 | RNF40 | ring finger protein 40 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3443 | RNF41 | ring finger protein 41 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3444 | RNPEPL1 | arginyl aminopeptidase (aminopeptidase B)-like 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3445 | ROBO2 | roundabout, axon guidance receptor, homolog 2 (Drosophila) | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3446 | ROBO3 | roundabout, axon guidance receptor, homolog 3 (Drosophila) | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3447 | ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 6 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3448 | ROCK1 | Rho-associated, coiled-coil containing protein kinase 1 | 0 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 |
3449 | ROCK2 | Rho-associated, coiled-coil containing protein kinase 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3450 | ROD1 | ROD1 regulator of differentiation 1 (S. pombe) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3451 | ROGDI | rogdi homolog (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3452 | ROM1 | retinal outer segment membrane protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3453 | ROR1 | receptor tyrosine kinase-like orphan receptor 1 | 0 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 |
3454 | ROR2 | receptor tyrosine kinase-like orphan receptor 2 | 0 | 13 | 0 | 1,755 | 0 | 1.00 | 1.00 |
3455 | RORA | RAR-related orphan receptor A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3456 | RORB | RAR-related orphan receptor B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3457 | RORC | RAR-related orphan receptor C | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3458 | ROS1 | c-ros oncogene 1 , receptor tyrosine kinase | 10 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
3459 | RP1L1 | retinitis pigmentosa 1-like 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3460 | RPA3 | replication protein A3, 14kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3461 | RPAP1 | RNA polymerase II associated protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3462 | RPH3A | rabphilin 3A homolog (mouse) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3463 | RPL11 | ribosomal protein L11 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3464 | RPL3 | ribosomal protein L3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3465 | RPL6 | ribosomal protein L6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3466 | RPN1 | ribophorin I | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3467 | RPRD1A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
3468 | RPS14 | ribosomal protein S14 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3469 | RPS6KA1 | ribosomal protein S6 kinase, 90kDa, polypeptide 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3470 | RPS6KA2 | ribosomal protein S6 kinase, 90kDa, polypeptide 2 | 2 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3471 | RPS6KA3 | ribosomal protein S6 kinase, 90kDa, polypeptide 3 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
3472 | RPS6KA4 | ribosomal protein S6 kinase, 90kDa, polypeptide 4 | 2 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3473 | RPS6KA6 | ribosomal protein S6 kinase, 90kDa, polypeptide 6 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3474 | RPS6KB1 | ribosomal protein S6 kinase, 70kDa, polypeptide 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3475 | RPS6KB2 | ribosomal protein S6 kinase, 70kDa, polypeptide 2 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3476 | RPS6KC1 | ribosomal protein S6 kinase, 52kDa, polypeptide 1 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3477 | RPS9 | ribosomal protein S9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3478 | RPSA | ribosomal protein SA | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3479 | RPTOR | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 | |
3480 | RPUSD3 | RNA pseudouridylate synthase domain containing 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3481 | RPUSD4 | RNA pseudouridylate synthase domain containing 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3482 | RRAGD | Ras-related GTP binding D | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3483 | RRAS2 | related RAS viral (r-ras) oncogene homolog 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3484 | RRM1 | ribonucleotide reductase M1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3485 | RRP12 | ribosomal RNA processing 12 homolog (S. cerevisiae) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3486 | RRP7A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
3487 | RRP9 | ribosomal RNA processing 9, small subunit (SSU) processome component, homolog (yeast) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3488 | RSF1 | remodeling and spacing factor 1 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3489 | RSPH3 | radial spoke head 3 homolog (Chlamydomonas) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3490 | RSPH6A | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
3491 | RSPO2 | R-spondin 2 homolog (Xenopus laevis) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3492 | RSU1 | Ras suppressor protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3493 | RTN1 | reticulon 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3494 | RTN4 | reticulon 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3495 | RTP1 | receptor (chemosensory) transporter protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3496 | RTTN | rotatin | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3497 | RUFY1 | RUN and FYVE domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3498 | RUNX1 | runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) | 0 | 180 | 0 | 24,300 | 0 | 1.00 | 1.00 |
3499 | RUNX1T1 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3500 | RUVBL1 | RuvB-like 1 (E. coli) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3501 | RWDD1 | RWD domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3502 | RYK | RYK receptor-like tyrosine kinase | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3503 | RYR2 | ryanodine receptor 2 (cardiac) | 60 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3504 | RYR3 | ryanodine receptor 3 | 24 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3505 | S100A7A | S100 calcium binding protein A7A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3506 | S1PR3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
3507 | S1PR5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
3508 | SACS | spastic ataxia of Charlevoix-Saguenay (sacsin) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3509 | SAFB | scaffold attachment factor B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3510 | SALL3 | sal-like 3 (Drosophila) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3511 | SAMD7 | sterile alpha motif domain containing 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3512 | SAMD9 | sterile alpha motif domain containing 9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3513 | SAPS2 | SAPS domain family, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3514 | SARS | seryl-tRNA synthetase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3515 | SASH1 | SAM and SH3 domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3516 | SATB1 | SATB homeobox 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3517 | SATL1 | spermidine/spermine N1-acetyl transferase-like 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3518 | SBNO1 | strawberry notch homolog 1 (Drosophila) | 2 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3519 | SCAI | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
3520 | SCAPER | S phase cyclin A-associated protein in the ER | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3521 | SCARA3 | scavenger receptor class A, member 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3522 | SCARA5 | scavenger receptor class A, member 5 (putative) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3523 | SCARB1 | scavenger receptor class B, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3524 | SCARF2 | scavenger receptor class F, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3525 | SCGB3A2 | secretoglobin, family 3A, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3526 | SCHIP1 | schwannomin interacting protein 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3527 | SCLT1 | sodium channel and clathrin linker 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3528 | SCML1 | sex comb on midleg-like 1 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3529 | SCN10A | sodium channel, voltage-gated, type X, alpha subunit | 8 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3530 | SCN11A | sodium channel, voltage-gated, type XI, alpha subunit | 6 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3531 | SCN1B | sodium channel, voltage-gated, type I, beta | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3532 | SCN3A | sodium channel, voltage-gated, type III, alpha subunit | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3533 | SCN3B | sodium channel, voltage-gated, type III, beta | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3534 | SCN4A | sodium channel, voltage-gated, type IV, alpha subunit | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3535 | SCN5A | sodium channel, voltage-gated, type V, alpha subunit | 6 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3536 | SCN9A | sodium channel, voltage-gated, type IX, alpha subunit | 5 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3537 | SCNN1B | sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3538 | SCNN1G | sodium channel, nonvoltage-gated 1, gamma | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3539 | SCP2 | sterol carrier protein 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3540 | SCRIB | scribbled homolog (Drosophila) | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3541 | SCUBE1 | signal peptide, CUB domain, EGF-like 1 | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3542 | SCUBE3 | signal peptide, CUB domain, EGF-like 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3543 | SCYL1 | SCY1-like 1 (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3544 | SCYL2 | SCY1-like 2 (S. cerevisiae) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3545 | SDC3 | syndecan 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3546 | SDCBP2 | syndecan binding protein (syntenin) 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3547 | SDF4 | stromal cell derived factor 4 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3548 | SDR16C5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
3549 | SDR9C7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
3550 | SEC16B | SEC16 homolog B (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3551 | SEC24C | SEC24 related gene family, member C (S. cerevisiae) | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3552 | SEC61G | Sec61 gamma subunit | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3553 | SEC63 | SEC63 homolog (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3554 | SEMA3A | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3555 | SEMA3B | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B | 2 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3556 | SEMA3F | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3557 | SEMA4B | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3558 | SEMA4C | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3559 | SEMA4G | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3560 | SEMA5A | sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3561 | SEMA5B | sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3562 | SEMA6B | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3563 | SEMA7A | semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) | 3 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3564 | SENP3 | SUMO1/sentrin/SMT3 specific peptidase 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3565 | SENP5 | SUMO1/sentrin specific peptidase 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3566 | SENP6 | SUMO1/sentrin specific peptidase 6 | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3567 | SENP7 | SUMO1/sentrin specific peptidase 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3568 | SEPT2 | septin 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3569 | SEPT6 | septin 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3570 | SERGEF | secretion regulating guanine nucleotide exchange factor | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3571 | SERPINA1 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3572 | SERPINA10 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3573 | SERPINA11 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11 | 0 | 10 | 0 | 1,350 | 0 | 1.00 | 1.00 |
3574 | SERPINA12 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3575 | SERPINA3 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3576 | SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3577 | SERPINA9 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3578 | SERPINB1 | serpin peptidase inhibitor, clade B (ovalbumin), member 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3579 | SERPINB10 | serpin peptidase inhibitor, clade B (ovalbumin), member 10 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3580 | SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3581 | SERPINB4 | serpin peptidase inhibitor, clade B (ovalbumin), member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3582 | SERPINB7 | serpin peptidase inhibitor, clade B (ovalbumin), member 7 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3583 | SERPINB8 | serpin peptidase inhibitor, clade B (ovalbumin), member 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3584 | SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3585 | SERPINE2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3586 | SERPING1 | serpin peptidase inhibitor, clade G (C1 inhibitor), member 1, (angioedema, hereditary) | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3587 | SERPINI1 | serpin peptidase inhibitor, clade I (neuroserpin), member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3588 | SERPINI2 | serpin peptidase inhibitor, clade I (pancpin), member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3589 | SESN2 | sestrin 2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3590 | SETBP1 | SET binding protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3591 | SETD1B | SET domain containing 1B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3592 | SETD2 | SET domain containing 2 | 4 | 28 | 0 | 3,780 | 0 | 1.00 | 1.00 |
3593 | SETD4 | SET domain containing 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3594 | SETD7 | SET domain containing (lysine methyltransferase) 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3595 | SETDB1 | SET domain, bifurcated 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3596 | SETDB2 | SET domain, bifurcated 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3597 | SEZ6 | seizure related 6 homolog (mouse) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3598 | SEZ6L | seizure related 6 homolog (mouse)-like | 9 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3599 | SF1 | splicing factor 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3600 | SF3A1 | splicing factor 3a, subunit 1, 120kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3601 | SF3B1 | splicing factor 3b, subunit 1, 155kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3602 | SFI1 | Sfi1 homolog, spindle assembly associated (yeast) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3603 | SFMBT2 | Scm-like with four mbt domains 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3604 | SFPQ | splicing factor proline/glutamine-rich (polypyrimidine tract binding protein associated) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3605 | SFRP1 | secreted frizzled-related protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3606 | SFRP2 | secreted frizzled-related protein 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3607 | SFRS1 | splicing factor, arginine/serine-rich 1 (splicing factor 2, alternate splicing factor) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3608 | SFRS16 | splicing factor, arginine/serine-rich 16 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3609 | SFRS6 | splicing factor, arginine/serine-rich 6 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3610 | SFT2D1 | SFT2 domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3611 | SFTPB | surfactant, pulmonary-associated protein B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3612 | SGCZ | sarcoglycan zeta | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3613 | SGK1 | serum/glucocorticoid regulated kinase 1 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3614 | SGK2 | serum/glucocorticoid regulated kinase 2 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3615 | SGK3 | serum/glucocorticoid regulated kinase family, member 3 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3616 | SGMS1 | sphingomyelin synthase 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3617 | SGMS2 | sphingomyelin synthase 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3618 | SGPP1 | sphingosine-1-phosphate phosphatase 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3619 | SGPP2 | sphingosine-1-phosphate phosphotase 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3620 | SGSH | N-sulfoglucosamine sulfohydrolase (sulfamidase) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3621 | SH2D3A | SH2 domain containing 3A | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3622 | SH2D6 | SH2 domain containing 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3623 | SH3BP1 | SH3-domain binding protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3624 | SH3BP2 | SH3-domain binding protein 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3625 | SH3BP4 | SH3-domain binding protein 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3626 | SH3GL3 | SH3-domain GRB2-like 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3627 | SH3TC1 | SH3 domain and tetratricopeptide repeats 1 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3628 | SHANK1 | SH3 and multiple ankyrin repeat domains 1 | 3 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3629 | SHANK2 | SH3 and multiple ankyrin repeat domains 2 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3630 | SHB | Src homology 2 domain containing adaptor protein B | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3631 | SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3632 | SHC3 | SHC (Src homology 2 domain containing) transforming protein 3 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3633 | SHCBP1 | SHC SH2-domain binding protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3634 | SHE | Src homology 2 domain containing E | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3635 | SHH | sonic hedgehog homolog (Drosophila) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3636 | SHMT2 | serine hydroxymethyltransferase 2 (mitochondrial) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3637 | SHROOM2 | shroom family member 2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3638 | SIAH2 | seven in absentia homolog 2 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3639 | SIDT1 | SID1 transmembrane family, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3640 | SIGLEC11 | sialic acid binding Ig-like lectin 11 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3641 | SIGLEC5 | sialic acid binding Ig-like lectin 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3642 | SIGLEC7 | sialic acid binding Ig-like lectin 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3643 | SIGLEC8 | sialic acid binding Ig-like lectin 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3644 | SIK1 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 | |
3645 | SIK2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 | |
3646 | SIK3 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 | |
3647 | SIM2 | single-minded homolog 2 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3648 | SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3649 | SIPA1L1 | signal-induced proliferation-associated 1 like 1 | 8 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3650 | SIPA1L2 | signal-induced proliferation-associated 1 like 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3651 | SIPA1L3 | signal-induced proliferation-associated 1 like 3 | 8 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3652 | SIRPD | signal-regulatory protein delta | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3653 | SIRT3 | sirtuin (silent mating type information regulation 2 homolog) 3 (S. cerevisiae) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3654 | SIRT5 | sirtuin (silent mating type information regulation 2 homolog) 5 (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3655 | SIRT6 | sirtuin (silent mating type information regulation 2 homolog) 6 (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3656 | SIX4 | SIX homeobox 4 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3657 | SKI | v-ski sarcoma viral oncogene homolog (avian) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3658 | SKIL | SKI-like oncogene | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3659 | SKIV2L | superkiller viralicidic activity 2-like (S. cerevisiae) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3660 | SKP2 | S-phase kinase-associated protein 2 (p45) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3661 | SLA | Src-like-adaptor | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3662 | SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3663 | SLC10A4 | solute carrier family 10 (sodium/bile acid cotransporter family), member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3664 | SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3665 | SLC11A2 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3666 | SLC12A3 | solute carrier family 12 (sodium/chloride transporters), member 3 | 0 | 10 | 0 | 1,350 | 0 | 1.00 | 1.00 |
3667 | SLC12A5 | solute carrier family 12, (potassium-chloride transporter) member 5 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3668 | SLC12A6 | solute carrier family 12 (potassium/chloride transporters), member 6 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3669 | SLC14A1 | solute carrier family 14 (urea transporter), member 1 (Kidd blood group) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3670 | SLC14A2 | solute carrier family 14 (urea transporter), member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3671 | SLC16A1 | solute carrier family 16, member 1 (monocarboxylic acid transporter 1) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3672 | SLC16A14 | solute carrier family 16, member 14 (monocarboxylic acid transporter 14) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3673 | SLC16A2 | solute carrier family 16, member 2 (monocarboxylic acid transporter 8) | 0 | 8 | 0 | 1,080 | 0 | 1.00 | 1.00 |
3674 | SLC16A3 | solute carrier family 16, member 3 (monocarboxylic acid transporter 4) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3675 | SLC16A5 | solute carrier family 16, member 5 (monocarboxylic acid transporter 6) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3676 | SLC17A6 | solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3677 | SLC1A2 | solute carrier family 1 (glial high affinity glutamate transporter), member 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3678 | SLC1A7 | solute carrier family 1 (glutamate transporter), member 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3679 | SLC22A13 | solute carrier family 22, member 13 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3680 | SLC22A18 | solute carrier family 22, member 18 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3681 | SLC22A2 | solute carrier family 22 (organic cation transporter), member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3682 | SLC22A3 | solute carrier family 22 (extraneuronal monoamine transporter), member 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3683 | SLC22A9 | solute carrier family 22 (organic anion transporter), member 9 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3684 | SLC24A6 | solute carrier family 24 (sodium/potassium/calcium exchanger), member 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3685 | SLC25A13 | solute carrier family 25, member 13 (citrin) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3686 | SLC25A21 | solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3687 | SLC25A43 | solute carrier family 25, member 43 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3688 | SLC26A10 | solute carrier family 26, member 10 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3689 | SLC26A4 | solute carrier family 26, member 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3690 | SLC29A1 | solute carrier family 29 (nucleoside transporters), member 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3691 | SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3692 | SLC2A2 | solute carrier family 2 (facilitated glucose transporter), member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3693 | SLC30A1 | solute carrier family 30 (zinc transporter), member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3694 | SLC30A5 | solute carrier family 30 (zinc transporter), member 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3695 | SLC30A8 | solute carrier family 30 (zinc transporter), member 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3696 | SLC30A9 | solute carrier family 30 (zinc transporter), member 9 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3697 | SLC33A1 | solute carrier family 33 (acetyl-CoA transporter), member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3698 | SLC35A2 | solute carrier family 35 (UDP-galactose transporter), member A2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3699 | SLC35B2 | solute carrier family 35, member B2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3700 | SLC35D3 | solute carrier family 35, member D3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3701 | SLC35F2 | solute carrier family 35, member F2 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3702 | SLC38A1 | solute carrier family 38, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3703 | SLC38A2 | solute carrier family 38, member 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3704 | SLC38A4 | solute carrier family 38, member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3705 | SLC38A6 | solute carrier family 38, member 6 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3706 | SLC39A12 | solute carrier family 39 (zinc transporter), member 12 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3707 | SLC39A2 | solute carrier family 39 (zinc transporter), member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3708 | SLC43A3 | solute carrier family 43, member 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3709 | SLC44A4 | solute carrier family 44, member 4 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3710 | SLC45A1 | solute carrier family 45, member 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3711 | SLC46A2 | solute carrier family 46, member 2 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3712 | SLC4A1 | solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3713 | SLC4A10 | solute carrier family 4, sodium bicarbonate transporter-like, member 10 | 10 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3714 | SLC4A3 | solute carrier family 4, anion exchanger, member 3 | 0 | 10 | 0 | 1,350 | 0 | 1.00 | 1.00 |
3715 | SLC4A5 | solute carrier family 4, sodium bicarbonate cotransporter, member 5 | 8 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3716 | SLC4A7 | solute carrier family 4, sodium bicarbonate cotransporter, member 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3717 | SLC5A5 | solute carrier family 5 (sodium iodide symporter), member 5 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3718 | SLC5A7 | solute carrier family 5 (choline transporter), member 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3719 | SLC6A3 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3720 | SLC6A5 | solute carrier family 6 (neurotransmitter transporter, glycine), member 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3721 | SLC7A10 | solute carrier family 7, (neutral amino acid transporter, y+ system) member 10 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3722 | SLC7A13 | solute carrier family 7, (cationic amino acid transporter, y+ system) member 13 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3723 | SLC7A14 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3724 | SLC7A4 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3725 | SLC7A6 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3726 | SLC7A7 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3727 | SLC8A1 | solute carrier family 8 (sodium/calcium exchanger), member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3728 | SLC8A3 | solute carrier family 8 (sodium-calcium exchanger), member 3 | 5 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3729 | SLC9A1 | solute carrier family 9 (sodium/hydrogen exchanger), member 1 (antiporter, Na+/H+, amiloride sensitive) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3730 | SLC9A2 | solute carrier family 9 (sodium/hydrogen exchanger), member 2 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3731 | SLC9A4 | solute carrier family 9 (sodium/hydrogen exchanger), member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3732 | SLCO1A2 | solute carrier organic anion transporter family, member 1A2 | 7 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3733 | SLCO1B1 | solute carrier organic anion transporter family, member 1B1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3734 | SLCO1B3 | solute carrier organic anion transporter family, member 1B3 | 4 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3735 | SLCO2A1 | solute carrier organic anion transporter family, member 2A1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3736 | SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3737 | SLCO4C1 | solute carrier organic anion transporter family, member 4C1 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3738 | SLCO6A1 | solute carrier organic anion transporter family, member 6A1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3739 | SLFN5 | schlafen family member 5 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3740 | SLIT2 | slit homolog 2 (Drosophila) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3741 | SLITRK1 | SLIT and NTRK-like family, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3742 | SLITRK4 | SLIT and NTRK-like family, member 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3743 | SLITRK5 | SLIT and NTRK-like family, member 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3744 | SLK | STE20-like kinase (yeast) | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3745 | SMAD2 | SMAD family member 2 | 0 | 11 | 0 | 1,485 | 0 | 1.00 | 1.00 |
3746 | SMAD3 | SMAD family member 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3747 | SMAD4 | SMAD family member 4 | 0 | 162 | 0 | 21,870 | 0 | 1.00 | 1.00 |
3748 | SMARCA1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3749 | SMARCA2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3750 | SMARCA4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 3 | 29 | 0 | 3,915 | 0 | 1.00 | 1.00 |
3751 | SMARCA5 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3752 | SMARCAD1 | SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3753 | SMARCAL1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3754 | SMARCB1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | 0 | 131 | 0 | 17,685 | 0 | 1.00 | 1.00 |
3755 | SMARCC1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3756 | SMARCC2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 | 2 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3757 | SMARCD3 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3758 | SMC2 | structural maintenance of chromosomes 2 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3759 | SMC3 | structural maintenance of chromosomes 3 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3760 | SMC4 | structural maintenance of chromosomes 4 | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
3761 | SMC5 | structural maintenance of chromosomes 5 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3762 | SMC6 | structural maintenance of chromosomes 6 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3763 | SMCR7L | Smith-Magenis syndrome chromosome region, candidate 7-like | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3764 | SMG1 | 6 | 11 | 0 | 1,485 | 0 | 1.00 | 1.00 | |
3765 | SMG5 | Smg-5 homolog, nonsense mediated mRNA decay factor (C. elegans) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3766 | SMG6 | Smg-6 homolog, nonsense mediated mRNA decay factor (C. elegans) | 1 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3767 | SMG7 | Smg-7 homolog, nonsense mediated mRNA decay factor (C. elegans) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3768 | SMO | smoothened homolog (Drosophila) | 0 | 26 | 0 | 3,510 | 0 | 1.00 | 1.00 |
3769 | SMOX | spermine oxidase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3770 | SMR3B | submaxillary gland androgen regulated protein 3B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3771 | SMTN | smoothelin | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3772 | SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3773 | SMYD4 | SET and MYND domain containing 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3774 | SNIP1 | Smad nuclear interacting protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3775 | SNRK | SNF related kinase | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3776 | SNRNP200 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 | |
3777 | SNRPA | small nuclear ribonucleoprotein polypeptide A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3778 | SNRPA1 | small nuclear ribonucleoprotein polypeptide A' | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3779 | SNRPB2 | small nuclear ribonucleoprotein polypeptide B'' | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3780 | SNTB1 | syntrophin, beta 1 (dystrophin-associated protein A1, 59kDa, basic component 1) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3781 | SNX13 | sorting nexin 13 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3782 | SNX19 | sorting nexin 19 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3783 | SNX2 | sorting nexin 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3784 | SNX25 | sorting nexin 25 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3785 | SNX27 | sorting nexin family member 27 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3786 | SNX4 | sorting nexin 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3787 | SNX5 | sorting nexin 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3788 | SNX8 | sorting nexin 8 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3789 | SOAT1 | sterol O-acyltransferase (acyl-Coenzyme A: cholesterol acyltransferase) 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3790 | SOCS1 | suppressor of cytokine signaling 1 | 0 | 70 | 0 | 9,450 | 0 | 1.00 | 1.00 |
3791 | SOCS4 | suppressor of cytokine signaling 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3792 | SOCS5 | suppressor of cytokine signaling 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3793 | SOCS6 | suppressor of cytokine signaling 6 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3794 | SOHLH1 | spermatogenesis and oogenesis specific basic helix-loop-helix 1 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3795 | SORBS1 | sorbin and SH3 domain containing 1 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3796 | SORCS1 | sortilin-related VPS10 domain containing receptor 1 | 8 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3797 | SORCS2 | sortilin-related VPS10 domain containing receptor 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3798 | SORCS3 | sortilin-related VPS10 domain containing receptor 3 | 6 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3799 | SORL1 | sortilin-related receptor, L(DLR class) A repeats-containing | 4 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3800 | SOS1 | son of sevenless homolog 1 (Drosophila) | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3801 | SOSTDC1 | sclerostin domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3802 | SOX11 | SRY (sex determining region Y)-box 11 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3803 | SOX13 | SRY (sex determining region Y)-box 13 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3804 | SOX30 | SRY (sex determining region Y)-box 30 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3805 | SOX5 | SRY (sex determining region Y)-box 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3806 | SOX8 | SRY (sex determining region Y)-box 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3807 | SP1 | Sp1 transcription factor | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3808 | SP100 | SP100 nuclear antigen | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3809 | SP110 | SP110 nuclear body protein | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3810 | SP3 | Sp3 transcription factor | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3811 | SPACA4 | sperm acrosome associated 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3812 | SPAG1 | sperm associated antigen 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3813 | SPAG17 | sperm associated antigen 17 | 17 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3814 | SPAG5 | sperm associated antigen 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3815 | SPAG6 | sperm associated antigen 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3816 | SPAG7 | sperm associated antigen 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3817 | SPAG9 | sperm associated antigen 9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3818 | SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3819 | SPAST | spastin | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3820 | SPATA13 | spermatogenesis associated 13 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3821 | SPATA2 | spermatogenesis associated 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3822 | SPATA21 | spermatogenesis associated 21 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3823 | SPATC1 | spermatogenesis and centriole associated 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3824 | SPC25 | SPC25, NDC80 kinetochore complex component, homolog (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3825 | SPDEF | SAM pointed domain containing ets transcription factor | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3826 | SPEG | SPEG complex locus | 7 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3827 | SPEN | spen homolog, transcriptional regulator (Drosophila) | 7 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
3828 | SPERT | spermatid associated | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3829 | SPHK1 | sphingosine kinase 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3830 | SPHKAP | SPHK1 interactor, AKAP domain containing | 21 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3831 | SPI1 | spleen focus forming virus (SFFV) proviral integration oncogene spi1 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3832 | SPIB | Spi-B transcription factor (Spi-1/PU.1 related) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3833 | SPIN3 | spindlin family, member 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3834 | SPIN4 | spindlin family, member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3835 | SPINT4 | serine peptidase inhibitor, Kunitz type 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3836 | SPIRE2 | spire homolog 2 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3837 | SPN | sialophorin (leukosialin, CD43) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3838 | SPNS3 | spinster homolog 3 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3839 | SPO11 | SPO11 meiotic protein covalently bound to DSB homolog (S. cerevisiae) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3840 | SPOCD1 | SPOC domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3841 | SPOCK3 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3842 | SPON2 | spondin 2, extracellular matrix protein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3843 | SPRED2 | sprouty-related, EVH1 domain containing 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3844 | SPRED3 | sprouty-related, EVH1 domain containing 3 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3845 | SPRY1 | sprouty homolog 1, antagonist of FGF signaling (Drosophila) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3846 | SPSB2 | splA/ryanodine receptor domain and SOCS box containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3847 | SPTAN1 | spectrin, alpha, non-erythrocytic 1 (alpha-fodrin) | 2 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3848 | SPTB | spectrin, beta, erythrocytic (includes spherocytosis, clinical type I) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3849 | SPTBN1 | spectrin, beta, non-erythrocytic 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3850 | SPTBN2 | spectrin, beta, non-erythrocytic 2 | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3851 | SPTBN4 | spectrin, beta, non-erythrocytic 4 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3852 | SPTBN5 | spectrin, beta, non-erythrocytic 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3853 | SPTLC1 | serine palmitoyltransferase, long chain base subunit 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3854 | SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3855 | SREBF2 | sterol regulatory element binding transcription factor 2 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3856 | SRF | serum response factor (c-fos serum response element-binding transcription factor) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3857 | SRGAP1 | SLIT-ROBO Rho GTPase activating protein 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3858 | SRGAP3 | SLIT-ROBO Rho GTPase activating protein 3 | 3 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3859 | SRMS | src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3860 | SRPK2 | SFRS protein kinase 2 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3861 | SRPK3 | SFRS protein kinase 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3862 | SRRM1 | serine/arginine repetitive matrix 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3863 | SRRM2 | serine/arginine repetitive matrix 2 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3864 | SSFA2 | sperm specific antigen 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3865 | SSNA1 | Sjogren syndrome nuclear autoantigen 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3866 | SSTR1 | somatostatin receptor 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3867 | ST14 | suppression of tumorigenicity 14 (colon carcinoma) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3868 | ST6GAL1 | ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3869 | ST7 | suppression of tumorigenicity 7 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3870 | ST8SIA4 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3871 | STAB1 | stabilin 1 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3872 | STAB2 | stabilin 2 | 7 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3873 | STAG2 | stromal antigen 2 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3874 | STAG3 | stromal antigen 3 | 2 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3875 | STAM | signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3876 | STAP2 | signal transducing adaptor family member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3877 | STARD8 | StAR-related lipid transfer (START) domain containing 8 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3878 | STAT1 | signal transducer and activator of transcription 1, 91kDa | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3879 | STAT2 | signal transducer and activator of transcription 2, 113kDa | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3880 | STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3881 | STAT4 | signal transducer and activator of transcription 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3882 | STAT5A | signal transducer and activator of transcription 5A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3883 | STAT5B | signal transducer and activator of transcription 5B | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3884 | STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3885 | STAU1 | staufen, RNA binding protein, homolog 1 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3886 | STEAP3 | STEAP family member 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3887 | STIM2 | stromal interaction molecule 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3888 | STK10 | serine/threonine kinase 10 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3889 | STK11 | serine/threonine kinase 11 | 0 | 138 | 0 | 18,630 | 0 | 1.00 | 1.00 |
3890 | STK17B | serine/threonine kinase 17b | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3891 | STK19 | serine/threonine kinase 19 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3892 | STK24 | serine/threonine kinase 24 (STE20 homolog, yeast) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3893 | STK3 | serine/threonine kinase 3 (STE20 homolog, yeast) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3894 | STK31 | serine/threonine kinase 31 | 6 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3895 | STK32A | serine/threonine kinase 32A | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3896 | STK32B | serine/threonine kinase 32B | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3897 | STK32C | serine/threonine kinase 32C | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3898 | STK33 | serine/threonine kinase 33 | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3899 | STK36 | serine/threonine kinase 36, fused homolog (Drosophila) | 4 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
3900 | STK38 | serine/threonine kinase 38 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3901 | STK38L | serine/threonine kinase 38 like | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3902 | STK39 | serine threonine kinase 39 (STE20/SPS1 homolog, yeast) | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3903 | STMN2 | stathmin-like 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3904 | STMN4 | stathmin-like 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3905 | STRA6 | stimulated by retinoic acid gene 6 homolog (mouse) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3906 | STRADB | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 | |
3907 | STRBP | spermatid perinuclear RNA binding protein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3908 | STS | steroid sulfatase (microsomal), isozyme S | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3909 | STX11 | syntaxin 11 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3910 | STX12 | syntaxin 12 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3911 | STX17 | syntaxin 17 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3912 | STX5 | syntaxin 5 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3913 | STXBP2 | syntaxin binding protein 2 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3914 | STXBP3 | syntaxin binding protein 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3915 | STYK1 | serine/threonine/tyrosine kinase 1 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3916 | SUCLA2 | succinate-CoA ligase, ADP-forming, beta subunit | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3917 | SUCLG2 | succinate-CoA ligase, GDP-forming, beta subunit | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3918 | SUFU | suppressor of fused homolog (Drosophila) | 0 | 10 | 0 | 1,350 | 0 | 1.00 | 1.00 |
3919 | SULF1 | sulfatase 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3920 | SULF2 | sulfatase 2 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3921 | SULT6B1 | sulfotransferase family, cytosolic, 6B, member 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3922 | SUN2 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
3923 | SUN3 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
3924 | SUPV3L1 | suppressor of var1, 3-like 1 (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3925 | SURF1 | surfeit 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3926 | SUSD3 | sushi domain containing 3 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3927 | SUV39H2 | suppressor of variegation 3-9 homolog 2 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3928 | SUV420H1 | suppressor of variegation 4-20 homolog 1 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3929 | SV2B | synaptic vesicle glycoprotein 2B | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3930 | SV2C | synaptic vesicle glycoprotein 2C | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3931 | SWAP70 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
3932 | SYK | spleen tyrosine kinase | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3933 | SYNE1 | spectrin repeat containing, nuclear envelope 1 | 27 | 22 | 0 | 2,970 | 0 | 1.00 | 1.00 |
3934 | SYNE2 | spectrin repeat containing, nuclear envelope 2 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3935 | SYNJ2 | synaptojanin 2 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3936 | SYNPO | synaptopodin | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
3937 | SYP | synaptophysin | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3938 | SYT1 | synaptotagmin I | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3939 | SYT14 | synaptotagmin XIV | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3940 | SYT3 | synaptotagmin III | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3941 | SYT6 | synaptotagmin VI | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3942 | SYT9 | synaptotagmin IX | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3943 | TACC2 | transforming, acidic coiled-coil containing protein 2 | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3944 | TACC3 | transforming, acidic coiled-coil containing protein 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3945 | TACR3 | tachykinin receptor 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3946 | TAF1 | TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa | 7 | 13 | 0 | 1,755 | 0 | 1.00 | 1.00 |
3947 | TAF15 | TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3948 | TAF1L | TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 210kDa-like | 0 | 15 | 0 | 2,025 | 0 | 1.00 | 1.00 |
3949 | TAF2 | TAF2 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 150kDa | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3950 | TAF4B | TAF4b RNA polymerase II, TATA box binding protein (TBP)-associated factor, 105kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3951 | TAF6 | TAF6 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 80kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3952 | TAF7L | TAF7-like RNA polymerase II, TATA box binding protein (TBP)-associated factor, 50kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3953 | TANC1 | tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3954 | TAOK1 | TAO kinase 1 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
3955 | TAOK2 | TAO kinase 2 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3956 | TAOK3 | TAO kinase 3 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3957 | TARBP2 | TAR (HIV-1) RNA binding protein 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3958 | TAS1R1 | taste receptor, type 1, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3959 | TAS1R2 | taste receptor, type 1, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3960 | TAS2R13 | taste receptor, type 2, member 13 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3961 | TAS2R3 | taste receptor, type 2, member 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3962 | TAX1BP1 | Tax1 (human T-cell leukemia virus type I) binding protein 1 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3963 | TBC1D19 | TBC1 domain family, member 19 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3964 | TBC1D20 | TBC1 domain family, member 20 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3965 | TBC1D4 | TBC1 domain family, member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3966 | TBC1D8B | TBC1 domain family, member 8B (with GRAM domain) | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3967 | TBC1D9B | TBC1 domain family, member 9B (with GRAM domain) | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3968 | TBCCD1 | TBCC domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3969 | TBCK | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 | |
3970 | TBK1 | TANK-binding kinase 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3971 | TBX1 | T-box 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3972 | TBX18 | T-box 18 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3973 | TBX20 | T-box 20 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3974 | TBX22 | T-box 22 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
3975 | TBX4 | T-box 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3976 | TBXAS1 | thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3977 | TCEAL5 | transcription elongation factor A (SII)-like 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3978 | TCEB3B | transcription elongation factor B polypeptide 3B (elongin A2) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3979 | TCF12 | transcription factor 12 (HTF4, helix-loop-helix transcription factors 4) | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
3980 | TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3981 | TCF7L1 | transcription factor 7-like 1 (T-cell specific, HMG-box) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3982 | TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
3983 | TCHH | trichohyalin | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3984 | TCN2 | transcobalamin II; macrocytic anemia | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3985 | TCOF1 | Treacher Collins-Franceschetti syndrome 1 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3986 | TCP1 | t-complex 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3987 | TDRD5 | tudor domain containing 5 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3988 | TDRD9 | tudor domain containing 9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3989 | TEAD2 | TEA domain family member 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3990 | TEC | tec protein tyrosine kinase | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3991 | TECPR2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 | |
3992 | TECTA | tectorin alpha | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
3993 | TEK | TEK tyrosine kinase, endothelial (venous malformations, multiple cutaneous and mucosal) | 4 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 |
3994 | TEKT4 | tektin 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3995 | TEPP | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
3996 | TERF1 | telomeric repeat binding factor (NIMA-interacting) 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
3997 | TERF2 | telomeric repeat binding factor 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3998 | TERF2IP | telomeric repeat binding factor 2, interacting protein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
3999 | TERT | telomerase reverse transcriptase | 0 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 |
4000 | TESK1 | testis-specific kinase 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4001 | TESK2 | testis-specific kinase 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4002 | TEX11 | testis expressed 11 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4003 | TEX14 | testis expressed 14 | 0 | 8 | 0 | 1,080 | 0 | 1.00 | 1.00 |
4004 | TFAP2C | transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4005 | TFAP2D | transcription factor AP-2 delta (activating enhancer binding protein 2 delta) | 8 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4006 | TFDP1 | transcription factor Dp-1 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
4007 | TFDP2 | transcription factor Dp-2 (E2F dimerization partner 2) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4008 | TFE3 | transcription factor binding to IGHM enhancer 3 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4009 | TFEC | transcription factor EC | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4010 | TFG | TRK-fused gene | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4011 | TGFBR1 | transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53kDa) | 0 | 8 | 0 | 1,080 | 0 | 1.00 | 1.00 |
4012 | TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0 | 12 | 0 | 1,620 | 0 | 1.00 | 1.00 |
4013 | TGFBRAP1 | transforming growth factor, beta receptor associated protein 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4014 | TGM1 | transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase) | 1 | 10 | 0 | 1,350 | 0 | 1.00 | 1.00 |
4015 | TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4016 | TGM5 | transglutaminase 5 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4017 | TGS1 | trimethylguanosine synthase homolog (S. cerevisiae) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4018 | TH1L | TH1-like (Drosophila) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4019 | THADA | thyroid adenoma associated | 6 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4020 | THAP9 | THAP domain containing 9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4021 | THBS1 | thrombospondin 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4022 | THBS3 | thrombospondin 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4023 | THOC5 | THO complex 5 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4024 | THOC6 | THO complex 6 homolog (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4025 | THOC7 | THO complex 7 homolog (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4026 | THOP1 | thimet oligopeptidase 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4027 | THRAP3 | thyroid hormone receptor associated protein 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4028 | THRB | thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4029 | TIAM1 | T-cell lymphoma invasion and metastasis 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4030 | TICAM1 | toll-like receptor adaptor molecule 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4031 | TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4032 | TIGIT | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4033 | TIMELESS | timeless homolog (Drosophila) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4034 | TIMP2 | TIMP metallopeptidase inhibitor 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4035 | TIMP3 | TIMP metallopeptidase inhibitor 3 (Sorsby fundus dystrophy, pseudoinflammatory) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4036 | TINAG | tubulointerstitial nephritis antigen | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4037 | TJP3 | tight junction protein 3 (zona occludens 3) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4038 | TLK1 | tousled-like kinase 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4039 | TLK2 | tousled-like kinase 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4040 | TLL1 | tolloid-like 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4041 | TLN1 | talin 1 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4042 | TLR8 | toll-like receptor 8 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4043 | TLR9 | toll-like receptor 9 | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4044 | TLX3 | T-cell leukemia homeobox 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4045 | TM7SF4 | transmembrane 7 superfamily member 4 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4046 | TM9SF4 | transmembrane 9 superfamily protein member 4 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4047 | TMBIM4 | transmembrane BAX inhibitor motif containing 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4048 | TMCO5A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4049 | TMED1 | transmembrane emp24 protein transport domain containing 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4050 | TMEM101 | transmembrane protein 101 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4051 | TMEM110 | transmembrane protein 110 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4052 | TMEM125 | transmembrane protein 125 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4053 | TMEM130 | transmembrane protein 130 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4054 | TMEM132C | transmembrane protein 132C | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4055 | TMEM140 | transmembrane protein 140 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4056 | TMEM146 | transmembrane protein 146 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4057 | TMEM151A | transmembrane protein 151A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4058 | TMEM161A | transmembrane protein 161A | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4059 | TMEM164 | transmembrane protein 164 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4060 | TMEM168 | transmembrane protein 168 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4061 | TMEM202 | transmembrane protein 202 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4062 | TMEM206 | transmembrane protein 206 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4063 | TMEM229B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4064 | TMEM38A | transmembrane protein 38A | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4065 | TMEM39A | transmembrane protein 39A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4066 | TMEM47 | transmembrane protein 47 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4067 | TMEM50B | transmembrane protein 50B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4068 | TMEM63B | transmembrane protein 63B | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4069 | TMEM74 | transmembrane protein 74 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4070 | TMEM82 | transmembrane protein 82 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4071 | TMEM8A | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 | |
4072 | TMEM90B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4073 | TMPRSS2 | transmembrane protease, serine 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4074 | TMPRSS3 | transmembrane protease, serine 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4075 | TMPRSS4 | transmembrane protease, serine 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4076 | TMPRSS6 | transmembrane protease, serine 6 | 2 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
4077 | TMSB15B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4078 | TMTC4 | transmembrane and tetratricopeptide repeat containing 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4079 | TMUB2 | transmembrane and ubiquitin-like domain containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4080 | TNC | tenascin C (hexabrachion) | 5 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
4081 | TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4082 | TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0 | 139 | 0 | 18,765 | 0 | 1.00 | 1.00 |
4083 | TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4084 | TNFRSF11B | tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4085 | TNFRSF13B | tumor necrosis factor receptor superfamily, member 13B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4086 | TNFRSF14 | tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4087 | TNFRSF19 | tumor necrosis factor receptor superfamily, member 19 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4088 | TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4089 | TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4090 | TNFRSF25 | tumor necrosis factor receptor superfamily, member 25 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4091 | TNFRSF6B | tumor necrosis factor receptor superfamily, member 6b, decoy | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4092 | TNFRSF8 | tumor necrosis factor receptor superfamily, member 8 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4093 | TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4094 | TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4095 | TNFSF13 | tumor necrosis factor (ligand) superfamily, member 13 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4096 | TNFSF18 | tumor necrosis factor (ligand) superfamily, member 18 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4097 | TNFSF4 | tumor necrosis factor (ligand) superfamily, member 4 (tax-transcriptionally activated glycoprotein 1, 34kDa) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4098 | TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4099 | TNFSF9 | tumor necrosis factor (ligand) superfamily, member 9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4100 | TNIK | TRAF2 and NCK interacting kinase | 5 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4101 | TNIP1 | TNFAIP3 interacting protein 1 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4102 | TNIP2 | TNFAIP3 interacting protein 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4103 | TNK1 | tyrosine kinase, non-receptor, 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4104 | TNK2 | tyrosine kinase, non-receptor, 2 | 0 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 |
4105 | TNKS | tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4106 | TNKS1BP1 | tankyrase 1 binding protein 1, 182kDa | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4107 | TNKS2 | tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2 | 0 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
4108 | TNMD | tenomodulin | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4109 | TNN | tenascin N | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4110 | TNNI3 | troponin I type 3 (cardiac) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4111 | TNNI3K | TNNI3 interacting kinase | 9 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
4112 | TNPO1 | transportin 1 | 2 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
4113 | TNPO3 | transportin 3 | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4114 | TNR | tenascin R (restrictin, janusin) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4115 | TNS1 | tensin 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4116 | TNS4 | tensin 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4117 | TOB1 | transducer of ERBB2, 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4118 | TOE1 | target of EGR1, member 1 (nuclear) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4119 | TOMM40L | translocase of outer mitochondrial membrane 40 homolog (yeast)-like | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4120 | TOP1 | topoisomerase (DNA) I | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4121 | TOP2A | topoisomerase (DNA) II alpha 170kDa | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4122 | TOP2B | topoisomerase (DNA) II beta 180kDa | 2 | 9 | 0 | 1,215 | 0 | 1.00 | 1.00 |
4123 | TOP3A | topoisomerase (DNA) III alpha | 3 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4124 | TOP3B | topoisomerase (DNA) III beta | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4125 | TOPBP1 | topoisomerase (DNA) II binding protein 1 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
4126 | TOPORS | topoisomerase I binding, arginine/serine-rich | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4127 | TOR1A | torsin family 1, member A (torsin A) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4128 | TOR1AIP1 | torsin A interacting protein 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4129 | TOX | thymocyte selection-associated high mobility group box | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4130 | TP53 | tumor protein p53 | 0 | 907 | 0 | 122,445 | 0 | 1.00 | 1.00 |
4131 | TP53AIP1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4132 | TP53BP1 | tumor protein p53 binding protein 1 | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4133 | TP53BP2 | tumor protein p53 binding protein, 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4134 | TP53TG5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4135 | TP63 | tumor protein p63 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
4136 | TP73 | tumor protein p73 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4137 | TPBG | trophoblast glycoprotein | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4138 | TPH2 | tryptophan hydroxylase 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4139 | TPM4 | tropomyosin 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4140 | TPO | thyroid peroxidase | 5 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
4141 | TPPP3 | tubulin polymerization-promoting protein family member 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4142 | TPR | translocated promoter region (to activated MET oncogene) | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
4143 | TPST2 | tyrosylprotein sulfotransferase 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4144 | TPTE | transmembrane phosphatase with tensin homology | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4145 | TPX2 | TPX2, microtubule-associated, homolog (Xenopus laevis) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4146 | TRAF1 | TNF receptor-associated factor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4147 | TRAF2 | TNF receptor-associated factor 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4148 | TRAF3IP2 | TRAF3 interacting protein 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4149 | TRAF3IP3 | TRAF3 interacting protein 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4150 | TRAIP | TRAF interacting protein | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4151 | TRAM1L1 | translocation associated membrane protein 1-like 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4152 | TRAPPC10 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4153 | TRAPPC3 | trafficking protein particle complex 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4154 | TREM1 | triggering receptor expressed on myeloid cells 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4155 | TREML1 | triggering receptor expressed on myeloid cells-like 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4156 | TREML2 | triggering receptor expressed on myeloid cells-like 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4157 | TRERF1 | transcriptional regulating factor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4158 | TRIB1 | tribbles homolog 1 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4159 | TRIB3 | tribbles homolog 3 (Drosophila) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4160 | TRIM14 | tripartite motif-containing 14 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4161 | TRIM16 | tripartite motif-containing 16 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4162 | TRIM2 | tripartite motif-containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4163 | TRIM21 | tripartite motif-containing 21 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4164 | TRIM23 | tripartite motif-containing 23 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4165 | TRIM24 | tripartite motif-containing 24 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4166 | TRIM25 | tripartite motif-containing 25 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4167 | TRIM29 | tripartite motif-containing 29 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4168 | TRIM3 | tripartite motif-containing 3 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
4169 | TRIM31 | tripartite motif-containing 31 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4170 | TRIM32 | tripartite motif-containing 32 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4171 | TRIM33 | tripartite motif-containing 33 | 0 | 8 | 0 | 1,080 | 0 | 1.00 | 1.00 |
4172 | TRIM36 | tripartite motif-containing 36 | 0 | 10 | 0 | 1,350 | 0 | 1.00 | 1.00 |
4173 | TRIM37 | tripartite motif-containing 37 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4174 | TRIM4 | tripartite motif-containing 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4175 | TRIM42 | tripartite motif-containing 42 | 10 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
4176 | TRIM45 | tripartite motif-containing 45 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4177 | TRIM46 | tripartite motif-containing 46 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4178 | TRIM55 | tripartite motif-containing 55 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4179 | TRIM56 | tripartite motif-containing 56 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
4180 | TRIM58 | tripartite motif-containing 58 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4181 | TRIM60 | tripartite motif-containing 60 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4182 | TRIM63 | tripartite motif-containing 63 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4183 | TRIM67 | tripartite motif-containing 67 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4184 | TRIM7 | tripartite motif-containing 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4185 | TRIM9 | tripartite motif-containing 9 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4186 | TRIML1 | tripartite motif family-like 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4187 | TRIML2 | tripartite motif family-like 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4188 | TRIO | triple functional domain (PTPRF interacting) | 3 | 11 | 0 | 1,485 | 0 | 1.00 | 1.00 |
4189 | TRIP11 | thyroid hormone receptor interactor 11 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
4190 | TRIP12 | thyroid hormone receptor interactor 12 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4191 | TRIP4 | thyroid hormone receptor interactor 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4192 | TRIP6 | thyroid hormone receptor interactor 6 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4193 | TRMT12 | tRNA methyltransferase 12 homolog (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4194 | TRMT2A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4195 | TRMT5 | TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4196 | TRPA1 | transient receptor potential cation channel, subfamily A, member 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4197 | TRPC4 | transient receptor potential cation channel, subfamily C, member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4198 | TRPC4AP | transient receptor potential cation channel, subfamily C, member 4 associated protein | 5 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4199 | TRPC5 | transient receptor potential cation channel, subfamily C, member 5 | 6 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4200 | TRPC6 | transient receptor potential cation channel, subfamily C, member 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4201 | TRPM1 | transient receptor potential cation channel, subfamily M, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4202 | TRPM2 | transient receptor potential cation channel, subfamily M, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4203 | TRPM3 | transient receptor potential cation channel, subfamily M, member 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4204 | TRPM4 | transient receptor potential cation channel, subfamily M, member 4 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4205 | TRPM5 | transient receptor potential cation channel, subfamily M, member 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4206 | TRPM6 | transient receptor potential cation channel, subfamily M, member 6 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
4207 | TRPM7 | transient receptor potential cation channel, subfamily M, member 7 | 1 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
4208 | TRPS1 | trichorhinophalangeal syndrome I | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
4209 | TRPV5 | transient receptor potential cation channel, subfamily V, member 5 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4210 | TRRAP | transformation/transcription domain-associated protein | 0 | 20 | 0 | 2,700 | 0 | 1.00 | 1.00 |
4211 | TSC1 | tuberous sclerosis 1 | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
4212 | TSC2 | tuberous sclerosis 2 | 2 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
4213 | TSC22D4 | TSC22 domain family, member 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4214 | TSEN2 | tRNA splicing endonuclease 2 homolog (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4215 | TSGA10 | testis specific, 10 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4216 | TSHR | thyroid stimulating hormone receptor | 0 | 41 | 0 | 5,535 | 0 | 1.00 | 1.00 |
4217 | TSHZ3 | teashirt zinc finger homeobox 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4218 | TSKS | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4219 | TSN | translin | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4220 | TSPAN14 | tetraspanin 14 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4221 | TSPAN4 | tetraspanin 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4222 | TSPAN8 | tetraspanin 8 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4223 | TSSK1B | testis-specific serine kinase 1B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4224 | TTBK1 | tau tubulin kinase 1 | 2 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
4225 | TTBK2 | tau tubulin kinase 2 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4226 | TTC12 | tetratricopeptide repeat domain 12 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4227 | TTC13 | tetratricopeptide repeat domain 13 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4228 | TTC15 | tetratricopeptide repeat domain 15 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4229 | TTC18 | tetratricopeptide repeat domain 18 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4230 | TTC27 | tetratricopeptide repeat domain 27 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4231 | TTC3 | tetratricopeptide repeat domain 3 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4232 | TTC35 | tetratricopeptide repeat domain 35 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4233 | TTC39A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4234 | TTK | TTK protein kinase | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4235 | TTLL10 | tubulin tyrosine ligase-like family, member 10 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4236 | TTLL12 | tubulin tyrosine ligase-like family, member 12 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4237 | TTLL2 | tubulin tyrosine ligase-like family, member 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4238 | TTLL3 | tubulin tyrosine ligase-like family, member 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4239 | TTLL5 | tubulin tyrosine ligase-like family, member 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4240 | TTN | titin | 173 | 79 | 0 | 10,665 | 0 | 1.00 | 1.00 |
4241 | TTPAL | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4242 | TUBB2A | tubulin, beta 2A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4243 | TUBB2B | tubulin, beta 2B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4244 | TUBGCP3 | tubulin, gamma complex associated protein 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4245 | TUBGCP6 | tubulin, gamma complex associated protein 6 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4246 | TULP1 | tubby like protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4247 | TUSC3 | tumor suppressor candidate 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4248 | TUT1 | terminal uridylyl transferase 1, U6 snRNA-specific | 3 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4249 | TWF1 | twinfilin, actin-binding protein, homolog 1 (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4250 | TWF2 | twinfilin, actin-binding protein, homolog 2 (Drosophila) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4251 | TXNDC15 | thioredoxin domain containing 15 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4252 | TXNDC3 | thioredoxin domain containing 3 (spermatozoa) | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4253 | TYK2 | tyrosine kinase 2 | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
4254 | TYR | tyrosinase (oculocutaneous albinism IA) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4255 | TYRO3 | TYRO3 protein tyrosine kinase | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4256 | TYRP1 | tyrosinase-related protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4257 | UAP1 | UDP-N-acteylglucosamine pyrophosphorylase 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4258 | UBA5 | ubiquitin-like modifier activating enzyme 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4259 | UBAP2L | ubiquitin associated protein 2-like | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4260 | UBE2G2 | ubiquitin-conjugating enzyme E2G 2 (UBC7 homolog, yeast) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4261 | UBE2H | ubiquitin-conjugating enzyme E2H (UBC8 homolog, yeast) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4262 | UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4263 | UBE2O | ubiquitin-conjugating enzyme E2O | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
4264 | UBE4A | ubiquitination factor E4A (UFD2 homolog, yeast) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4265 | UBE4B | ubiquitination factor E4B (UFD2 homolog, yeast) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4266 | UBOX5 | U-box domain containing 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4267 | UBP1 | upstream binding protein 1 (LBP-1a) | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4268 | UBQLN2 | ubiquilin 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4269 | UBR1 | ubiquitin protein ligase E3 component n-recognin 1 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4270 | UBR4 | ubiquitin protein ligase E3 component n-recognin 4 | 0 | 11 | 0 | 1,485 | 0 | 1.00 | 1.00 |
4271 | UBR5 | ubiquitin protein ligase E3 component n-recognin 5 | 7 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
4272 | UCHL1 | ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4273 | UGDH | UDP-glucose dehydrogenase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4274 | UGGT2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4275 | UGT1A9 | UDP glucuronosyltransferase 1 family, polypeptide A9 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4276 | UGT3A1 | UDP glycosyltransferase 3 family, polypeptide A1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4277 | UGT3A2 | UDP glycosyltransferase 3 family, polypeptide A2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4278 | UHRF2 | ubiquitin-like, containing PHD and RING finger domains, 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4279 | UIMC1 | ubiquitin interaction motif containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4280 | ULK1 | unc-51-like kinase 1 (C. elegans) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4281 | ULK2 | unc-51-like kinase 2 (C. elegans) | 1 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
4282 | UMPS | uridine monophosphate synthetase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4283 | UNC13B | unc-13 homolog B (C. elegans) | 6 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4284 | UNC45B | unc-45 homolog B (C. elegans) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4285 | UNC5B | unc-5 homolog B (C. elegans) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4286 | UNG | uracil-DNA glycosylase | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4287 | UPF2 | UPF2 regulator of nonsense transcripts homolog (yeast) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4288 | UPK3B | uroplakin 3B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4289 | UQCC | ubiquinol-cytochrome c reductase complex chaperone, CBP3 homolog (yeast) | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4290 | UQCR11 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4291 | UQCRC2 | ubiquinol-cytochrome c reductase core protein II | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4292 | URB2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 | |
4293 | USF1 | upstream transcription factor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4294 | USH1G | Usher syndrome 1G (autosomal recessive) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4295 | USH2A | Usher syndrome 2A (autosomal recessive, mild) | 13 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4296 | USP11 | ubiquitin specific peptidase 11 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4297 | USP16 | ubiquitin specific peptidase 16 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4298 | USP2 | ubiquitin specific peptidase 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4299 | USP24 | ubiquitin specific peptidase 24 | 2 | 6 | 0 | 810 | 0 | 1.00 | 1.00 |
4300 | USP26 | ubiquitin specific peptidase 26 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4301 | USP28 | ubiquitin specific peptidase 28 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4302 | USP29 | ubiquitin specific peptidase 29 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4303 | USP31 | ubiquitin specific peptidase 31 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4304 | USP35 | ubiquitin specific peptidase 35 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4305 | USP37 | ubiquitin specific peptidase 37 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4306 | USP38 | ubiquitin specific peptidase 38 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4307 | USP4 | ubiquitin specific peptidase 4 (proto-oncogene) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4308 | USP42 | ubiquitin specific peptidase 42 | 5 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4309 | USP43 | ubiquitin specific peptidase 43 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4310 | USP44 | ubiquitin specific peptidase 44 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4311 | USP47 | ubiquitin specific peptidase 47 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4312 | USP49 | ubiquitin specific peptidase 49 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4313 | USP53 | ubiquitin specific peptidase 53 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4314 | USP54 | ubiquitin specific peptidase 54 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4315 | USP6 | ubiquitin specific peptidase 6 (Tre-2 oncogene) | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4316 | USP8 | ubiquitin specific peptidase 8 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4317 | UTP20 | UTP20, small subunit (SSU) processome component, homolog (yeast) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4318 | UTS2R | urotensin 2 receptor | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4319 | UVRAG | UV radiation resistance associated gene | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
4320 | VAC14 | Vac14 homolog (S. cerevisiae) | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4321 | VANGL1 | vang-like 1 (van gogh, Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4322 | VAPB | VAMP (vesicle-associated membrane protein)-associated protein B and C | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4323 | VAT1L | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4324 | VAV1 | vav 1 guanine nucleotide exchange factor | 5 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
4325 | VAV2 | vav 2 guanine nucleotide exchange factor | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
4326 | VAV3 | vav 3 guanine nucleotide exchange factor | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4327 | VCAM1 | vascular cell adhesion molecule 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4328 | VCAN | versican | 12 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
4329 | VCL | vinculin | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4330 | VCPIP1 | valosin containing protein (p97)/p47 complex interacting protein 1 | 2 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
4331 | VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4332 | VEGFC | vascular endothelial growth factor C | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4333 | VEPH1 | ventricular zone expressed PH domain homolog 1 (zebrafish) | 0 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
4334 | VHL | von Hippel-Lindau tumor suppressor | 0 | 545 | 0 | 73,575 | 0 | 1.00 | 1.00 |
4335 | VIM | vimentin | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4336 | VIPAR | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4337 | VIPR2 | vasoactive intestinal peptide receptor 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4338 | VLDLR | very low density lipoprotein receptor | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4339 | VPRBP | Vpr (HIV-1) binding protein | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4340 | VPS13A | vacuolar protein sorting 13 homolog A (S. cerevisiae) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4341 | VPS13B | vacuolar protein sorting 13 homolog B (yeast) | 3 | 10 | 0 | 1,350 | 0 | 1.00 | 1.00 |
4342 | VPS18 | vacuolar protein sorting 18 homolog (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4343 | VPS24 | vacuolar protein sorting 24 homolog (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4344 | VPS41 | vacuolar protein sorting 41 homolog (S. cerevisiae) | 5 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4345 | VPS45 | vacuolar protein sorting 45 homolog (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4346 | VPS72 | vacuolar protein sorting 72 homolog (S. cerevisiae) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4347 | VRK1 | vaccinia related kinase 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4348 | VSIG2 | V-set and immunoglobulin domain containing 2 | 0 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
4349 | VTN | vitronectin | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4350 | VWA2 | von Willebrand factor A domain containing 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4351 | VWA3A | von Willebrand factor A domain containing 3A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4352 | VWF | von Willebrand factor | 12 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4353 | WAC | WW domain containing adaptor with coiled-coil | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4354 | WARS | tryptophanyl-tRNA synthetase | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4355 | WASF2 | WAS protein family, member 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4356 | WBP11 | WW domain binding protein 11 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4357 | WBP4 | WW domain binding protein 4 (formin binding protein 21) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4358 | WBSCR17 | Williams-Beuren syndrome chromosome region 17 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4359 | WBSCR27 | Williams Beuren syndrome chromosome region 27 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4360 | WDFY1 | WD repeat and FYVE domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4361 | WDFY3 | WD repeat and FYVE domain containing 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4362 | WDR24 | WD repeat domain 24 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4363 | WDR34 | WD repeat domain 34 | 1 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
4364 | WDR44 | WD repeat domain 44 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4365 | WDR49 | WD repeat domain 49 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4366 | WDR52 | WD repeat domain 52 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4367 | WDR53 | WD repeat domain 53 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4368 | WDR6 | WD repeat domain 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4369 | WDR67 | WD repeat domain 67 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4370 | WDR69 | WD repeat domain 69 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4371 | WDR70 | WD repeat domain 70 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4372 | WDR72 | WD repeat domain 72 | 5 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4373 | WDR83 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4374 | WDR88 | WD repeat domain 88 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4375 | WDTC1 | WD and tetratricopeptide repeats 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4376 | WEE1 | WEE1 homolog (S. pombe) | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4377 | WEE2 | WEE1 homolog 2 (S. pombe) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4378 | WFDC1 | WAP four-disulfide core domain 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4379 | WFS1 | Wolfram syndrome 1 (wolframin) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4380 | WHSC1 | Wolf-Hirschhorn syndrome candidate 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4381 | WIF1 | WNT inhibitory factor 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4382 | WISP1 | WNT1 inducible signaling pathway protein 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4383 | WISP2 | WNT1 inducible signaling pathway protein 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4384 | WNK1 | WNK lysine deficient protein kinase 1 | 6 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
4385 | WNK2 | WNK lysine deficient protein kinase 2 | 1 | 7 | 0 | 945 | 0 | 1.00 | 1.00 |
4386 | WNK3 | WNK lysine deficient protein kinase 3 | 6 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
4387 | WNK4 | WNK lysine deficient protein kinase 4 | 2 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4388 | WNT10B | wingless-type MMTV integration site family, member 10B | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4389 | WNT11 | wingless-type MMTV integration site family, member 11 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4390 | WNT16 | wingless-type MMTV integration site family, member 16 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4391 | WNT2 | wingless-type MMTV integration site family member 2 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4392 | WNT5B | wingless-type MMTV integration site family, member 5B | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4393 | WNT6 | wingless-type MMTV integration site family, member 6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4394 | WNT8B | wingless-type MMTV integration site family, member 8B | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4395 | WNT9A | wingless-type MMTV integration site family, member 9A | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4396 | WRN | Werner syndrome | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4397 | WT1 | Wilms tumor 1 | 0 | 185 | 0 | 24,975 | 0 | 1.00 | 1.00 |
4398 | WWC1 | WW and C2 domain containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4399 | WWC2 | WW and C2 domain containing 2 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4400 | WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4401 | XAB2 | XPA binding protein 2 | 3 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4402 | XBP1 | X-box binding protein 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4403 | XDH | xanthine dehydrogenase | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
4404 | XIAP | X-linked inhibitor of apoptosis | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4405 | XIRP1 | xin actin-binding repeat containing 1 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4406 | XIRP2 | xin actin-binding repeat containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4407 | XKRX | XK, Kell blood group complex subunit-related, X-linked | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4408 | XPO1 | exportin 1 (CRM1 homolog, yeast) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4409 | XPO4 | exportin 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4410 | XPO5 | exportin 5 | 1 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4411 | XPO7 | exportin 7 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4412 | XRCC1 | X-ray repair complementing defective repair in Chinese hamster cells 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4413 | XRCC4 | X-ray repair complementing defective repair in Chinese hamster cells 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4414 | XRCC5 | X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining; Ku autoantigen, 80kDa) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4415 | XRCC6 | X-ray repair complementing defective repair in Chinese hamster cells 6 (Ku autoantigen, 70kDa) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4416 | YES1 | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4417 | YIPF1 | Yip1 domain family, member 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4418 | YSK4 | yeast Sps1/Ste20-related kinase 4 (S. cerevisiae) | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
4419 | YTHDC2 | YTH domain containing 2 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4420 | YWHAB | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4421 | YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4422 | YY2 | YY2 transcription factor | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4423 | ZAK | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 | |
4424 | ZAN | zonadhesin | 13 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4425 | ZAP70 | zeta-chain (TCR) associated protein kinase 70kDa | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4426 | ZBTB16 | zinc finger and BTB domain containing 16 | 4 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4427 | ZBTB24 | zinc finger and BTB domain containing 24 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4428 | ZBTB3 | zinc finger and BTB domain containing 3 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4429 | ZBTB33 | zinc finger and BTB domain containing 33 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4430 | ZBTB4 | zinc finger and BTB domain containing 4 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4431 | ZBTB41 | zinc finger and BTB domain containing 41 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4432 | ZBTB46 | zinc finger and BTB domain containing 46 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4433 | ZC3H11A | zinc finger CCCH-type containing 11A | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4434 | ZC3H12B | zinc finger CCCH-type containing 12B | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4435 | ZC3H13 | zinc finger CCCH-type containing 13 | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4436 | ZC3H3 | zinc finger CCCH-type containing 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4437 | ZC3H6 | zinc finger CCCH-type containing 6 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4438 | ZC3H7B | zinc finger CCCH-type containing 7B | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4439 | ZCCHC14 | zinc finger, CCHC domain containing 14 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4440 | ZCCHC24 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4441 | ZDHHC14 | zinc finger, DHHC-type containing 14 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4442 | ZDHHC4 | zinc finger, DHHC-type containing 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4443 | ZDHHC5 | zinc finger, DHHC-type containing 5 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4444 | ZDHHC7 | zinc finger, DHHC-type containing 7 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4445 | ZEB1 | zinc finger E-box binding homeobox 1 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4446 | ZEB2 | zinc finger E-box binding homeobox 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4447 | ZFAT | zinc finger and AT hook domain containing | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4448 | ZFC3H1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4449 | ZFHX4 | zinc finger homeobox 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4450 | ZFP106 | zinc finger protein 106 homolog (mouse) | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4451 | ZFP82 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4452 | ZFPM1 | zinc finger protein, multitype 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4453 | ZFYVE20 | zinc finger, FYVE domain containing 20 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4454 | ZFYVE26 | zinc finger, FYVE domain containing 26 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4455 | ZFYVE9 | zinc finger, FYVE domain containing 9 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
4456 | ZHX2 | zinc fingers and homeoboxes 2 | 5 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4457 | ZIC1 | Zic family member 1 (odd-paired homolog, Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4458 | ZIC3 | Zic family member 3 heterotaxy 1 (odd-paired homolog, Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4459 | ZIK1 | zinc finger protein interacting with K protein 1 homolog (mouse) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4460 | ZMAT4 | zinc finger, matrin type 4 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4461 | ZMIZ1 | zinc finger, MIZ-type containing 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4462 | ZMYM4 | zinc finger, MYM-type 4 | 2 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
4463 | ZMYND10 | zinc finger, MYND-type containing 10 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
4464 | ZMYND8 | zinc finger, MYND-type containing 8 | 1 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
4465 | ZNF10 | zinc finger protein 10 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4466 | ZNF155 | zinc finger protein 155 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4467 | ZNF160 | zinc finger protein 160 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4468 | ZNF17 | zinc finger protein 17 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4469 | ZNF18 | zinc finger protein 18 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4470 | ZNF182 | zinc finger protein 182 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4471 | ZNF189 | zinc finger protein 189 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
4472 | ZNF217 | zinc finger protein 217 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4473 | ZNF22 | zinc finger protein 22 (KOX 15) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4474 | ZNF232 | zinc finger protein 232 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4475 | ZNF25 | zinc finger protein 25 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4476 | ZNF277 | zinc finger protein 277 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4477 | ZNF28 | zinc finger protein 28 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4478 | ZNF280C | zinc finger protein 280C | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4479 | ZNF281 | zinc finger protein 281 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4480 | ZNF286A | zinc finger protein 286A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4481 | ZNF295 | zinc finger protein 295 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4482 | ZNF318 | zinc finger protein 318 | 5 | 5 | 0 | 675 | 0 | 1.00 | 1.00 |
4483 | ZNF333 | zinc finger protein 333 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4484 | ZNF33A | zinc finger protein 33A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4485 | ZNF343 | zinc finger protein 343 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4486 | ZNF358 | zinc finger protein 358 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4487 | ZNF366 | zinc finger protein 366 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4488 | ZNF384 | zinc finger protein 384 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
4489 | ZNF385D | zinc finger protein 385D | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4490 | ZNF423 | zinc finger protein 423 | 11 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4491 | ZNF43 | zinc finger protein 43 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4492 | ZNF431 | zinc finger protein 431 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4493 | ZNF432 | zinc finger protein 432 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4494 | ZNF436 | zinc finger protein 436 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4495 | ZNF438 | zinc finger protein 438 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4496 | ZNF442 | zinc finger protein 442 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4497 | ZNF454 | zinc finger protein 454 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4498 | ZNF471 | zinc finger protein 471 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4499 | ZNF473 | zinc finger protein 473 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4500 | ZNF480 | zinc finger protein 480 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4501 | ZNF496 | zinc finger protein 496 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4502 | ZNF497 | zinc finger protein 497 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4503 | ZNF507 | zinc finger protein 507 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4504 | ZNF521 | zinc finger protein 521 | 8 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4505 | ZNF532 | zinc finger protein 532 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4506 | ZNF540 | zinc finger protein 540 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4507 | ZNF543 | zinc finger protein 543 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4508 | ZNF546 | zinc finger protein 546 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4509 | ZNF547 | zinc finger protein 547 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4510 | ZNF558 | zinc finger protein 558 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4511 | ZNF560 | zinc finger protein 560 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4512 | ZNF569 | zinc finger protein 569 | 1 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4513 | ZNF572 | zinc finger protein 572 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4514 | ZNF585A | zinc finger protein 585A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4515 | ZNF608 | zinc finger protein 608 | 0 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
4516 | ZNF614 | zinc finger protein 614 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4517 | ZNF624 | zinc finger protein 624 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4518 | ZNF630 | zinc finger protein 630 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4519 | ZNF644 | zinc finger protein 644 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4520 | ZNF645 | zinc finger protein 645 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4521 | ZNF646 | zinc finger protein 646 | 2 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4522 | ZNF649 | zinc finger protein 649 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4523 | ZNF668 | zinc finger protein 668 | 1 | 4 | 0 | 540 | 0 | 1.00 | 1.00 |
4524 | ZNF675 | zinc finger protein 675 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4525 | ZNF687 | zinc finger protein 687 | 0 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4526 | ZNF708 | zinc finger protein 708 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4527 | ZNF746 | zinc finger protein 746 | 3 | 3 | 0 | 405 | 0 | 1.00 | 1.00 |
4528 | ZNF750 | zinc finger protein 750 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4529 | ZNF75A | zinc finger protein 75a | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4530 | ZNF763 | zinc finger protein 763 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4531 | ZNF786 | zinc finger protein 786 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4532 | ZNF79 | zinc finger protein 79 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4533 | ZNF804A | zinc finger protein 804A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4534 | ZNF831 | zinc finger protein 831 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4535 | ZNF835 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4536 | ZNF839 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4537 | ZNF85 | zinc finger protein 85 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4538 | ZNF862 | 1 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4539 | ZNHIT1 | zinc finger, HIT type 1 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4540 | ZNHIT2 | zinc finger, HIT type 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4541 | ZNHIT6 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4542 | ZP2 | zona pellucida glycoprotein 2 (sperm receptor) | 3 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4543 | ZRANB1 | zinc finger, RAN-binding domain containing 1 | 2 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4544 | ZSCAN16 | zinc finger and SCAN domain containing 16 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4545 | ZSCAN2 | zinc finger and SCAN domain containing 2 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4546 | ZSCAN20 | zinc finger and SCAN domain containing 20 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4547 | ZSCAN5A | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 | |
4548 | ZSWIM4 | zinc finger, SWIM-type containing 4 | 0 | 2 | 0 | 270 | 0 | 1.00 | 1.00 |
4549 | ZW10 | ZW10, kinetochore associated, homolog (Drosophila) | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
4550 | ZZZ3 | zinc finger, ZZ-type containing 3 | 0 | 1 | 0 | 135 | 0 | 1.00 | 1.00 |
Notes
n = number of mutations in this gene in the individual set
cos = number of unique mutated sites in this gene in COSMIC
n_cos = overlap between n and cos
N_cos = number of individuals × cos
cos_ev = total evidence: number of reports in COSMIC for mutations seen in this gene
p = p-value for seeing the observed amount of overlap in this gene
q = q-value, False Discovery Rate (Benjamini-Hochberg procedure)